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ON THE NATURE OF THINGS  
Titus Lucretius Carus (c.99-55 BCE) 
Rewritten into poem form by anonymous. 
 
No single thing abides; but all things flow. 
Fragment to fragment clings - the things thus grow 
Until we know and name them. By degrees  
They melt, and are no more the things we know. 
 
Globed from the atoms falling slow or swift 
I see the suns, I see the systems lift 
Their forms; and even the systems and the suns 
Shall go back slowly to the eternal drift. 
 
You too, oh earth - your empires, lands, and seas - 
Least with your stars, of all the galaxies, 
Globed from the drift like these, like these you too 
Shalt go. You are going, hour by hour, like these. 
 
The seeds that once were we take flight and fly,  
Winnowed to earth, or whirled along the sky, 
Not lost but disunited. Life lives on.  
It is the lives, the lives, the lives, that die. 
 
Flakes of the water, on the waters cease!  
Soul of the body, melt and sleep like these. 
Atoms to atoms - weariness to rest -  
Ashes to ashes - hopes and fears to peace! 
 
O Science, lift aloud your voice that stills 
The pulse of fear, and through the conscience thrills-  
Thrills through the conscience with the news of peace-  
How beautiful your feet are on the hills! 
 
 
 
This poem is a shortened version of Titus Lucretius Carus’ (c.99-55 BCE ) epic “De rerum natura” 
which describes ”everything in nature”: the physical origin of the universe, the atomic structure of 
matter and the emergence and evolution of life forms.  
 
 
 
While this is a rather broad topic, this thesis has a more limited focus.... 
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 SAMMENFATNING 
Pseudomonas aeruginosa er en opportunistisk patogen, der forårsager kronisk lungebetændelse 
i patienter med cystisk fibrose og livstruende infektioner i personer med et svækket 
immunforsvar. Denne bakterie er i stand til at producere en lang række skadelige 
virulensfaktorer såsom toksiner, vævsnedbrydende enzymer samt produkter, der kan svække 
værtens immunsystem. P. aeruginosa vokser primært som vækstbelægninger, såkaldte biofilm, 
hvilket beskytter den mod værtens immunforsvar og mod antimikrobielle stoffer. Dertil 
kommer at P. aeruginosa har en naturlig høj tolerance overfor mange af de typer af antibiotika, 
der bruges mest, hvilket understreger behovet for nye strategier, der kan benyttes til at 
bekæmpe denne sygdomsfremkaldende bakterie. 
 
P. aeruginosa der lever i en biofilm udviser en organiseret adfærd, der minder om flercellede 
organismer. P. aeruginosa regulerer udtryk af virulensfaktorer, elementer involveret i 
biofilmdannelse og produkter som påvirker immunforsvaret via en form for bakteriel 
kommunikation kaldet quorum sensing. Denne afhandling omhandler bl.a. en strategi, der 
søger at modvirke P. aeruginosas virulens og sygdomsfremkaldende egenskaber ved at 
forhindre bakterierne i at kommunikere. En behandlingsform, der er målrettet mod bakteriel 
kommunikation fremfor bakteriel vækst har den fordel at den ikke medfører det voldsomme 
selektionspres for udvikling af resistens som eller er det primære problem ved den 
konventionelle brug af antibiotika. 
 
De to første artikler i denne afhandling (artikel 1 og 2) beskriver screeningen af ekstrakter fra 
eukaryoter (skimmelsvampe og marine hvirvelløse organismer) for tilstedeværelsen af quorum 
sensing hæmmere. Som det fremgår af disse to artikler ser det ud til at molekyler med 
inhiberende effekt på bakteriel kommunikation er hyppigt forekommende blandt eukaryoter, 
hvilket indikerer at evnen til at interagere med koordineret bakteriel adfærd giver højere 
organismer en evolutionær fordel. Quorum sensing antagonister såsom de to mykotoksiner 
patulin og penicillinsyre (artikel 1) og de tre manoalid-forbindelser (artikel 2) har 2(5H)-
furanon-strukturen tilfælles. Da denne struktur forefindes i så forskellige organismer indikerer 
det at evnen til at producere denne furanon-type enten er opstået parallelt i forskellige 
organismer eller er en reminiscens fra en gammel fælles oprindelse for såvel marine 
organismer som skimmelsvampe og at dette træk pga. selektion er bevaret gennem tiderne.  
 
De fleste typer af antibiotika, der anvendes nu til dags stammer fra naturlige kilder. Det antages 
almindeligvis at antibiotika er evolveret i naturen som en del af et forsvar mod konkurrenter i 
kampen om føde og plads. Denne formodning er dog for nylig blevet udfordret og det er istedet 
foreslået at antibiotikas økologiske rolle er som budbringere fremfor våben. 
Artikel 3 i denne afhandling undersøger anvendelsen af lave koncentrationer af naturlige samt 
syntetiske antibiotika som hæmmere af bakteriel kommunikation og dermed også virkende 
mod virulensfaktorer. Tre slags antibiotika der ofte benyttes til at behandle infektioner med P. 
aeruginosa er i stand til at nedsætte produktionen af en række quorum sensing regulerede 
virulensfaktorer når de benyttes i koncentrationer, der ikke påvirker bakteriernes vækst. Dette 
indikerer at antibiotika muligvis har multiple anvendelsesmuligheder; som stoffer der slår 
bakterier ihjel eller hæmmer deres vækst og som antagonister af bakteriel kommunikation og 
dermed inhibitorer af sygdomsfaktorer. Det er således rimeligt at formode at vi end ikke fuldt 
ud udnytter potentialet af det medikamenter vi allerede kender. 
 
Som beskrevet i det sidste manuskript i denne afhandling (artikel 4) så producerer P. 
aeruginosa også stoffer med multifunktionelle egenskaber; de to quorum sensing 
signalmolekyler; Pseudomonas Quinolone Signal og N-3-oxododecanoyl L-homoserine lakton 
 
  
kan påvirke immunforsvaret udover deres funktion som budbringere af bakteriel 
kommunikation. Disse to signalmolekyler er i stand til at svække aktiviteter essentielle for 
immunforsvarscellernes evne til at bekæmpe bakterieinfektioner, og dette fænomen bidrager 
muligvis til P. aeruginosa evne til at etablere en infektion. 
 
Nøglen til at bekæmpe denne bakterie kan meget vel ligge i udviklingen af en ny form for 
behandling der søger at bekæmpe denne patogens koordinerede adfærd, dens produktion af 
virulensfaktorer og dens evne til at svække værtens immunforsvar. Denne nøgle findes 
formodentlig allerede og er ”lige til at samle op”, hvis man søger blandt eukaryoter der har 
udviklet evnen til at producere quorum sensing antagonister.  
 
 
 
 
 
 
 SUMMARY 
Pseudomonas aeruginosa is an increasingly prevalent opportunistic pathogen which causes 
chronic pneumonia in cystic fibrosis patients and severe life-threatening infections in 
immunocompromised persons. This pathogen produces a range of malicious virulence factors 
such as toxins, tissue degrading enzymes and components capable of impairing the hosts’ 
immunity. P. aeruginosa readily assumes the biofilm lifestyle which confers efficient 
protection against the activity of the host defence system. In addition, P. aeruginosa exhibit an 
inherent tolerance to many of the antibiotics most commonly used, which emphasises the 
urgent need for development of novel strategies that will help us to defeat this pathogen.  
 
P. aeruginosa biofilm cells display a multicellular-like coordinated behaviour and control 
expression of virulence factors, elements involved in biofilm development and 
immunomodulating factors by means of signal molecule mediated communication, known as 
quorum sensing.  This thesis explores a strategy which aims to counteract P. aeruginosa 
virulence and pathogenicity by impeding its cell-to-cell communication. A treatment regime, 
which focuses on targeting bacterial communication instead of growth, has the immediate 
advantage that it does not impose a harsh selection pressure for resistance which is the main 
drawback of conventional antibiotics.  
 
The first two articles included in the present thesis (article 1 and 2) describe the screening of 
extracts of eukaryotic organisms (microfungi and marine invertebrates) for the presence of 
quorum sensing antagonists. As revealed in these two articles, production of compounds 
capable of interfering with bacterial communication seems to be common among eukaryotes, 
supporting the idea that the ability interact with coordinated bacterial behaviour provides 
higher organisms with an evolutionary advantage. Interestingly, quorum sensing inhibitors 
such as patulin and penicillic acid (article 1) and the three manoalide compounds (article 2) 
share the 2(5H)-furanone moiety. Since these furanones are found in extracts of diverse groups 
of organisms, it suggests that the ability to produce them either has evolved in parallel in 
different organisms or that the ability to produce such compounds is a reminiscence of an 
ancient shared ancestor (of a range of marine invertebrates and microfungi), the trait of which 
has been maintained through times by selective forces. 
 
Most of the antibiotics used today originate from natural sources. The general assumption is 
that antibiotics have evolved in nature to counteract growth of competitors; however, this idea 
has recently been challenged, and it has been suggested that the ecological role of antibiotics is 
as communication messengers instead of defeating competitors.  
Article 3 included in this thesis investigates the application of low concentrations of natural as 
well as synthetic antibiotics as inhibitors of bacterial communication and in turn production of 
virulence factors. Three renowned antibiotics which are frequently used in the clinic to treat P. 
aeruginosa infections were found to decrease the expression and production of a range of 
quorum sensing regulated virulence factors when administered in subminimum inhibitory 
concentrations. This suggest that antibiotics may display dual activities; as bactericidal or 
bacteriostatic agents and as antagonists of bacterial communication. Taking this into account, it 
is fair to assume that we have not even fully explored and exploited the potential of the drugs 
we know today.  
 
As described in the final manuscript (article 4), P. aeruginosa also produces multifunctional 
compounds; two quorum sensing signal molecules; the Pseudomonas Quinolone Signal and N-
3-oxododecanoyl L-homoserine lactone exhibit the ability to modulate activities of the immune 
defence in addition to functioning as quorum sensing mediators. The two signal molecules 
 
 impair activities of immune cells crucial for the pro-inflammatory and antibacterial responses 
of the host, and this phenomenon may contribute to the successful establishment of P. 
aeruginosa in its host.  
 
The key to combat this bacterium may lay in the development of a novel chemotherapy which 
aims at impeding the coordinated behaviour of this pathogen, its production of virulence 
factors and its ability to alter the response of the immune defence. This key probably already 
exists and may be found among eukaryotic organisms which have evolved to produce quorum 
sensing antagonists. 
 
  
INTRODUCTION 
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INTRODUCTION 
Last century started with the promising prospect of antibiotics as highly efficient drugs for 
treatment of bacterial infections, but closed with the gloomy scenario of rapid development of 
multi-resistant bacteria. The discovery of antibiotics undoubtedly opened one of the greatest 
medical breakthroughs of the last century. Antibiotics however, target the ability of bacteria to 
grow and proliferate, thus such compounds also induce a simple “survival of the fittest” 
selection for the bacteria to evolve mechanisms to withstand this effect. The American Food 
and Drug Administration (FDA) has proposed that if action is not taken to prevent it, the 
increasing emergence of antibiotic resistant bacteria could make us face previously treatable 
diseases that have again become untreatable, as in the days before antibiotics were developed. 
Moreover, according to FDA around 70 % of the bacteria causing infections in hospitals are 
currently resistant to one or more of the drugs most commonly used. Thus, there is an urgent 
need to find new strategies to defeat pathogenic bacteria based on principles that are unlikely to 
impose selection pressures for the bacteria to develop tolerance against them. 
 
One strategy is the development of anti-pathogenic drugs which function to attenuate bacteria 
with respect to virulence rather than defeating bacterial growth. One such target is 
interbacterial communication known as quorum sensing, used by many Gram-negative 
pathogens to synchronise expression of virulence genes in response to the density of the 
surrounding bacterial population (287). Obstruction of cell-to-cell communication, and thus 
virulence factor production, may prevent bacterial establishment of a successful invasion and 
improve the prospects of the host’s immune system to clear the bacterial infection, particularly 
if this strategy is used in combination with conventional antibiotics (134). Proof of this concept 
has been provided by several in vivo experiments; e.g. applying the pulmonary infection model 
where mice are intratracheally challenged with bacteria embedded in alginate beads resembling 
the initial stages of a chronic lung infection (292). Mice infected this way with P. aeruginosa 
and treated with compounds inhibiting quorum sensing clear the bacteria faster and have lower 
mortalities than untreated mice similarly infected. (Described in article 1 and (134, 322, 426)). 
 
Besides being an increasing medical challenge, the opportunistic pathogen P. aeruginosa is an 
important model organism for analysing the impact of environmental conditions on the 
expression of virulence factors. P. aeruginosa is often responsible for very persistent infections 
especially in immunocompromised patients, partly due to its intrinsic resistance against most 
applied antibiotics. Another very remarkable and important feature of this organism is its 
ability to interact with eukaryotic cells. Notably it has been shown that P. aeruginosa, via 
quorum sensing signal molecules, affects functions of the immune system in mammalian 
organisms (359, 378). By interfering with the immune defence, P. aeruginosa may improve its 
prospects for surviving the hostile environment within the host. The pathogenic properties of 
this bacterium are however, not restricted to mammalian hosts; P. aeruginosa has been shown 
to cause disease in the nematode Caenorhabditis elegans, the fruit fly Drosophila 
melanogaster and the plant Arabidopsis thaliana (16, 62, 306, 315). In addition, P. aeruginosa 
strains have been shown to inhibit the growth of a broad spectrum of phytopathogenic fungi 
(21, 176).  
 
Bacteria living in association with eukaryotes (such as soil bacteria and pathogens) often use 
quorum sensing to coordinate their activities, including the production of compounds 
potentially detrimental to other organisms. In order to defend themselves and their habitat, 
eukaryotes devoid of cell mediated immune defences produce bioactive compounds that can 
counteract menacing bacteria and/or their virulence. Thus a logical place to search for quorum 
sensing antagonists is in natural libraries of chemically rich organisms such as fungi, plants and 
INTRODUCTION 
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marine invertebrates. This application of one aspect of prokaryotic-eukaryotic interaction has 
been explored in article 1 and 2 included in this thesis. Article 1 “Identity and Effects of 
Quorum Sensing Inhibitors Produced by Penicillium Species” entail the screening of extracts 
of microfungi for the presence of quorum sensing inhibitors. Two secondary fungal metabolites, 
patulin and penicillic acid, are identified as efficient inhibitors of quorum sensing. Article 2 
“Quorum sensing antagonism from marine organisms“ describes the results of screening 284 
organisms from the Great Barrier Reef where three sesterterpenoid compounds were found to 
be highly active. Intriguingly, one of these bioactive manoalides were already known to be a 
potent inhibitor of human phospholipase A2 (IC50 0.02-0.2 µM) and thus hold potential for 
treatments against autoinflammatory conditions such as rheumatoid arthritis along with the 
ability to inhibit quorum sensing (153). Other examples of drugs capable of affecting multiple 
targets are described in the third article “Effects of antibiotics on quorum sensing in 
Pseudomonas aeruginosa”. This article demonstrates that although antibiotics are 
conventionally used to kill or inhibit growth of microorganisms some may also have 
applications as antagonists of bacterial cell-to-cell communication. The last manuscript, article 
4 “Pseudomonas aeruginosa Quorum Sensing Signal Molecules interfere with dendritic cell 
induced T cell proliferation” also deal with dual functioning compounds. As is demonstrated in 
this study, OdDHL and PQS are not only functioning as quorum sensing signal molecules, they 
also have the capacity to alter the immune defence of the host. 
 
The intention of this thesis is to explore the interaction between the prokaryote P. aeruginosa 
(mediated via its signal molecules) and cells of the immune defence. It also investigates the 
potential of using signal antagonists derived from natural sources (eukaryotic organisms) to 
prevent bacterial quorum sensing. As demonstrated in this thesis; P. aeruginosa is, via its cell 
to cell communication, intertwined with higher organisms in a network of cross-kingdom 
interactions, and this may - at least partly - explain why this microbe is a rather successful 
opportunistic pathogen which is difficult to combat with the present day technologies. At the 
same time these cross-kingdom interactions offer a solution to counteracting P. aeruginosa 
infections by targeting communication of this bacterium, e.g. by using naturally evolved 
quorum sensing antagonists.  
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THE PATHOGEN P. AERUGINOSA 
hy individuals, but has been found in relation to 
 AERUGINOSA AND YSTIC FIBROSIS
ecessive disease and, according to Centers for Disease 
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Pseudomonas aeruginosa is a single flagellated Gram-negative rod belonging to the family 
Pseudomonadaceae as a part of the γ-proteobacteria. (See figure 1). It is an aerobic bacterium; 
but during oxygen limitations it is able to exploit nitrite/nitrate as terminal electron acceptors 
(124, 208). The optimum growth temperature for P. aeruginosa is 37 °C, it can, however, grow 
even at temperatures as high as 43 °C. It inhabits a wide variety of ecological niches such as 
soil, vegetation and aquatic environments and it is capable of causing disease in many 
eukaryotic organisms e.g. plants, insects and humans (62, 306, 315). 
 
Figure 1. P. aeruginosa is a single flagellated aerobic rod. Each 
cell measures 0.5 to 0.8 μm by 1.5 to 3.2 μm. (Phase Imaging 
Atomic Force Microscopy of dry PAO1
F
 
 
The sequenced P. aeruginosa PAO1 strain has a 
genome sized 6.3 million base pairs and 5570 
predicted ORFs (Open Reading Frames) thus its 
genome is almost 50 % larger than the Escherichia 
coli genome. Moreover, the P. aeruginosa genome 
contains a high proportion of regulatory genes (8.4 % 
of predicted ORFs) which is presumed to contribute 
to its adaptability, broad host range and high intrinsic 
resistance to a wide range of antimicrobial substances
around 5 % of the genes in E. coli and Bacillus subtilis
0.3% of the total ORFs in PAO1 code for proteins in
pathogenic potential of this versatile bacterium is also r
encoding secreted virulence factors such as toxins and tissue degrading enzymes including 
proteases and elastases (371). 
 (121, 178, 371). In comparison, only 
 are regulatory genes (371). In addition, 
volved in antimicrobial resistance. The 
eflected by the high number of genes 
P. aeruginosa seldom infects healt
periodontitis and to be the cause of keratitis among users of contact lenses (22, 98, 383, 416). 
Over the last few decades, P. aeruginosa has emerged as a major opportunistic human 
pathogen accounting for a high number of hospital-acquired infections, especially at intensive 
care units (122, 213, 338, 387). This bacterium often infects decubitus ulcers and burns wounds 
thereby retarding healing or even causing enlargement of the wounds (64). P. aeruginosa 
infections are also commonly found among immune suppressed individuals e.g. AIDS patients 
or cancer patients undergoing chemotherapy. It is also the predominant cause of pneumonia in 
persons afflicted by Cystic Fibrosis where it is the main source of morbidity and mortality due 
to lung failure caused by prolonged P. aeruginosa infection (142, 171, 205)  
P. C  
Cystic fibrosis (CF) is an autosomal r
Control and Prevention (CDC), the incidence rate is 1: 2500 among non-Hispanic Caucasians 
and 1:13.000 and 1:15.000 among Hispanic Caucasians and African Americans, respectively 
(45). According to the Danish CF foundation there is around 435 CF patients in Denmark 
(www.cf-dk.org, 2007). The disease is caused by dysfunction of a cAMP-regulated chloride 
channel, CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) and more than 1500 
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different mutations leading to CF have until now been identified (1). CFTR is sited at the 
apical surface of epithelia cells including those located in the respiratory, gastrointestinal, 
hepatobiliary and reproductive systems where it is involved in electrolyte secretion and 
absorption across the epithelium. As the name implies the CFTR protein is a “conductance 
regulator” and thereby it affects many important transport systems involved in the maintenance 
of the basal state fluid balance. Inactivating mutations in CFTR result in an increased 
resorption and a decreased secretion of water, which among other serious effects leads to a 
lowered amount of fluid in the airways of patients suffering from CF (See figure 2). It is 
presumed that the reduced surface to liquid volume in the airways impairs ciliary function 
thereby reducing mucociliary clearance and creating the basis for recurrent infections (205). In 
young CF patients a variety of bacteria such as Haemophilus influenzae, Staphylococcus 
aureus and Streptococcus pneumonia cause pneumonia. From the age 10-14 P. aeruginosa 
becomes the predominant pathogen in the CF lung, sometimes followed by coinfection by 
Burkholderia cepacia (18, 97).  
 
 
Figure 2.  Mucociliary clearance in normal airway versus CF airway. In the normal airway, t ithelium is 
ther factors besides reduced bacterial clearing caused by high mucus viscosity might 
he ep
covered with a differentiated mucus layer with the upper part being more viscous. Concerted beating of the 
epithelial cell cilia causes the mucus to flow toward the esophagus and thereby removing the bacteria. In the CF 
airway the mucus layer is more uniformly viscous and the beating of the cilia are not sufficient to propel the 
mucus and bacteria towards the esophagus. (Figure adapted from (205)). 
 
O
predispose CF patients to chronic bacterial colonisation. It has been proposed that CFTR 
functions as an epithelial cell receptor for P. aeruginosa being involved in bacterial 
internalization and clearance from the lung and that the lack of this host factor in CF patients 
may be a critical factor for the hypersusceptibility of these patients to P. aeruginosa chronic 
lung infections (302-304). The increased bacterial survival in the CF lung may in part be 
caused by impaired phagocytic killing by neutrophils due to the elevated chloride 
concentration (375). CF airway epithelia have been reported to constitutively overexpress the 
transcription factor nuclear factor kappa B (NF-κB) which is a central player in inflammation. 
Increased NF-κB activity may be involved in the exaggerated interleukin-8 (IL-8) production 
reported in the CF lung leading to excessive neutrophil infiltration and thus tissue destruction 
(29, 374). Furthermore phosphorylation by the extracellular signal-regulated kinase (ERK) has 
been shown to increase in CF cell lines, probably causing an enhanced expression of 
proinflammatory cytokines such as IL-1β, IL-6 and IL-8 (394). It thus seems that, even in the 
absence of a bacterial infection, factors associated with the CFTR mutation cause an intrinsic 
inflammation. This is supported by a recent study which showed over-expression of 
proinflammatory proteins in the airways of a 24-week-old CF-fetus (393). 
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. aeruginosa produces several enzymes with elastolytic activity and besides causing structural 
Figure 3. Effects of elastases on host defence mechanisms and inflammation. Both bacteria and neutrophils 
F patients receive intensive antibiotic treatments and although the bacterial load decreases 
ANTIBIOTIC RESISTANCE IN P. AERUGINOSA STRAINS 
sm to grow in the presence of an 
irst of all, the permeability of the P. aeruginosa cell membrane is 10-100 fold lower than for 
P
damage the elastases also stimulate the production of pro-inflammatory mediators such as IL-8, 
which further induces neutrophilic influx. When present in excess during a prolonged period, 
neutrophils and their products, including released DNA from dying neutrophils, actually impair 
the host’s ability to clear bacterial infection and enhance P. aeruginosa biofilm production 
(246, 309, 403). Elastases also impair mucociliary clearance by direct effects on ciliary 
function and by inducing mucus production. Moreover, elastase inhibits opsonophagocytosis 
by cleaving of immunoglobulin G (386). (See figure 3).  
produce elastases. Besides destruction of epithelium tissue the hinge region of immunoglobulin G and 
complement receptors are cleaved by elastase (Figure from (54)). 
 
C
shortly after a treatment period the infection is never fully eradicated. Several factors account 
for this phenomenon such as P. aeruginosa’s intrinsic high tolerance to many clinically 
important antibiotics as well as its ability to develop resistance against antibacterial agents. 
Many clinical P. aeruginosa strains isolated from CF patients have a mucoid phenotype and 
secrete high amounts of polysaccharides such as alginate, which may protect the bacterium 
against antibiotics and actions of the immune defence. 
Resistance can be defined as the ability of a microorgani
elevated level of antimicrobials (195). As mentioned earlier, P. aeruginosa has an intrinsic 
high resistance against most antibiotics, which significantly contributes to eradication failure. 
Different mechanisms accounts for this inherent multi-drug resistance against a range of 
structurally and functionally different xenobiotics such as chloramphenicol, kanamycin, 
imipenem, tetracycline and many dyes (172, 173, 229, 313).  
 
F
other Gram-negative bacteria, and this protects it from harmful substances entering the cell 
(264). Other important factors adding to P. aeruginosa’s ability to tolerate high doses of 
xenobiotics are the constitutively expressed multidrug efflux pumps such as MexAB-OprM 
and Mex pumps induced by the presence of antibiotics such as MexXY–OprM, MexCD–OprJ 
and MexEF–OprN (263, 308). (For an outline of the P. aeruginosa MexAB-OprM efflux pump 
see figure 4). 
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igure 4. Schematic illustration of the MexAB-
anner by the use of proton motif force. (Figure 
which target the activity of antibiotics such as chromosomal β-lactamase present in 
ed (109, 
As outlined above, several intrinsic and acquired resistance elements add to the difficulties of 
y P. aeruginosa. Another important factor contributing to P. 
F
OprM efflux pump in P. aeruginosa. The efflux 
pump extrudes drugs in an energy-dependent 
m
adapted from (262).) 
 
Efflux is usually not considered to confer 
high levels of resistance, but due to cross 
resistance it may narrow down the choice 
antibiotics in the clinic (202). Induced 
efflux of antibiotics may also favour the 
emergence of target mutations due to 
lowered intra-bacterial antibiotic concentrat
PAO1 suggest that there may be as many as 
membrane proteins (OMPs) (371). OMPs h
transport of antibiotics, export of virulence fa
motility. 
 
In addition to these antibiotic evading mechanisms, P. aeruginosa has the ability to produce 
nzymes 
ions (261). Predictions based on the sequenced 
30 efflux systems in P. aeruginosa and 150 outer 
ave clinical relevance as they are involved in 
ctors and in anchoring mediators of adhesion and 
e
most clinical strains and aminoglycoside acetyltransferase (67, 122). Resistance to 
fluoroquinolones and aminoglycosides are often mediated by gene elements which enable the 
bacteria to modify targets of the antibiotic such as methylation of 16S rRNA and mutations in 
the DNA gyrase gyrA gene and the topoisomerase IV parC gene (81, 177, 247, 437).  
 
While P. aeruginosa definitely does not lack mechanisms to escape the actions of antibiotics, 
nly few novel antibiotics with antipseudomonal activity are currently being developo
229). This is certainly worrying, as infections caused by resistant strains are associated with a 
three-fold higher rate of mortality, a nine-fold higher rate of secondary bacteraemia and a two-
fold increase in the length of hospital stay (109) thus, besides the personal consequences for 
the patients, resistant strains also considerably increase healthcare costs. Unfortunately it seems 
that the frequencies of multidrug-resistant P. aeruginosa (defined as resistance to at least three 
main classes of antipseudomonal agents such as β-lactams, carbapenems, aminoglycosides and 
fluoroquinolones) are increasing worldwide, reaching frequencies of up to 20 % in intensive 
care units in the USA and >30 % in Asia (95, 222, 229, 269, 334). Faced with such a gloomy 
picture, the development of new therapeutic strategies, including drugs acting on new targets is 
urgently needed (168, 229). 
P. AERUGINOSA BIOFILMS 
eradicating infections caused b
aeruginosa pathogenesis in clinical settings is the biofilm mode of growth involved in chronic 
as well as in acute infections (342). Centers for Disease Control and Prevention (CDC) and 
National Institute of Health (NIH) estimate that 65-80 % of all human bacterial infections 
involve biofilms. Biofilms are defined as a microbially derived sessile community 
characterized by cells that are irreversibly attached to a substratum or interface or to each other, 
and embedded in a matrix of self-produced extracellular polymeric substances (EPS), and 
exhibit an altered phenotype with respect to growth rate and gene transcription (86). This mode 
of growth is likely to represent the prevalent form of microorganisms in nature, and visible to 
the naked eye, these microbial communities were among the first to be studied. 300 years ago 
Antoni van Leeuwenhoek scraped dental plaque from his teeth and observed the “animalculi” 
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ing microcolonies, 
evelopment of a highly differentiated structure (“towers” or “mushrooms”), maturation and 
producing this coating. Despite this old finding, bacteria have most often been studied in the 
laboratory as planktonic cells, freely suspended in liquid growth media. Rediscovery of the 
phenomena that microorganisms attach to and grow on surfaces has added new knowledge to 
understanding the true nature of bacterial living.  
 
Biofilm formation is a complex process involving several steps. These steps include attachment 
of the cells to substratum, growth and aggregation of cells form
d
maintenance of architecture, and release of cells subsequently followed by recolonisation of 
new areas (267, 339). (See Figure 5 for details). 
 
 
 
Figure 5. Biofilm development in P. aeruginosa. 1 Initial attachment to substratum, 2 the bacteria adhere to 
eachother 3 forming small microcolonies, 4 the three-dimensional structure of the mature biofim develops an 5 
ells are released (sloughing off) and recolonise new areas of substratum. (Graphic and photos by Peg Dirckx and 
 of the matrix depends 
n the phenotype of the bacteria producing the EPS. Mucoid P. aeruginosa strains overproduce 
c  
50 μm   50 μm 
d 
c
David Davies, Center for Biofilm Engineering, Montana State University, Bozeman.) 
 
The biofilm consists of heterogeneously distributed bacterial cells (cells constitute 5-20 % of 
the biofilm volume) embedded in an EPS matrix. The exact composition
o
the exopolysaccharide alginate (composed of uronic acid β-D-mannuronate and its C-5 epimer 
α-L-guluronate), whereas in the non-mucoid matrix the predominant exopolysaccharides are 
polymers of glucose and rhamnose (423). Also extracellular products such as proteins, nucleic 
acids, metabolites and absorbed nutrients are parts of the biofim matrix (142, 411). As a 
consequence of its complex structure the micro milieu are very heterogeneous throughout the 
biofilm, with gradients present from the waterfilled channels containing dissolved oxygen and 
nutrient into the base of the biofilm. Hence the metabolic state of the cells differs likewise. 
(See figure 6 describing the heterogeneity of the physiological activity within a P. aeruginosa 
biofilm). 
 
 
 
 a 
PSEUDOMONAS AERUGINOSA 
 
 
 
 
 
 
 
 
 
 24
Figure 6 Heterogeneity of the physiological activity within a P. aeruginosa biofilm. Frozen sections of biofilms 
examined by epifluorescent microscopy. Media flow at the top and substratum at the bottom. a Biofilm section 
post-stained with the DNA stain DAPI. Blue indicates the distribution of all cells independent of metabolic 
ry acti he 
 
 
 50 μm 
a b 
50 μm
c 
50 μm
activity. b Biofilm stained with 5-cyano 2,3-ditolyl tetrazolium chloride. Red indicates respiratory activity, mainly 
found at the top. c. Biofilm section post-stained with acridine orange. Orange/red indicates putative regions of 
rapid growth and green regions with slow or no growth. Yellow indicate an intermediate growth rate. In 
accordance with the respirato vity, rapid growth is found near t media flow. (Figure adapted from (430)). 
 
It has been shown that P. aeruginosa cells growing as biofilms tolerate 100-1000 times more 
antibiotics than their planktonic counterparts (15, 46, 145). By the conventional definition and
criterion of resistance as an increased Minimum Inhibitory Concentration (MIC), biofilm cells 
do not necessarily show increased resistance against antibiotics. However, the survival of cells 
in biofilms treated with antibiotics might be increased compared to planktonic cultures. Thus, 
most of the studies reporting elevated resistance of biofilm cells describe an increased 
tolerance to killing rather than growth inhibition (365). The mechanisms for the increased 
tolerance of biofilm living cells towards antibiotics are not fully elucidated. Several factors 
may contribute to the protection of cells in the biofilm mode of growth, perhaps also depending 
on the properties of various antibiotics. The matrix is assumed to reduce the diffusion of some 
antibiotics in a rate depending on the nature of the applied compounds and the biofilm matrix 
composition. An investigation by (210) showed that a P. aeruginosa strain with a mutation in 
the ndvB locus, required for the synthesis of periplasmic glucans, was unable to develop high-
level biofilm-specific resistance to tobramycin, gentamicin and ciprofloxacin. This suggest that 
the glucans sequester these antimicrobial agents in the periplasm, however this mechanism 
does not work for all antibiotics as the resistance of this strain against nalidixic acid was 
unchanged (210). 
 
Figure 7. Mechanisms suggested contributing to antibiotic resistance in 
biofilms. Slow penetration. Antibiotic (yellow) may fail to penetrate 
beyond the surface layers of the biofilm. Resistant phenotype. Some of 
the bacteria may differentiate into a protected phenotypic state (green) 
Altered microenviroment. In zones of nutrient depletion or waste product 
accumulation (red) antibiotic action may be antagonized. (From (367)). 
 
Aminoglycosides (like gentamicin and tobramycin) bind to 
the anionic polysaccharide in the matrix, reducing the free 
concentration of antibiotic being the driving force of the 
diffusion, and this might inhibit the distribution of these 
antimicrobials (152, 258). The biofilm matrix may confer a 
diffusion barrier and may contribute to the enhanced 
resistance of biofilm living cells, but it is probably not the 
sole explanation on the lowered sensitivity to antibiotics of 
biofilm living cells (366). However, if the decreased diffusion 
rate is combined with a rapid (enzymatic) degradation of the 
antimicrobial compound it could inhibit the penetration of  
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active antibiotics (12). Another hypothesis for the enhanced resistance is based on the earlier 
mentioned heterogeneous microenviroment within the biofilm, where the nutrients and waste 
products are unevenly distributed. The accumulation of waste products or the depletion of 
oxygen and/or nutrients may cause the bacteria to enter a non-growing state, and thereby 
protect them against killing by antibiotics targeting growth (388). (See figure 7). When the 
antibiotic treatment is ended, surviving cells start proliferating and restore the biofilm 
population. (Refer to figure 8).  
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igure 8.  Model of biofilm tolerance. An initial treatment with antibiotics kills planktonic cells and the majority 
 has been observed that even newly formed - and hence thin – biofilms protect the cells 
ultiple resistance mechanisms such as those mentioned above may act together to cause the 
 has been demonstrated that quorum sensing is crucial for the development of a normal 
F
of biofilm cells. The immune system may eradicate planktonic survivors, but the cells persisting in the biofilm are 
protected from the host defences by the EPS. When antibiotic concentration drops, these cells reestablish the 
biofilm and the infection relapses. (Figure from (195)). 
 
It
against killing even though the biofilm matrices at this stage are too thin to pose a barrier to the 
penetration of antibiotics and metabolic substrates (59, 65). However, a recent proteomic study 
shows that P. aeruginosa biofilm cells overall mostly seem to resemble exponentially growing 
planktonic cells (230). Collectively, this suggests that the biofilm mode of growth causes a 
minor subpopulation of cells within the biofilm to differentiate into a protected phenotype 
analogous to spore formation. 
 
M
improved tolerance to bactericidal agents of biofilms however, the multicellular nature of the 
biofilm is likely to play a central part in the explanation model. Lowered antibiotic penetration 
is dependent on the ability of the microorganisms to form aggregates to affect the diffusion rate. 
Local variations in the concentration of nutrients and waste products only exist if the cell 
clusters reach a critical mass. The existence of non-growing cells is dependent on the other 
cells in the biofilm to propagate the genome, whereas the growing cells depend on the dormant 
cells to re-establish the community after the event of catastrophic killing. Thus to treat biofilm 
related infections, the strategy should be targeted to the multicellular level involved in the 
development of the heterogeneous biofilms rather than essential functions of the individual 
cells.  
 
It
biofilm in P. aeruginosa and for the high tolerance to antibiotics of P. aeruginosa biofilms (66, 
281, 346). Therefore, potential therapies against biofilm infections could involve treatment 
with inhibitors of the signalling system. 
QUORUM SENSING 
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QUORUM SENSING  
In order to be able to survive under changing conditions and in hostile environments, bacteria 
have evolved systems to monitor and respond appropriately to environmental stimuli such as 
nutrients, stressors and - for some bacteria – cell density. The latter depends on small diffusible 
signal molecules constitutively produced by the bacteria, which interact with transcriptional 
activators to couple gene expression with cell population density. This enables the bacteria to 
function as a group and to some degree exhibit multicellular behaviour. This form of cell to 
cell communication is termed quorum sensing. In Gram-negative bacteria this phenomenon is 
mainly mediated by N-acyl L-homoserine lactones (AHLs), consisting of a conserved 
homoserine lactone ring with an N-acyl side chain. The AHLs predominantly vary in the 
presence or absence of a keto- or hydroxy- group on the C3 of the acyl chain and the length 
and saturation of this chain. (See figure 9). 
O
O
N
H
R1O
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Figure 9. General structure for the AHL signal molecule. R1 is -H, -OH or =O; R2 is (-CH2)1-13-CH3 or -CH2-CH2-
CH=CH-(CH2)5-CH3 
 
Also a number of Gram-positive bacteria apply signal mediators to coordinate behaviour with 
cell density. Gram-positive bacteria use peptides as ligands for the receptor of a two-
component signalling module thereby activating a complex adaptation response involving 
many genes (206). In the following however, the term ”quorum sensing” is exclusively used 
about AHL-mediated quorum sensing in Gram-negative bacteria, unless otherwise stated. 
 
Quorum sensing relies on two key proteins; the LuxR-homologue (the LuxR-type response 
regulator) which is the receptor protein recognising the signal molecules and the LuxI-
homologue synthesising the signal molecules (AHLs). The AHLs are produced constitutively 
at a basal low level, and are distributed in the cell and the surrounding environment either 
actively or by diffusion. Hence, the concentration of AHL increases with increasing cell 
density and reaching a certain level, corresponding to a "quorate" cell density, the signal 
molecule binds to the LuxR-homologue which thereby becomes activated. The activated 
complex then functions as a transcription factor, which binds to the promoter region of quorum 
sensing regulated genes triggering their expression (103).  
Quorum sensing was first identified in the marine symbiont bacteria V. fischeri (formerly 
Photobacterium fischeri) where the lux system controls the expression of bioluminescence 
(251, 252, 355). The signal molecule produced via the LuxI synthetase is 3-oxo-hexanoyl L-
homoserine lactone (OHHL) which binds to and activates LuxR. The OHHL-LuxR complex 
dimerizes and binds to the lux box located in the luxI promoter region thereby activating 
transcription of the lux operon; luxICDABEG, which leads to induction of luminescence. (See 
figure 10). Since luxI is a part of the lux operon, positive feed back regulation takes place and 
results in a burst of bioluminescence. Hence, the quorum sensing system is also termed an 
autoinducer system; even though not all of the cell-cell communication systems today known 
include autoinducing loops.  
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Figure 10.  The regulation of bioluminescence in V. fischeri. A. At low cell density, transcription of genes 
encoding bioluminescence (luxICDABEG) is weak and insufficient for light emission due to low levels of OHHL. 
B. At high cell density OHHL reaches a high concentration indicating that the population is “quorate” and OHHL 
binds to LuxR leading to transcription of luxICDABEG. This further causes amplification of OHHL and 
production of luminescence. Adapted from (412). 
 
Numerous Vibrio species are known to produce quorum sensing signals presumably to regulate 
expression of virulence factors including entero- and exotoxins and enzymes linked to 
pathogenicity (37, 61, 216). Full commercial exploitation of aquaculture is often hampered by 
bacterial infections caused by Vibrio species (117, 197). In collaboration with the Australian 
Institute of Marine Science I have recently investigated the presence of AHLs in tropical ornate 
rock lobster rearing tanks and in lobster larvae (phyllosomas). AHLs were first found to be 
produced within the biofilm attached to the rearing tank at day 7 and were then present through 
the remaining period of the 21 day larval-rearing run. Interestingly, quorum sensing inducing 
signals were first detected in the phyllosoma samples at day 9 to 12 although at low levels 
before being strongly expressed at day 15. This coincided with a mass mortality event within 
the larval-rearing tank and suggests that quorum sensing plays a significant role for the 
pathogenicity of aquaculture pathogens (32). 
 
Since the discovery of the lux quorum sensing system in V. fischeri, a number of Gram-
negative bacteria belonging to the α- β- and γ- subclasses of the proteobacteria have been 
found to produce LuxR and LuxI-type proteins (reviewed by (249)). However, not all the luxR 
type proteins are transcriptional activators, a few function as repressors of gene expression. 
Examples are EsaR of Pantoe stewartii and VirR of Erwinia carotovora ssp. atroseptica which 
govern the expression of specific target genes by repression and AHL-dependent derepression 
(39, 232, 397). 
 
E. coli and Salmonella enterica serovar Typhimurium both harbour a gene encoding a signal 
receptor of the LuxR family, SdiA, but not a corresponding signal-generating enzyme. Instead, 
it seems that SdiA enables these two organisms to respond to AHLs generated by other 
microbial species (8, 354, 390, 436). Besides interacting with AHL, the E. coli SdiA 
transcription factor also responds to a stationary phase signal; indole which is secreted in large 
quantities into rich medium by E. coli. Indole has been shown to control several genes (e.g., 
astD, tnaB, gabT), multi-drug exporters, and an E. coli pathogenicity island (50, 138, 188, 404). 
While indole seems to function as a repressor of E. coli biofilm formation it stimulates biofilm 
formation in pseudomonads and has thus been suggested to be an inter-species signal molecule 
(188). Interestingly, it has been shown that indole inhibits quorum sensing in the V. fischerii 
lux system (320). 
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e Research Collaboratory for Structural Bioinformatics. 
olecule diffuses freely or is 
As in V. fischeri, where the luminescence only develops when a sufficiently high cell 
population is reached to allow the presence of a visible light, it is presumed that quorum 
sensing in other bacteria controls the production of specific products which need to be present 
only at high cell density. For pathogenic bacteria it may be important to reduce production of 
virulence factors (which alarm the immune defence) until the cell population has reached a 
“critical mass” that can cope with the immune defence. This strategy is likely to minimise the 
hosts’ ability to mount a sufficient and effective defence against the invading bacteria (282, 
419, 442). Moreover, it is obviously also more cost-efficient to delay expression of 
“expensive” proteins until they are needed, that is, at dense cell populations. 
QUORUM SENSING IN P. AERUGINOSA 
Two AHL-mediated quorum sensing circuits have been identified in P. aeruginosa; the LasI-
LasR and the RhlI-RhlR system. They function in concert to control the expression of an array 
of genes, among these many genes encoding virulence factors (106, 181, 285). The final step in 
the synthesis of OdDHL (N-3-oxododecanoyl-L-homoserine lactone) and BHL (N-butanoyl-L-
homoserine lactone) are mediated by LasI and RhlI, respectively. Each system modulates a 
regulon comprising an overlapping set of genes. However, it is presumed that a regulatory 
hierarchy exists in which LasR-OdDHL activates the transcription of rhlR (180). Hence, genes 
controlled by the RhlI-RhlR system require a functional LasI-LasR system for full activation. 
Under phosphate-limiting conditions various transcriptional activators, including the global 
regulatory gene Vfr, the alternative sigma factor σ54 and RhlR itself participate in the 
regulation of rhlR expression (225). It has been shown in a heterologous genetic background (E. 
coli) that OdDHL is able to compete with BHL for the binding site of RhlR, and thus inhibit 
the translation of RhlR activated genes, indicating that LasI - through OdDHL - controls RhlR 
activity at a posttranslational level (295). Advancing the explanation of posttranscriptional 
control of the las system, it has been shown that RhlR forms homodimers both in the presence 
and absence of BHL, whereas OdDHL induce monomerization of the RhlR homodimer (392). 
LasR forms multimers only in the presence of OdDHL and this form is presumed to be the one 
responsible for its ability to function as a transcriptional activator (30, 169).  
 
The crystal structure of the ligand-binding domain (LBD) of LasR bound to OdDHL has 
recently been solved, showing that the LasR monomer structure resembles, to some degree, the 
LuxR homologues TraR (Agrobacterium tumefaciens) and SdiA (E. coli) but with differences 
in the quaternary organization and the positioning of the acyl chain (30). The LBD of the LasR 
protein bound to OdDHL is shown in figure 11. 
 
Figure 11. The tetramer structure of the ligand-binding 
domain of the LasR protein bound to OdDHL. (Accession 
number 2UV0. From www.rcsb.org/pd
th
PDB Simple viewer).  
 
P. aeruginosa cells are permeable to BHL which 
freely diffuses into and out of the cells, whereas a 
membrane efflux pump is involved in active 
transport of OdDHL (290). A likely explanation of 
this difference is that the length and/or the 
substitution of the N-acyl side chain determine 
hether the signal mw
actively transported.  
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n the production of PQS, suggesting a regulatory 
y originally identified because of a third property; their antibiotic activities 
(126, 190, 192). 
have also been 
und to influence the expression of quorum sensing regulated genes (88, 401). 
 to be involved in the quorum 
Besides the AHL signal molecules BHL and OdDHL, a third intercellular signal has been 
found to be part of the quorum sensing regulon in P. aeruginosa. This molecule; 2-heptyl-3-
hydroxy-4-quinolone (designated the Pseudomonas quinolone signal; PQS) has been shown to 
play an important role in the infection of nematodes and mice (104, 182, 429). PQS has also 
been found in sputum, bronchoalveolar lavage fluid and mucopurulent fluid from distal 
airways of CF lungs removed at transplant (60). PQS is produced at the end of the exponential 
phase and peaks in the late phase of growth, which suggests that the production is not only 
controlled by the las and rhl quorum sensing system since they are activated well before onset 
of the main production of PQS (294). PQS acts as a coinducer for a LysR-type transcriptional 
activator, PqsR (formerly MvfR; Multiple virulence factor Regulator) (429). PqsR interacts 
with PQS and functions as a transcriptional activator until the stationary phase, when a 
negative feedback mechanism via the rhl system seems to repress expression of pqsR (42, 223). 
The transcription of the pqsABCDE operon is induced by PqsR-PQS thereby creating an 
autoinducing loop as this operon is a part of the PQS synthesis gene cluster (399, 429). PQS is 
also involved in the regulation of other quorum sensing related genes, among these BHL and 
multiple virulence factors such as pyocyanin, elastase and phospholipase (42, 224, 429). LasR 
has been found to be necessary for the production of PQS, which indicates that PQS play a role 
as an additional connecting link between the las and rhl quorum systems. Moreover, the ratio 
of OdDHL to BHL might have an influence o
balance between the quorum sensing systems (223).  
Recently it has been shown that PQS forms complexes with iron(III) at physiological pH which 
suggests that beside functioning as a signal molecule, PQS has a secondary function in iron 
entrapment to facilitate siderophore-mediated iron delivery (77). In accordance with the 
observation that PQS may assist iron-uptake, we have recently shown that expression of the 
pqs operon is induced in a subpopulation of biofilm cells under low-iron conditions (1 µM 
FeCl3) (434). Along with PQS, P. aeruginosa produces more than 50 other quinolone 
compounds, man
REGULATION OF THE QS CIRCUIT IN P. AERUGINOSA 
The paradigm stating that the transcription of quorum sensing regulated genes exist as a 
response on a high concentration of signal molecules, is only partially adequate to explain the 
complex quorum sensing system in P. aeruginosa. Several surveys have demonstrated that the 
addition of AHLs to low cell density cultures of P. aeruginosa does not induce expression of 
quorum sensing regulated genes (78, 224, 226). Different genes under the control of quorum 
sensing are expressed at different growth phases, indicating that the AHL concentration alone 
does not control the expression of quorum sensing controlled genes in P. aeruginosa (413). 
Environmental factors such as medium composition and oxygen availability 
fo
 
Factors other than LasI-LasR and RhlI-RhlR and presumed
sensing cascade in P. aeruginosa are briefly described below. 
The rpoS gene encodes the stationary-phase sigma factor (RpoS or σs) and is a central 
regulator controlling the expression of genes involved in cell survival in response to various 
stress effects, most notably stressors occurring in connection to cessation of growth (stationary 
phase) such as nutrient deprivation (102). RpoS also regulates the general stress response and 
protect the cell against oxidative stress, heat shock, increased osmolarity and low pH and other 
environmental challenges in a retroactive and a proactive manner (157, 201). In P. aeruginosa, 
the level of σs increases dramatically at the onset of the stationary phase and is regulated at the 
transcriptional and posttranscriptional levels. Several studies suggest a link between RpoS and 
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inosa RpoS and quorum-sensing 
re part of the same regulatory network. (See also figure 12). 
plex 
outcompetes RsaL binding to the lasI operator and lasI is then expressed (69, 318).  
 
/PQS, RpoS, RsaL 
nd Vfr have also been shown to be involved in the regulation of the quorum sensing system. 
n of RsmZ and RsmY is 
ependent on RsmA and the global regulator GacA (40, 136, 163). 
quorum sensing. Transcriptome analyses have shown that many quorum sensing regulated 
genes are induced at the onset of stationary phase or later during stationary phase, indicating a 
possible involvement of RpoS (134, 345, 401). The RhlI-RhlR system has been reported to 
activate the transcription of rpoS (180). Interestingly another study has reported that RpoS 
activates rhlI transcription (414). It thus seems that in P. aerug
a
 
RsaL is a pivotal modulator of quorum sensing and belongs together with many other 
important proteins to the tetrahelical superclass of helix-turn-helix (H-T-H)-containing proteins 
(319). rsaL is located downstream from lasR and is transcribed antisense relative to lasR. RsaL 
has been suggested to bind to the lasI operator region, at low cell densities -and hence low 
concentration of OdDHL- thereby directly repressing the expression of LasI by hindering the 
interaction between the lasI operator region and the LasR-OdDHL complex. As the 
concentration of LasR-OdDHL complex increases with increasing cell densities this com
 
Figure 12. Central elements in the P. aeruginosa quorum sensing cascade. LasI-LasR and RhlI-RhlR is activated 
by their cognate signal molecules; OdDHL and BHL, respectively. Other factors such as PqsR
a
 
RsmA (regulator of secondary metabolites) is a global posttranscriptional regulatory protein 
working in tandem with a small non-coding regulatory RNA molecule, RsmZ (also known as 
RsmB) located in the rpoS/fdxA intergenic region, to regulate the expression of the AHL 
synthase genes lasI and rhlI. RsmA functions as a negative regulator of quorum sensing by 
suppressing the production of OdDHL and BHL and thus decreasing levels of extracellular 
virulence factors such as proteases, elastases, PA-IL lectin, hydrogen cyanide and pyocyanin. 
RsmZ opposes the negative effect of rsmA on virulence factor production most likely by 
binding to RsmA (40, 136, 298). Another small non-coding RNA RsmY has been found to 
antagonize RsmA in a fashion similar to RsmZ (363). Expressio
d
 
The GacS/GacA two-component system has been suggested to positively regulate the 
transcription of lasR and rhlR and to control the production of BHL thereby regulating 
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nal mechanisms, where quorum sensing is 
robably only involved in the former (296, 297).  
eems that the QscR regulated genes are 
only partly overlapping the quorum sensing regulon. 
 synthetase; this 
effect may be due to an Hfq mediated stabilisation of RsmY RNA (363, 364). 
f lasR and to 
ositively regulate expression of exotoxin A and protease production (10, 410).  
HL influx and probably 
ereby regulates expression of quorum sensing controlled genes (84). 
transcription of quorum sensing controlled genes and biosynthesis of virulence factors (296, 
325). P. aeruginosa gacA mutants are less virulent compared to the wild-type in animal as well 
as plant models (316, 317). GacA has been found to modulate cyonogenesis positively at a 
post-transcriptional level. This suggest that the regulation exerted by the GacS/GacA system in 
P. aeruginosa is not functioning as a simple linear signal transduction pathway, but may 
involve both transcriptional and post-transcriptio
p
 
Besides LasR and RhlR a third LuxR type protein QscR (Quorum sensing control regulator) 
has been found in P. aeruginosa (57). QscR is proposed to form inactive heterodimers with 
LasR and/or RhlR in the absence of AHL; thereby inhibiting the expression of some quorum 
sensing controlled genes. When the concentration of signal molecules increases, the 
equilibrium would be changed towards the formation of the LasR-OdDHL homodimer 
complex and/or the RhlR homodimer bound to BHL, leading to expression of quorum sensing 
regulated genes (187). No cognate AHL synthase has been found for QscR, however it seems 
that OdDHL serves as a signal molecule for QscR (57, 193). Transcriptome analyses of a qscR 
mutant showed that QscR affects transcription of more than 400 genes, most of which are not 
affected by the Las and Rhl systems (193). It thus s
Hfq is a global regulatory protein belonging to the large family of Sm-like proteins, which 
forms homo-hexameric rings (265). The Hfq protein is highly conserved among bacteria, and it 
has been shown that Hfq from P. aeruginosa can functionally replace that of E. coli (362). Hfq 
controls the stability of mRNAs by interfering with ribosome binding and by affecting the 
length of poly-A tails (120, 398). In E. coli, the translation of the rpoS gene is stimulated by 
Hfq, presumably by modulation of the function of small regulatory RNAs (34, 239, 440). Hfq 
seems to be involved in P. aeruginosa virulence as an hfq mutant showed significantly 
attenuated pathogenesis compared to its wild-type parent when administered intraperitoneally 
in mice (361). A transcriptome analysis revealed that Hfq is involved in the regulation of 
around 5 % of all ORFs in P. aeruginosa PAO1 with around 25 % of the affected genes also 
being quorum sensing regulated (363). Hfq induces the expression of the BHL
Another global regulatory gene, vfr (virulence factor regulator) is also presumed to be part of 
the complex quorum sensing mechanism of P. aeruginosa (410). Vfr is a homologue of the E. 
coli catabolite repressor protein CRP (cAMP receptor protein) and Vfr has been shown to bind 
to a CRP-binding consensus sequence (CCS) located at the promotor region o
p
 
The regulator PprB has recently been reported to modulate quorum sensing and global gene 
expression in P. aeruginosa (84). The two-component regulatory system PprAB was first 
identified as a regulator of membrane permeability and sensitivity to antibiotics (405). While 
overexpression of pprB caused clinical strains to become more sensitive to antibiotics (405), 
knockout of the pprB gene caused a drastic reduction in virulence factor production and cell 
motility (84). Genes affected by an insertion mutation in pprB were mapped by transcriptomics 
and showed that 85.5 % of all genes activated by PprB were in addition quorum sensing 
regulated. Further analysis showed that PprB positively controls OdD
th
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the 
osttranscriptional virulence factor regulator DksA have been found to interact with the 
ystems, probably being important not only for the pathogenesis of this versatile 
bacterium, but also for the adaptation of this organism to a wide array of environmental 
a are involved in the infection process, 
uch as genes encoding proteases, elastase, exotoxins and factors favouring establishment of 
 
Tab  regulated virulence factors in P. aeruginosa. (Th haustive). 
Other factors such as the AraC-type global regulator system VqsM/VqsR, the alginate 
regulator protein AlgR2 (AlgQ), the negative virulence regulator MvaT and 
p
quorum sensing cascade of P. aeruginosa in a complex interplay (78, 85, 158, 159, 186).  
 
Thus, as outlined above, quorum sensing involves and is involved in a wide array of complex 
regulatory s
conditions. 
QUORUM SENSING AND THE EXPRESSION OF VIRULENCE FACTORS 
Many quorum sensing regulated genes of P. aeruginos
s
the pathogen such as biofilm components. See table 1. 
le 1. Quorum sensing
Product 
e list is not ex
Reference Gene 
Alkaline protease  aprA (106, 181) 
Catalase katA (125, 372) 
Chitinase 
97, 420) 
ctin  
69) 
ted  
e, lysyl class  66) 
  289, 314) 
chiC (100, 420)  
Cyanide hcnAB (181, 2
Cytotoxic le lecAB (421) 
Elastase B lasB (105, 285) 
Exotoxin A toxA (106, 3
LasA protease  lasA (385) 
PvdS-regula
endoproteas prpL (17, 2
Pyocyanin phz (35) 
Pyoverdin pvd (368) 
Rhamnolipid rhlABC (271,
Secretion mechanisms xcpPR (51) 
Superoxide dismutase sodAB (125) 
 
The P. aeruginosa elastase LasB (also called pseudolysin) degrades matrix proteins, which 
besides elastin (a major component of connective tissues being resistant to hydrolysis by most 
proteases) also includes laminin (a membrane associated glycoprotein), fibrin (a blood plasma 
protein) and collagen types III and IV (26, 128, 340). Consequently, LasB shows significant 
tissue degrading activity and are capable of destroying the structural lung proteins thereby 
causing extensive damage. Elastase has been suggested to be a potent inflammatory factor in 
mouse models (432). Besides the destruction of lung structural proteins, elastase has the 
capacity to inactivate crucial immune system components such as immunoglobulin, serum 
complement factors and the α1-proteinase inhibitor (87, 127, 143, 234, 344). Together with 
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alkaline protease, elastase inactivates the human cytokines interferon γ (INF-γ) and tumor 
necrosis factor α (TNF-α) (280). 
 
Another elastase; LasA has been demonstrated to enhance the elastolytic activity of other 
elastases, including human leukocyte elastase and LasB, in a dose-dependent manner (299, 
300). It is also a staphylolytic protease, which lyses S. aureus cells by cleaving the 
peptidoglycan pentaglycine interpeptides, and LasA is therefore also known as staphylolysin 
(166). LasA enhances the shedding of syndecan-1 from the surface of epithelial cells (277). 
Shedding of cell surface molecules as soluble extracellular domains is one of the host responses 
activated during tissue injury, and it seems that P. aeruginosa exploits this mechanism to 
romote its establishment within the host (276). Together with elastase B, LasA was one of the 
 family, 
cluding lactoferrin and decorin. PrpL has been shown to contribute to P. aeruginosa´s ability 
ther with LasB been found to inhibit activities of 
atural Killer cells and reduce lymphocyte proliferation, probably via cleavage of IL-2 (291, 
(endo)chitinolytic enzyme encoded by chiC. The production of 
hitinase is regulated – at least in part – by quorum sensing (100, 266, 420). Interestingly 
lence of P. aeruginosa in different in vivo models 
50, 189). Production of superoxide dismutase (SodM and SodB) and catalase (KatA) – and 
p
first factors of P. aeruginosa found to be controlled by quorum sensing, hence the name of the 
LasR protein (105, 181, 385). 
 
The endoprotease PrpL (protease IV, Piv) has also been found to have elastolytic activity (415). 
Besides cleaving elastin, PrpL able is to degrade casein and proteins of the transferrin
in
to persist in a rat chronic pulmonary infection model (415). PrpL production is controlled by 
quorum sensing like most other secreted virulence factors of P. aeruginosa (17, 266).  
 
Alkaline protease (AprA) is a metalloprotease and a member of the serralysin family. AprA has 
maximal enzymatic activity at alkaline pH, hence the name (272). The apr locus encodes 
beside AprA also an AprA specific small protease inhibitor (AprI) (89). The inhibitory protein 
consists of 131 residues, including a signal peptide of 25 residues which is cleaved off during 
secretion into the periplasm. The inhibitor is entirely located in the periplasm of P. aeruginosa, 
where its presumed physiological function is to protect the periplasmic proteins against the 
secreted protease (89, 129). AprA has toge
N
380). The two proinflammatory cytokines, IL-6 and IL-8 have also been shown to be degraded 
by the two proteases AprA and LasB (219). 
 
Chitin is a homopolymer of β-(1-4)-N-acetyl-D-glucosamine which is highly abundant 
throughout the natural world, and is found for instance in the exoskeletons of insects, in the 
shells of crustaceans, in nematodes and in the cell walls of many fungi and algae. Degradation 
of chitin converts the polymer into acetate, NH3 and fructose-6-phosphate. P. aeruginosa 
produces an extracellular 
c
water-soluble chitin, as well as chitosan (deacetylated chitin), has been found to accelerate 
wound healing (55, 231).  
 
An important part of the defence against bacteria is the phagocytes which release hydrogen 
peroxide and other Reactive Oxygen Species (ROS) in order to defeat invading 
microorganisms. However, many bacterial pathogens, including P. aeruginosa, exploit 
superoxide dismutase and catalytic enzyme systems to survive the oxidative stress within the 
host. P. aeruginosa produces at least three catalases; KatA, KatB, KatE and KatN and two 
superoxide dismutases SodB and SodM (the latter also known as SodA) (371). KatA and, to a 
lesser extent, KatB, but not KatE, have been shown to be required for resistance to peroxide 
and osmotic stresses in P. aeruginosa PA14 (189). Both superoxide dismutase and catalase 
have been found to be required for full viru
(1
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ith molecular oxygen and thereby produces superoxide and by dismutation, hydrogen 
peroxide (68). The ability of P. aeruginosa to generate phenazines has been found to be critical 
for pathogenicity in both a worm model (C. elegans) and a murine model of septicaemia (211).  
 
thus the ability to withstand ROS produced by cells of the immune defence – has been found to 
be controlled by quorum sensing (27, 125). 
 
A characteristic of P. aeruginosa compared to other fluorescent pseudomonads is the 
production of substantial quantities of the phenazine-derivative pyocyanin. (See proposed 
synthesis of pyocyanin and phenazines in figure 13).  The production of pyocyanin is 
controlled by quorum sensing, iron and phosphate availability (155). Pyocyanin displays redox 
activity and induces oxidative stress in cellular systems and thus has the potential to impair 
tissue repair (35, 242). Pyocyanin has been isolated from sputum of infected patients at levels 
above 100 μM and is reported to modify several host cell responses including altering the 
platelet eicosanoid metabolism and inhibit prostacyclin release (160, 174, 243-245, 418). When 
pyocyanin is reduced by the reaction with NAD(P)H, the reduced pigment immediately reacts 
w
 
Figure 13. Proposed mechanism for the synthesis of pyocyanin, 1-hydroxyphenazine, and phenazine-1-
carboxamide in P. aeruginosa PAO1. Two steps are suggested to be involved in the synthesis of pyocyanin from 
henazine-1-carboxylic acid. In the first step, catalyzed by the SAM-dp
p
ependent methyltransferase PhzM, 
 
 phase. 
esides being dependent on low iron concentration, the toxA expression is presumed to be 
henazine-1-carboxylic acid is converted to 5-methylphenazine-1-carboxylic acid betaine. The second step, 
catalyzed by the NAD(P)H-dependent flavoprotein monooxygenase PhzS, involves hydroxylative decarboxylation 
of 5-methylphenazine-1-carboxylic acid betaine to pyocyanin. (From (220)).  
 
Exotoxin A is a cytotoxic enzyme, which is able to ADP-ribosylate the eukaryotic elongation 
factor II, thereby inhibiting protein synthesis within the target host cell leading to cell death 
(149). Expression of exotoxin A (encoded by toxA) is complex and involves a cascade of 
regulators that results in the maximal production of exotoxin A in the stationary growth
B
regulated by factors such as PvdS (pyoverdine sigma factor) and connected to cell density and 
growth phase by the las encoded quorum sensing system and vfr (106, 203, 270, 410).  
 
In 1961 Liu et al. noticed that the “slime fraction” from burn wounds were more toxic than the 
cellular fraction (200). The toxicity of the “slime” was probably due to a high amount of 
hydrogen cyanide produced by P. aeruginosa infecting the wound. Goldfarb & Margraf, 1967 
found that P. aeruginosa isolates from burn wounds produced high levels of hydrogen cyanide 
(1.5-3.2 µg/ml or 56 to 118 µM). They also found cyanide directly in burn wounds infected by 
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zed by the membrane-bound enzyme HCN 
ynthase, which forms hydrogen cyanide and CO2 from glycine (43). Besides being controlled 
ins are presumed to participate in the initial infection process where they 
cilitate the binding to the respiratory, gastrointestinal or other epithelial surfaces (110, 310). 
passes 12 different proteins 
341). Quorum sensing has been shown to negatively 
odulate expression of the TTSS in P. aeruginosa (28), that is; the TTSS system is down-
mal 
iofilms (74, 275). RhlR-BHL promotes the transcription of rhlAB, and since the lasI-lasR 
P. aeruginosa and suggested that this could be implicated in the “almost universal lethality of 
P. aeruginosa septicaemia in burn patients” (116). This has later been supported by the finding 
that cyanide is the mediating factor in the paralytic killing model of C. elegans by P. 
aeruginosa (104). The toxicity of the cyanide ion is caused by its ability to bind to cytochrome 
c oxidase, thereby denaturing the enzyme and disrupting the electron transport chain. In P. 
aeruginosa hydrogen cyanide biosynthesis is cataly
s
by quorum sensing the synthesis of hydrogen cyanide seems to be partly regulated by oxygen 
availability via the anaerobic regulator ANR (297). 
 
P. aeruginosa produces different lectins which contribute to virulence. The galactophilic lectin 
PA-IL was the first to be characterized. It is a broad-spectrum hemagglutinin and agglutinates 
all types of erythrocytes from humans and various animals, as well as thrombocytes and 
leukocytes. Lect
fa
It has been demonstrated that RhlR-BHL - probably orchestrated by RpoS - controls expression 
of lectins (421). 
 
As outlined above, P. aeruginosa produces many virulence factors, the majority being 
exoproteins requiring transport mechanisms to be able to cross both membranes of the cell 
envelope. Several pathways facilitating the transport of exoproteins and cellular appendages 
proteins (e.g. type IV pili and flagella) have been identified, including the type III (or contact) 
secretion system and the autotransporter pathway (13, 96, 131). Many exoproteins are exported 
by the type II secretion machinery; the Xcp system, which encom
encoded by xcpA and xcpP-Z (96). Considering that the transport of the majority of the factors 
facilitated by the Xcp system are quorum sensing regulated it is not surprising that the Xcp 
system itself has been found to be quorum sensing regulated (51).  
The type III secretion system (TTSS) is involved in the secretion and translocation of several 
cytotoxic products into the cytosol of eukaryotic cells (reviewed by (431)). Expression of 
TTSS increases pathogenicity of P. aeruginosa and is associated with more severe infections 
and a higher mortality rate (5, 335, 
m
regulated under high cell density conditions and thus this system probably primarily plays a 
role in the early stages of an infection. 
 
P. aeruginosa synthesises extracellular glycolipids composed of L-rhamnose and 3-hydroxy-
alkanoic acid. The rhamnosyl transferases taking part in the rhamnolipid pathway are encoded 
by rhlAB and rhlC (214). Besides being a heat stable hemolysin, rhamnolipid rapidly lyse 
neutrophils, macrophages and different animal cells (154, 221, 350). Rhamnolipids are found 
in high concentrations in sputa of P. aeruginosa infected CF-patients where they impair ciliary 
beating and thus mucociliary transport (175, 323). The concentration of di-rhamnolipid in P. 
aeruginosa over night cultures is in the range of 50-100 µg/ml being sufficient to lyse 
erythrocytes (see article 3). Swarming motility has been demonstrated to be dependent on the 
rhlA gene which is required for the production of the 3-hydroxy-alkanoic acid moiety of 
rhamnolipid and rhlA has also been found to be important for the development of nor
b
quorum sensing system influences the rhlI-rhlR system the production of rhamnolipid is at 
least in part dependent on the lasI-lasR system and perhaps also PQS (224, 227). 
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of the catabolic pathway regulator CbrB 
(63). Moreover, mutations are found more frequently in lasR than e.g. in gacA and rhlR (204) 
ge for lasR mutations during an adaptation to an 
urred in the lasI and rhlI mutants which caused 
e development of 
. The strongly reduced 
HL content correlated with decreased expression and production of several virulence factors 
As outlined above, many virulence determinants playing crucial parts in the infection process 
are regulated by quorum sensing. Also many in vivo studies emphasise that quorum sensing is 
indeed involved in pathogenesis, as quorum sensing deficient P. aeruginosa strains are much 
less virulent in animal model systems (56, 151, 194, 287, 424, 425). Interestingly, mutations in 
lasR are often found in isolates from chronically infected CF patients. While the lasR mutant 
and its corresponding wild-type show similar growth rates initially, the lasR mutant seems to 
have a higher fitness than the wild-type in late (alkaline) cultures (135). This is supported by 
the observation that loss of lasR functionality may confer the bacterium with a growth 
advantage as a mutation in lasR increases expression 
again suggesting a selective advanta
environment (either a culture flask or the CF airways), indicating that quorum sensing may 
only be important in the initial stages of an infection. 
QUORUM SENSING AND BIOFILMS  
Since quorum sensing regulated genes are mainly activated at high cell densities it would be 
reasonable that quorum sensing is not involved in the early phase of biofilm development, 
where the cells attach to the substratum forming the first microcolonies, and the cell density 
has not yet reached a “quorate” concentration. However, this is an area of controversies. 
Glessner et al., 1999 applied the mutants PDO100 (ΔrhlI), PAO-JP1 (ΔlasI) and PAO-JP2 
(ΔrhlI-ΔlasI) to demonstrate that the las and rhl quorum sensing systems were required for 
type IV pilus-dependent twitching motility (115). Moreover, the ability of P. aeruginosa cells 
to adhere to human bronchial epithelial cells was also found to be dependent on the rhl 
quorum-sensing system (115). A later survey of las and rhl knock-out mutants showed that the 
mutants ability to move by twitching were unaltered compared to the wild-type, however 
during culturing, secondary mutations occ
accumulation of twitching-defective variants (25). Thus, the lack of twitching motility in 
quorum sensing mutants found by Glessner et al. 1999, might be explained by secondary 
mutations occurred as a consequence of a compensatory mechanism, instead of being caused 
by the strains’ quorum sensing deficiency. 
The impact of flagellar-mediated motility and type IV pili on biofilm development are disputed. 
Heydorn et al., 2002 studied continuously-fed biofilms and concluded that th
microcolonies is independent of twitching motility (137). Contrary to this, O’Toole and Kolter, 
1998 found that flagellar-mediated motility and type IV pili are necessary for biofilms 
formation (268), however the latter was based on investigations using a set-up without flow 
and a much shorter time frame for the experiment than Heydorn et al., 2002. 
Reimmann et al., 2002 constructed a P. aeruginosa PAO1 strain harbouring a gene encoding 
an AiiA homologue (an AHL lactonase). The expression of the AHL lactonase reduced the 
amount of OdDHL and completely prevented the accumulation of BHL
A
such as elastase, rhamnolipids, hydrogen cyanide and pyocyanin. Swarming was also reduced, 
but there was no observed effect on flagellar swimming or twitching motility, and the strains 
ability to adhere to a polyvinylchloride surface was not affected (326).  
 
The initial step of biofilm formation is a very complex, fairly controversial and not fully 
understood process, and whether or not quorum sensing takes part of this stage is a question 
which still needs further investigations to be answered. However in later stages of the biofilm 
development, high cell densities occur, and several studies have demonstrated the importance 
of quorum sensing coordinated activities for the maturation of a normal biofilm. Davies et al., 
1998 demonstrated that a specific lasI -mutant (the PAO-JP1 also used by Glessner et al., 
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. Moreover, quorum sensing was also shown 
 be important for the high tolerance of PAO1 biofilms when treated with kanamycin, since 
 of 
ofilm escaped the grazing by neutrophils. (See figure 15, next page). 
ecently it has further been demonstrated that rhamnolipid released by a wild-type P. 
aeruginosa biofilm caused the neutrophils to rapidly undergo necrosis, and thereby hindered 
their normal antimicrobial actions (154). This suggests that rhamnolipid is a key virulence 
factor of P. aeruginosa. 
 
2002) formed flat, thin and undifferentiated biofilms that, unlike wild-type biofilms, were 
sensitive to the biocide sodium dodecyl sulphate (SDS). The mutant biofilms appeared as the 
wild-type when grown in the presence of exogenous OdDHL (66). Based on the mutants 
utilized by Glessner et al., 1999 and Davies et al., 1998 (PDO100, PAO-JP1 and PAO-JP2), 
Shih & Huang, 2002 confirmed the importance of quorum sensing - and especially the las-
system - for the development of normal biofilms
to
the quorum sensing mutants were much more susceptible to this antimicrobial agent (346). 
However, whether secondary mutations in the applied strains have any impact on the 
conclusions drawn in these papers, are unknown. 
 
Heydorn et al., 2002 found that the biofilm made by the lasI_mutant PAO-JP1 was 
indistinguishable from the dense wild-type biofilm at all time points, when both strains were 
grown under the same conditions and with citrate as carbon source (137). This suggests that 
quorum sensing may not be necessary for P. aeruginosa biofilm architecture under all 
conditions. This is supported by recent findings showing that quorum sensing mutants 
depending on the carbon sources either forms biofilms identical to the wild-type strain or 
biofilms with defects in the early steps of biofilm formation (349). This study further 
demonstrated that swarming plays a role in biofilm formation in agreement with findings by 
Pamp and Tolker-Nielsen, 2007 who observed that early microcolony formation and late 
migration-dependent structural development are dependent on biosurfactants and the ability
the bacteria to migrate (275). 
 
a b c d 
 
Figure 14. The quorum sensing mutant develops more flat and more tobramycin-sensitive biofilms than the wild-
type. Three days old Gfp-tagged P. aeruginosa biofilms were treated with 10 μg/m tobramycin and stained with 
propidium iodide to differentiate live/dead/ cells. a PAO1 wild-type biofilm before and b after treatment with 10 
μg/ml tobramycin. c ΔlasR-rhlR mutant before and d after treatment with 10 μg/ml. (From (27)). 
 
It has been shown that a biofilm formed by a lasR-rhlR-mutant of P. aeruginosa is much more 
susceptible to killing by tobramycin and hydrogen peroxide than its wild-type parent (27). (See 
figure 14). Moreover, while neutrophils readily phagocytosed the quorum sensing mutant 
biofilm, the wild-type bi
R
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Figure 15. Quorum sensing dependent tolerance of P. aeruginosa biofilms towards neutrophils. Three days old 
Gfp-tagged P. aeruginosa biofilms (wild-type (upper panel) and a lasR-rhlR mutant (lower panel)) were exposed 
to neutrophils for 2.5 hours (second and third picture in both panels). Neutrophils (red) were stained with SYTO 
62. While the wild-type biofilm escaped neutrophil grazing, the lasR-rhlR mutant biofilm were fully penetrated by 
neutrophils. As seen from the enlargement, neutrophils phagocytised the quorum sensing deficient bacteria. (27). 
 
The pel operon involved in the production of exopolysaccharides is important for formation of 
the biofilm matrix. The transcription of this operon has been found to be controlled by quorum 
sensing in P. aeruginosa PA14 (336). Intriguing, it was also found that pelA transcription and 
the formation of biofilm decreased dramatically when the temperature was changed from 25 °C 
to 37 °C (336). Thus, the pelA-G genes are probably not involved in biofilm formation in 
pneumonia and other host associated infections. (See colony morphologies of P. aeruginosa 
PA14 wild-type and the ΔpelA, ΔrhlI and ΔlasI mutants in figure 16). 
 
 
Figure 16. Colony morphologies of P. aeruginosa PA14. WT (wild-type) and the ΔpelA, ΔrhlI and ΔlasI mutants. 
The ΔpelA, and ΔlasI mutants do not exhibit the wrinkled morphology of the wild-type. (336). 
 
Whitchurch et al., 2002 showed that treatment with DNase I inhibited development of P. 
aeruginosa biofilms and dissolved already established biofilms, thereby suggesting that 
extracellular DNA is an important factor of P. aeruginosa biofilms, perhaps as a structural 
component (411). A more recent study showed that the extracellular DNA is generated via a 
mechanism dependent on quorum sensing, flagella and type IV pili (11). Moreover, biofilms 
formed by quorum sensing mutants, a fliMpilA mutant and a DNase I treated wild-type biofilm 
were more susceptible to SDS than the untreated wild-type biofilm (11). This suggests that the 
quorum sensing controlled release of extracellular DNA may be involved in the enhanced 
tolerance of wild-type P. aeruginosa biofilms against antimicrobial treatments. 
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As several studies suggest that quorum sensing may be involved in the formation of structured 
and antimicrobial-tolerant biofilms, the possibility of inhibiting quorum sensing of biofilm 
forming bacteria and thereby promoting their clearance has been explored. Hentzer et al., 2003 
showed that the quorum sensing inhibitory compound 30 (C30) increased biofilm susceptibility 
to tobramycin and SDS (134). C30 was also used to treat mice in a pulmonary infection model 
and greatly promoted clearance of the infecting bacteria (134, 426). In article 1 it is described 
how the treatment of mice with the quorum sensing inhibitor patulin caused a 20-fold lower 
bacterial count in the lungs of the patulin treated mice compared to the placebo treated group, 
showing that this quorum sensing inhibitor significantly promotes bacterial clearing (322). 
Also other studies have demonstrated the concept and prospects of bacterial quorum sensing as 
a new drug target (56, 320). 
QUORUM SENSING INHIBITORS 
As outlined in the previous parts, an approach to decrease bacterial virulence and enhance 
biofilm susceptibility could be to target quorum sensing and thus attenuate the 
microorganism’s ability to establish a successful infection. Different strategies are conceivable 
in order to inhibit quorum sensing: 
QSI STRATEGY I – TARGETING THE AHL-SYNTHASE  
One strategy aiming to inhibit quorum sensing could be to impede the signal molecule 
generation mediated by the LuxI-homologue. Key elements in the synthesis of the different 
AHLs are acyl-ACPs (acyl-acyl carrier proteins) as the primary source of acyl chain and SAM 
(S-adenosyl methionine) as the amino donor for the homoserine lactone ring moiety. (See the 
model representing OdDHL formation mediated by LasI in figure 17). 
 
 
 
 
a b 
Figure 17. Representation of the model structure of the OdDHL synthetase LasI. a. Close-up of LasI. Interacting 
residues are shown in green, SAM in purple and acyl-phosphopantetheine in orange (48). b. Structure of LasI 
based on the crystal structure solved by (119). (From www.rcsb.org/pdb Protein Databank of the Research 
Collaboratory for Structural Bioinformatics Accession number 1RO5. PDB Simple viewer).  
  
Parsek et al., 1999 demonstrated that it was possible to block the RhlI mediated synthesis of 
BHL by the use of SAM analogues such as S-adenocylcystein and buteryl-SAM (283). In a 
biological system however, the concept of using SAM analogues may have an unwanted 
pleiotropic effect, as SAM is an important cofactor involved in various reactions, not limited to 
AHL synthesis.  
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QSI STRATEGY II – THE SIGNAL MOLECULE 
In a very interesting study Chun et al., 2004 demonstrated that human airway epithelia have the 
ability to inactivate OdDHL. The inactivation is selective for long chain AHLs, and does not 
influence BHL concentration. The process responsible for the long chain AHL inactivation was 
not elucidated, but enzymatic degradation was suggested to be involved (58). Yang et al., 2005 
found quorum quenching activity in mouse, rabbit, horse, goat, human and bovine sera, but not 
in sera from chicken and fish. By the use of HPLC/MS analyses lactonase-like enzymes with 
properties reminiscent of paraoxonases were revealed in the six active mammalian sera 
samples (433). Paraoxonases 1-3 (PON1-3) are esterases and have the capacity to retard the 
accumulation of lipid peroxides in low-density lipoprotein (LDL), thus retarding the oxidation 
of these lipoproteins and attenuating their pro-inflammatory effects (257, 324, 406). 
Interestingly, it has been demonstrated that PON1-3 also have the ability to degrade OdDHL 
and thereby inhibit quorum sensing (274). 
Several soil living bacterial species which produce enzymes capable of degrading AHLs have 
been isolated, among these Arthrobacter, Bacillus, Comamonas, Ralstonia, Rhodococcus and 
Variovorax species (82, 185, 198, 278, 279, 389). AHLases hydrolysing the ester bond of the 
homoserine lactone ring as well as amino-acylases hydrolysing the amide bond has been 
identified. Apparently, some strains are able to degrade and utilize AHLs as the sole energy, 
carbon and nitrogen source (185, 279). 
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Figure 18. Proposed enzymatic degradation pathways of AHLs. The complete break down and utilization of the 
signal molecules requires several different classes of enzymes. It is possible that only some of the enzymes (e.g. 
acylases) are present in the strains identified as having AHL degrading activity (After (185)). 
 
Interestingly, P. aeruginosa has been shown to produce at least two acylases PvdQ (PA2385) 
and QuiP (PA1032) with OdDHL-degrading activity (147, 148, 353). This suggests that PvdQ 
and QuiP may be involved in quorum sensing regulation. 
The soft-rot phytopathogen Erwinia carotovora relies on OHHL to control and coordinate 
activation of genes encoding extracellular plant cell wall degrading enzymes in a cell density-
dependent manner (39). Using an experimental system with transgenic tobacco plants 
producing OHHL1 it was shown that the OHHL releasing plants had enhanced resistance to 
infection by E. carotovora. Exogenous addition of OHHL to wild-type plants similarly 
 
1 In the article by Mae et al., 2001 is the E. carotovora oxo-AHL abbreviated as OHL. To avoid confusion is the 
already introduced abbreviation OHHL for N-3-oxo-hexanoyl-L-homoserine lactone applied here, and OHL is 
reserved for N-octanoyl-L-homoserine lactone. 
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increased the resistance against the pathogen (209). It is possible that the enhanced resistance 
of the tobacco plants supplied with OHHL (either transgenic or exogenous supplementation) is 
due to a premature production of virulence factors by E. carotovora before the bacteria 
population are quorate and thus earlier induction of the plant defence systems.  
In another model, plants were infected with E. carotovora transformed to express an AHL-
lactonase from Bacillus sp. The transformed E. carotovora strain released less AHLs, had 
decreased production of pectolytic enzymes and attenuated pathogenicity compared to the 
wild-type parent (83). Whether AHLases or acylases is applicable for the treatment of human 
infections is still an open question. In particular it is important to ensure that acylases are not 
interfering with other substrates in the body than the AHL produced by infecting bacteria. 
A new method to inhibit quorum sensing via binding of the signal molecule to AHL-specific 
monoclonal antibodies has recently been suggested. An antibody named RS2-1G9 is proposed 
to be capable of inhibiting quorum sensing of P. aeruginosa by encapsulating the polar lactone 
moiety of AHLs. This suggests future antibody-based therapy that target quorum sensing (73). 
QSI STRATEGY III – TARGETING THE REGULATOR PROTEIN 
Another way of attenuating quorum sensing signal transduction is to impede the interaction 
between the LuxR-homologue and the signal molecule.  
Much effort has been done to develop competitive inhibitors by synthesising AHL analogues 
designed to fit to the LuxR-homologue receptor site without activating the protein. Studies of 
the structure-activity relationship of AHL analogues have revealed that the ability to bind and 
activate LuxR-homologues depends on the length and flexibility of the acyl chain and on the 
presence of the 3-oxo moiety (286). Reverchon et al., 2002 modified the extremity of the acyl 
chain in OHHL by introducing ramified alkyl, cycloalkyl or aryl substituents at the C-4 
position. Most of the analogues with either acyclic or cyclic alkyl substituents had agonist 
activity in the applied lux quorum sensing system of V. fischeri. However, the phenyl 
substituted analogues displayed significant antagonist activity suggesting a mechanism where 
the aryl group interacts with an aromatic amino acid in the receptor site of LuxR, thereby 
preventing it from forming the active dimer (327). Smith et al., 2003 synthesised a focused 
library of AHL analogues, based on changes in the homoserine lactone moiety. By replacing 
the lactone with other ring structures such as aniline derivatives or cyclohexanol, the agonist 
effect of the original signal molecule was changed into an antagonistic effect of the analogue 
(356, 357). By investigating a range of lactones with a sulphur containing acyl chain we have 
recently identified N (heptylsulfanylacetyl) L-homoserine lactone as a potent inhibitor of 
quorum sensing (293).   
 
IDENTIFYING INHIBITORS OF THE REGULATOR PROTEIN 
One approach to identify novel quorum sensing inhibitors is the use of in silico screening 
methods. Taha et al., 2006 used modelling based on OdDHL to predict a collection of chemical 
functionalities in a 3D space likely to be involved in OdDHL-LasR interaction. Training on 
known quorum sensing inhibitors led to the prediction of novel quorum sensing inhibitors. Six 
out of 19 tested compounds selected among the best hits of the model were found to inhibit 
quorum sensing. Four of the active compounds contained either mercury or tetravalent lead, 
thereby representing a novel class of quorum sensing inhibitors (376).  
 
The crystal structure of Ligand Binding Domain (LBD) of LasR has recently been solved (30) 
and this makes it possible to perform huge in silico screenings of libraries with the aim of 
identifying new potential quorum sensing inhibitors.  
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Muh et al., 2006 used an Ultra-High-Throughput screen based on an rsaL-reporter fusion to 
screen a library of approximately 200,000 compounds for inhibitors of LasR dependent gene 
expression. Although the chemical compounds in the library covered a large structural variety, 
the two most potent quorum sensing inhibitors both resembles OdDHL (241). In connection to 
this library screening a triphenyl compound (TP-1) was identified as an agonist of quorum 
sensing. Though structurally very different from OdDHL it was able to activate multiple LasR 
dependent promotors in a lasI-rhlI mutant of P. aeruginosa (240). Contrary to OdDHL, TP-1 is 
insensitive to high pH and the action of paraoxonases and thus suitable as a scaffold for the 
development of inhibitors of quorum sensing (240). 
 
I have recently contributed to a study applying alternative high-throughput screens for 
identification of potential quorum sensing antagonists. 1200 AHL analogues were synthesised 
and cross linked to 3D hydrogel microarray slides in a spatially-separated and -addressable 
way. Soluble LuxR-type receptors from the plant pathogen E. carotovora subsp. carotovora 
(Ecc), CarR1-167 and EccR1-182, were purified, labelled with fluorescent tags (Cy3 or Cy5) and 
used in microarray–based protein–binding screens. Fluorescent spots indicate protein-ligand 
interaction and the molecules identified by this screen are potential antagonists of quorum 
sensing (260). While this concept is very elegant, it has two major drawbacks: 1.) It selects 
equally well for inducers as well as inhibitors of quorum sensing. 2.) Since the molecules are 
identified by the use of a regulator protein, information about the ability of the molecules to 
cross the bacterial cell membrane is not achieved. Overall a system like this based solely on 
protein-ligand interaction may be useful as a first high-throughput screen but needs to be 
accompanied by at least one screen implying quorum sensing at a cell level, e.g. as outlined in 
the following section. My contribution to this study was to investigate potential inhibitors by 
the use of quorum sensing monitor strains. Two different quorum sensing antagonists were 
identified via this combined approach. (Manuscript submitted to Angewandte Chemie). 
 
Besides the generalised strategies for targeting quorum sensing described above, other 
concepts are possible. As outlined earlier, the quorum sensing system of P. aeruginosa consists 
of a network of regulators, and each of these regulators may hold the key for novel concepts of 
inhibiting quorum sensing in this organism. One way to inhibit quorum sensing in P. 
aeruginosa is discussed in article 3, where it is described how antibiotics seems to decrease 
expression of the two-component regulator PprAB, which regulate membrane permeability, 
sensitivity to antibiotics and OdDHL efflux. Interaction with PprAB may be a novel way to 
counteract P. aeruginosa virulence via the quorum sensing system. 
SCREENING FOR QUORUM SENSING INHIBITORS 
Three of the articles included in this thesis (article 1-3) entail screening for quorum sensing 
inhibitors. In the following sections, different concepts for screening for quorum sensing 
inhibitors applied in these articles will be briefly discussed.  
 
The simplest way to screen for quorum sensing inhibitors is to use an easily 
measurable/detectable quorum sensing regulated trait, e.g. violacin production by 
Chromobacterium violaceum, prodigiosin biosynthesis by Serratia marcescens and pigment 
(pyocyanin) production by P. aeruginosa and then investigate changes in the phenotype as a 
response on potential quorum sensing inhibitors. Another approach, based on the same concept, 
is to fuse a reporter gene expressing an easily detectable product (e.g. gfp or lacZ) to the 
promoter -including the lux box - of a gene regulated by quorum sensing.  
The stability of the original Gfp makes it unsuitable for monitoring fluctuations in gene 
expression. Changes introduced to the C-terminal end of Gfp, such as in Gfp(ASV), makes the 
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protein more unstable as it is rendered susceptible to the bacterium’s intracellular tail specific 
housekeeping proteases (14). The half-life of Gfp(ASV) is about 110 min. allowing online 
monitoring of changes in gene expression to be seen within a time span of a few hours (14). 
The construct consisting of a quorum sensing regulated gene fused to a reporter gene can be 
maintained in an AHL producing strain such as the PlasB::gfp(ASV) chromosomal insert in 
PAO1 used in article 1 and 2. The addition of a quorum sensing inhibitor to this type of 
construction will result in a lowered expression of reporter gene to an extent proportional to the 
efficiency of the inhibitor. Besides monitoring expression of the phenotypic trait or expression 
of the reporter, it is important to observe growth in order to avoid false-positives/false-
negatives due to toxic/nutritional effects. 
 
An alternative screening approach is the Quorum Sensing Inhibitor Selector (QSIS) (320). This 
system is basically constructed from the same key elements as described above. One important 
difference is that the reporter gene has been replaced with a gene encoding a lethal product. 
The quorum sensing regulator protein (the LuxR homologue) will, in the presence of AHL 
signals, induce expression of the toxic gene product, thereby impeding cell proliferation. Hence, 
growth will only commence if quorum sensing is blocked by the presence of exogenous, non-
toxic inhibitors.  
 
The QSIS1 system is employed in article 1-3 to screen for quorum sensing inhibitors in natural 
libraries (article 1-2) and among antibiotics (article 3). The QSIS1 selector system is based on 
the lux quorum sensing system from V. fischeri. The construct is harboured by a plasmid 
containing luxR controlled by its own promoter and phlA under the control of the luxI promoter 
(See figure 19 A). phlA encodes phospholipase A which originates from Serratia liquefaciens 
MG1 (114). Since the quorum sensing circuit in V. fischeri is an autoinducer system, the 
expression of the luxI gene is under the control of the regulator protein LuxR. When the signal 
molecule interacts with LuxR it induces the transcription of the gene under the control of the 
luxI promoter and in QSIS1 this leads to the expression of phospholipase A thereby causing 
lysis of the cell. If a quorum sensing inhibitor is present along with the signal molecule the 
production of phospholipase will be abolished, allowing the bacteria to grow (320). This 
rescuing effect of a functional inhibitor is easily visualized in a diffusion assay by maintaining 
QSIS1 in an E. coli constitutively expressing β-galactosidase (see figure 19 C). Another 
selector system based on the P. aeruginosa quorum sensing system, named QSIS2, has been 
used in addition to the QSIS1 system in article 1 and 2 to screen for quorum sensing inhibitors. 
QSIS2 harbours a plasmid carrying the lasB promoter fused to sacB which encodes the 
secretory levansucrase of Bacillus subtilis (See figure 19 B). SacB catalyses a 
transfructosylation reaction by which sucrose is hydrolysed, and along with the release of 
glucose the reaction contributes to the production of the polymer levan (107). Levan is lethal to 
Gram-negative bacteria, but the exact killing mechanism is not clarified (183). As in QSIS1, 
presence of quorum sensing inhibitors will rescue the cells from expression of the suicidal gene 
product. QSIS2 also carries a plasmid containing a part of the lux cassette (luxCDABE), thus 
growth of the QSIS2 causes bioluminescence and indicates the presence of a quorum sensing 
inhibitor. 
 
QUORUM SENSING 
 
 44
C A 
B 
 
 
Figure 19. The Quorum Sensing Inhibitor Selector systems; QSIS1 and QSIS2. A. Schematic outline of the 
essential parts of the plasmid in QSIS1. The gene encoding luxR is controlled by its own promoter, while 
expression of the lytic factor phospholipase A is regulated by quorum sensing via the luxI promoter. B. Outline of 
the QSIS2 system. The transcriptional regulatory protein LasR is constitutively expressed as it is controlled by the 
lac promoter. Expression of the cell toxic product SacB is controlled by the quorum sensing regulated lasB 
promoter. C. Extracts of marine organisms tested using the QSIS1 system. Extracts are loaded in wells in the agar 
and the plates are incubated over night. Three marine sponges showed strong quorum sensing inhibitory activities 
as seen from the blue rescuing zones around the wells marked with arrows.  
 
In the screening assay, the QSIS strains are cast into agar along with signal molecules. Test 
samples consisting of either extracts or pure compounds are added to wells made in the agar, 
creating a concentration gradient of the test sample when diffusing into the agar. Samples to be 
extracted could be microfungi as in article 1 or marine organisms (article 2) and pure 
compounds could be different antibiotics as in article 3 or compounds purified from extracts 
e.g. patulin, penicillic acid or manoalides. Depending on the nature (molecular weight, 
solubility etc.) of the components in the extract, the compounds diffuse with different rates and 
a crude separation may take place. Moreover, due to the concentration gradient, a range of 
concentrations are tested at the same time. After incubation, samples containing quorum 
sensing inhibitory compounds can be identified by a zone of growth (rescuing zones) around 
the application wells. Toxic compounds present in the test sample give a clearing zone near the 
well where growth is not possible. Compounds and extracts which possess quorum sensing 
inhibitory as well as toxic properties give a clearing zone near the well, where the highest 
concentration is present, followed by a zone of growth indicating quorum sensing inhibitory 
activity. When applying the screening system QSIS1, a blue rescuing zone emerges along with 
growth due to the presence of hydrolyzed X-Gal in the plate (See figure 19 C). Growth of 
QSIS2 can either be recorded as bioluminescence or by using tetrazolium as viability reporter. 
Most bacteria, among these P. aeruginosa, are capable of reducing the colour-less tetrazolium 
to the red-coloured triphenyl formazan (TPF) by using tetrazolium as an electron acceptor. 
Thus by adding a solution of tetrazolium to the QSIS2 test plate, wells containing quorum 
sensing inhibitory compounds can be identified due to a red zone around the well, where the 
active extract/compound was loaded. 
 
One additional example of this concept is a selector system based on the quorum sensing 
system of Burkholderia cepacia outlined in figure 20. I constructed this selector to be able to 
identify inhibitors of quorum sensing functioning against the B. cepacia cepI-cepR quorum 
sensing system. However, results obtained using this system were almost identical to results 
achieved by the use of QSIS1 and the cepI-cepR based selector was not further used, but shown 
here as an example of the Quorum Sensing Inhibitor Selector System. 
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Figure 20. Quorum Sensing Inhibitor Selector based on the B. cepacia cepI-cepR quorum sensing system. A.  
OHL binds to and activates CepR thereby inducing transcription of phlA. The expression of phospholipase leads 
to lysis of the cell, which dies. B. If a quorum sensing inhibitor is present along with OHL it abolishes the 
production of phospholipase, and the cell is able to proliferate. 
QUORUM SENSING INHIBITORS FROM NATURAL SOURCES 
As an alternative to synthesising and screening large compound collections, novel quorum 
sensing inhibitors may be identified by screening natural libraries. Nature is indeed ingenious 
and compounds with complex structures, difficult to synthesise in the laboratory, can be 
produced by living organisms via enzymatic processes. Moreover, as many plants, fungi and 
invertebrate organisms use chemical activities in the competition with other organisms, many 
of the secondary compounds they produce have strong bioactive properties and thus potentially 
medical applications. This view is supported by Newmann and Cragg by this quotation: 
“natural products play a dominant role in the discovery of leads for the development of drugs 
for the treatment of human diseases” and by the fact that more than 60 % of all new 
pharmaceuticals introduced the last 25 years are either natural products or derivatives/mimics 
of natural products (254, 256). Also many of the clinically important antibiotics used today 
such as aminoglycosides, cephalosporins, chloramphenicol and colistin are of natural origin (4, 
90, 370, 402, 408). It has been widely assumed that antibiotics in nature have been evolved by 
various microorganisms to fight competitors as an element in a Darwinistic “struggle for life”. 
However, a recent study questions this and put forth the argument that the concentrations of 
free antibiotics present in soil compared with laboratory conditions are very low (199). 
Antibiotics applied in concentrations not affecting growth (subminimum inhibitory 
concentrations, subMIC) have been shown to increase cytotoxicity, enhance bacterial motility 
and biofilm formation (139, 199, 443). This suggests that the ecological role of antibiotics in 
naturally occurring low concentrations may be as signalling mediators, organising surface 
colonization and fighting predators by enhanced cytotoxicity, rather than targeting growth of 
rivals (199).  
As described in article 3, three different antibiotics (azithromycin, ceftazidime and 
ciprofloxacin) decrease expression of many quorum sensing regulated genes of P. aeruginosa 
when applied in concentrations not affecting the growth rate of this bacterium. Moreover, the 
three antibiotics also impede the production of quorum sensing regulated virulence factors such 
as chitinase and protease. This supports the hypothesis that –at least some- antibiotics have 
dual activities; as bactericidal drugs when applied in (artificial) high concentrations and 
interacting with cell signalling when applied in low, non-toxic concentrations.  
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Antibiotics derived from various soil organisms are only representing one example of the 
success of naturally derived medicines; approximately one third of today’s best selling drugs 
are either natural products or have been developed based on lead structures provided by nature 
(255). Although around 70 % of the world is covered by oceans, almost all medicinally used 
natural products or derivatives thereof have been obtained from terrestrial organisms, and only 
few marine natural products are currently used as pharmaceuticals or are in clinical trials. 
However, due to the uniquely diverse and novel chemistry found among marine natural 
products, the oceans have been proposed to be the treasury of future drug development (93, 
307).  
In article 2 extracts of 284 marine organisms are investigated for quorum sensing inhibitory 
properties. Interestingly, many of the extracts being active in the QSIS screening systems also 
caused a clearing in the vicinity of the well where the extract was added, indicating bactericidal 
activity. Extracts of the marine sponge Luffariella variabilis and its metabolites manoalide, 
secomanoalide and manoalide monoacetate showed strong quorum sensing inhibitory 
properties, but weak to no toxicity against the two Gram-negative selector bacteria used in 
QSIS1 and 2 systems. However, the sesterpenoid manoalide and the two manoalide derivatives 
produced by this sponge have been reported to possess antibiotic properties against the Gram 
positive bacteria S. aureus and Streptomyces pyogenes (71, 248). Thus it seems that manoalide, 
secomanoalide and manoalide monoacetate also belong to the group of bioactive compounds 
with multiple functionalities. 
 
The archetypical example of quorum sensing inhibitors derived from marine sources are the 
very efficient inhibitors of quorum sensing derived from the benthic marine macro-alga 
Delisea pulchra which produces a suite of biologically active brominated furanones (113, 321). 
Synthetic derivates of these furanones (C56 and C30) have been shown to attenuate P. 
aeruginosa infections in vivo and inhibit quorum sensing in vitro (133, 134).  
Considering the functionalities of the halogenated furanones and the fact that the bromo groups 
represent excellent leaving groups, these inhibitors may function via irreversible binding to the 
LuxR (homologue) receptor site. Even though the halogenated furanones are capable of 
displacing OHHL from the LuxR protein it has not been possible to isolate a stable complex of 
the regulator protein bound to the inhibitor (215, 217). Western immunoblot analysis has 
shown that halogenated furanones dramatically enhance turnover of the LuxR protein, hence, it 
is likely that the lowered level of LuxR protein is the mode of action of the algae compounds 
(217).  Also the halo-furanones of D. pulchra possess numerous activities; in addition to their 
ability to inhibit quorum sensing they hold anti-fouling and antibacterial properties (70) as 
additional examples of multiple functioning compounds. 
 
Other examples of eukaryotic organisms possessing quorum sensing inhibitory activities are 
extracts of grapes and strawberries and exudates from pea seedlings (Pisum sativum) (101, 
379). Also garlic, a well known universal panacea in herbal medicine, possesses strong quorum 
sensing inhibitory activity (320). As described in article 1 fungi also produce quorum sensing 
inhibitors. From an ecological point of view it is not surprising that microfungi have developed 
the ability to produce compounds interfering with bacterial quorum sensing, as most of the 
antifungal products of P. aeruginosa (and of other pseudomonads as well) such as chitinase, 
phenazines and pyocyanin are under quorum sensing control (165, 305). By screening extracts 
of microfungi (Penicillium and Aspergillus sp.) two mycotoxins; patulin and penicillic acid 
were identified as strong quorum sensing inhibitors.  
 
Even though we did not fully elucidate the mechanism by which patulin and penicillic acid 
exert their action on quorum sensing, results obtained by Western protein blotting suggest that 
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the two mycotoxins decrease the half life of the LuxR-protein in a way similar to the 
degradation mediated by the halogenated furanones (See article 1).  
 
Figure 21. LBD of LasR and interactions with OdDHL 
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Penicillic acid and patulin are capable of 
forming covalent cross links with amino acids, 
e.g. cysteine, lysine, histidine and α-amino acids 
and thereby inactivate protein functionality (99).  
If such a cross linking reaction occurs within the 
receptor site of LasR or another LuxR 
homologue it may change the protein 
conformation making the protein a substrate for 
house keeping proteases. However, another 
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P. AERUGINOSA QUORUM SENSING IN CROSS-KINGDOM INTERACTIONS 
Communication between cells by means of signalling is universal in nature. In mammals 
structurally diverse molecules such as peptides (e.g. insulin) and small molecules (e.g. 
epinephrine) bring messages from one cell to another, insects use pheromones such as (R,E)- 
9-hydroxy-2-enoic acid to control swarms and 2,6-dichlorophenol as sex attractants. In fungi 
important cell signalling factors include farnesol and rhodotorucine A, while some plants use 
phytohormones such as the cytokinin zeatin to regulate plant development. As described in the 
previous section, bacteria also use signalling systems to coordinate socio-microbial behaviour. 
Considering that diverse organisms such as fungi and bacteria often inhabit the same ecological 
environment, it is not surprising that signals may be perceived across-kingdoms. 
 
As outlined in the previous sections, several eukaryotic organisms produce compounds capable 
of interfering with P. aeruginosa quorum sensing. Studies also indicate that P. aeruginosa is 
able to sense and respond to signalling compounds produced by its host. Wu et al., 2005 
showed that the inflammation cytokine interferon γ (INF-γ) binds to an outer membrane 
protein of P. aeruginosa; OprF, resulting in an enhanced expression of quorum sensing 
regulated virulence factors (427). In a study not yet finished, I have investigated the effect of 
human recombinant INF-γ on rhamnolipid production in P. aeruginosa PAO1 wild-type and its 
ΔlasI-ΔrhI derivative using the erythrocyte lysis assay described in article 3. Treatment with 
INF-γ (300 ng/mL) induced an earlier and higher pigment and rhamnolipid production (the 
latter measured as hemolysis capacity) by the P. aeruginosa wild-type than its untreated 
counterpart. Moreover, adding INF-γ to the lasI-rhI mutant, normally devoid of rhamnolipid 
production, induced the QS mutant to produce rhamnolipid, although very late (7 hours after 
the entrance to stationary phase and around 5 hours later than the INF-γ treated wild-type). See 
Figure 22 for details. 
 
 
 
Figure 22. Effect of INF-γ on P. aeruginosa virulence factor production. A Hemolysis capacity of supernatant 
from a P. aeruginosa PAO1 lasI-rhI mutant grown in the presence of INF-γ (left) or absence (right). Precipitation 
of the red blood cells (right) means no lysis whereas uniformly distribution of the red colour (left) indicates lysis. 
B Pigment production by P. aeruginosa PAO1 wild-type grown in the presence of INF-γ (left) or absence (right). 
P. aeruginosa pigment production is – at least partly - controlled by quorum sensing (see assay in (381)). 
B A 
 
I also performed a global DNA microarray analysis of the lasI-rhI mutant treated with INF-γ vs. 
an untreated lasI-rhI mutant, both harvested at the entry into stationary phase. The INF-γ 
treatment induced expression of several PQS controlled genes 20-70 fold, and changed the 
“absolute call” of the PQS genes from absent (undetectable) in the untreated ΔlasI-ΔrhI mutant 
to present (detectable) in the INF-γ treated mutant (according to the A/P/M evaluation by the 
GCOS DNA microarray analysis software vs.1.4). Likewise, did INF-γ treatment induce rhlA 
(PA3479) expression 10 fold. (The study is presently unpublished, but the results have been 
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presented at the conference “A genomic perspective to host-pathogen interaction” 7th  
September 2006 in Hinxton, England).  
The exact mechanism by which INF-γ exerts its effect on P. aeruginosa quorum sensing has 
not yet been fully revealed. Changes in OprF expression have been associated with quinolone 
resistance in P. aeruginosa, and another membrane porin of P. aeruginosa; OpmD (part of the 
MexGHI-OpmD pump) has been shown to be involved in PQS efflux (7, 112, 301). It is 
possible that binding of INF-γ to OprF somehow decreases PQS efflux, thereby increasing the 
intracellular PQS concentration which, in turn, via activation of PqsR further induces 
transcription of the PQS operon and rhlA. Regardless of the mechanisms by which P. 
aeruginosa perceive and react to the host inflammation cytokine INF-γ, P. aeruginosa is 
apparently able to detect and respond to changes in the host status. Another example is the 
ability of P. aeruginosa to sense the host produced κ-agonist dynorphin and react to the release 
of this stress opioid by enhanced expression of virulence factors by a mechanism involving 
quinolone signalling (438).  Dynorphin is an opiate-like stress factor released by neutrophils 
and other cells in connection to injury or inflammation. Thus, in order to be able to target the 
host when it is most susceptible, P. aeruginosa seems to have evolved the ability to monitor 
the presence of host factors indicative of inflammation and stress and time expression of 
virulence factors accordingly. 
 
Communication also proceeds in the opposite direction. P. aeruginosa signal molecules (in 
particular OdDHL) have been found to be implicated in interactions with eukaryotic cells: 
Candida albicans is a prevalent fungal pathogen causing infections in immunocompromised 
patients and may be found coexisting with P. aeruginosa. Studies in patient with mixed C. 
albicans and P. aeruginosa infections have shown that attenuation of P. aeruginosa, e.g. after 
treatment with antibiotics, is followed by an increase in the C. albicans population and the 
growth of C. albicans has been shown to be limited by the presence of P. aeruginosa (38, 164). 
C. albicans exists in a commensal yeast form and in a filament form associated with virulence 
and pathogenicity. Interestingly, P. aeruginosa only bind to and kills the filamentous form of 
C. albicans (140). Additionally, OdDHL inhibits C. albicans filamentation in concentrations 
not affecting fungal growth rates in a way resembling C. albicans own signal molecule farnesol 
(141). It thus seems that P. aeruginosa only tolerates habitat sharing with C. albicans in its 
non-virulent – and thus non-competing – yeast form. 
THE INFLAMMATORY PROCESS 
The inflammation process is another example of host-pathogen interaction. Microbial 
components such as lipopolysaccharide (LPS), CpG DNA and other PAMPs (Pathogen-
Associated Molecular Patterns) are recognised by Toll-like receptors (TLRs) whereupon 
proinflammatory cytokines and other soluble factors are released activating the complement 
pathway and attracting phagocytic cells such as neutrophils to the site of infection (6, 284). 
Through binding to TLR4, LPS also triggers cascades of intracellular signalling events, 
including those that lead to activation of Nuclear Factor κ B (NF-κB) which plays a key role in 
regulation of the immune response to infection (130, 439). The NF-κB proteins are normally 
sequestered in the cytoplasm as inactive complexes with specific inhibitors, such as IκBα (20). 
Upon activation by cellular stimuli, IκB kinase (IKK) phosphorylates IκBs, targeting these 
inhibitors for degradation. The released NF-κB can then migrate to the nucleus and induce 
expression of specific genes that have DNA-binding motifs for NF-κB, typically genes 
involved in inflammation and cell survival responses (162). LPS also triggers the three classes 
of mitogen-activated protein kinases (MAPK): the extracellular signal-regulated kinase (ERK) 
(also known as p42/44 MAPK), the c-jun N-terminal kinase (JNK) (also known as stress-
activated protein kinases (SAPKs)), and p38 MAPK (also known as cytokine suppressive anti-
P. AERUGINOSA QUORUM SENSING IN CROSS-KINGDOM INTERACTIONS 
 
 50
inflammatory drug binding protein (CSBP)). These MAPKs are in turn involved in the 
activation and induction of a large array of proinflammatory genes, such as those encoding the 
cytokines tumor necrosis factor α (TNF-α) and IL-8 and the prostaglandin-generating enzyme 
cyclooxygenase 2 (COX-2) (9, 179, 373). Binding of the inflammatory cytokines to their 
receptors on cells of the immune defence further amplify the innate immune response targeting 
the invading pathogen. Antigen presenting cells (APCs) such as dendritic cells (DCs) are 
induced to migrate to the site of infection by microbial products, inflammatory chemokines and 
TNF-α. The APCs internalize pathogens and display the antigens together with MHC (major 
histocompatibility complex) to B and T lymphocytes thereby also initiating and shaping the 
immune response.  
 
While the presence of any pathogen in general would lead to activation of the immune defence 
including the events outlined above, P. aeruginosa has been found to interfere with many of 
these cellular events associated with host immunity. Most remarkable are the effects of P. 
aeruginosa’s quorum sensing signal molecules. 
THE EFFECT OF ODDHL ON MAMMAL SIGNALLING PATHWAYS 
As described earlier, C. albicans reacts on the P. aeruginosa signal molecule OdDHL. Several 
studies also document the effect of this signal molecule on mammalian cells. One example is 
the pharmacological effect of OdDHL on the cardio vascular system. Experiments with porcine 
pulmonary and coronary blood vessels have demonstrated that OdDHL possesses vaso-
relaxing activity, which might increase the nutrient supply to an area infected with P. 
aeruginosa (184). OdDHL is also a very efficient inhibitor of ATP and UTP-induced secretion 
by CF human submucosal tracheal gland serous (HTGS) cells (IC50 in the picomolar range). 
The lack of responsiveness of HTGS cells in the presence of OdDHL (and to a lower degree 
other AHLs) were found to be related to the defect in CFTR, since adenovirus-mediated CFTR 
transfer conferred resistance to the effect of the signal molecules (337). This finding is highly 
interesting as P. aeruginosa is frequently found in the lungs of CF patients and OdDHL has 
been detected in CF lungs and sputum (92, 352).  
Human macrophages have been shown to increase their phagocytic activity when exposed to 
OdDHL; however OdDHL did not affect respiratory (oxidative) burst exhibited by stimulated 
macrophages (395). This stimulatory effect of OdDHL was found to be mediated via the p38 
MAP kinase pathway without involving the ERK pathway (p42/44 MAP kinase) (395). The 
p38 MAP kinase is involved in the regulation of many cellular processes including 
inflammation, cell differentiation, cell growth and death, while ERK (p42/44 MAP kinase) is a 
key effector in signalling proliferative responses in various cell types (49).  
It has also been demonstrated that human epithelial Caco-2 cells exposed to OdDHL show 
decreased transepithelial electrical resistance and reorganisation of F-actin indicating that 
OdDHL disrupts barrier integrity (396). F-actin is a filamentous polymer consisting of G-actin 
subunits. Actin is an important structural part of the cytoskeleton, involved in the formation 
and maintenance of tight junctions. OdDHL was also found to disrupt cell-cell adherence, 
probably due to the effect on F-actin (396). (See figure 23 for the effect of OdDHL on the 
apposition of Caco-2 cells). The authors concluded that this effect of OdDHL is, at least, partly 
mediated via the p38 and p42/44 MAP kinase pathways. Based on these observations, the 
authors suggest that OdDHL plays an important role in the destruction and dysfunction of 
epithelia cells during P. aeruginosa infections (396).  
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Figure 23. Disruption of the close apposition of Caco-2 cells by OdDHL. Examination by scanning electron 
microscopy (grey). Cells were either untreated (Caco-2) or stimulated for 2 h with 200 µM OdDHL (HSL). Effect 
of OdDHL on the organization of the actin cytoskeleton (red) in Caco-2 cells (396).  
 
Also calcium signalling has been found to be involved in OdDHL mediated interaction 
between P. aeruginosa and host cells. In a study investigating the effect of OdDHL on murine 
fibroblasts and human vascular endothelial cells (HUVECs), OdDHL was shown to modulate 
expression of immune mediators (IL-6 and COX-2) and to induce apoptosis accompanied by 
an increase in cytosolic calcium (348). Calcium ions act as second messengers in signal 
transduction, and changes in calcium concentration can be an intermediate event in several 
signal transduction cascades e.g. the PI3K (phosphoinositol-3-kinase) and MAPK signalling 
pathways. Ca2+ dependent signalling was found to mediate OdDHL induced apoptosis, while 
the OdDHL-imposed immunomodulatory effects was not linked to calcium signalling (348). 
Based on these data the authors suggested that OdDHL elicits at least two distinct cellular 
responses, one involving calcium signalling mediating apoptosis, and another implicated in an 
immunomodulatory response mediated by a pathway independent of calcium signalling.  
 
The effect of OdDHL on breast carcinoma (BC) cells has recently been investigated, and it 
seems that OdDHL blocks cell proliferation and induces apoptosis in BC cells (196). 
Investigating the effect of OdDHL on signalling pathways in the BC system, it was revealed 
that while OdDHL had only minor or no effect on MAPK pathways, OdDHL seemed to 
partially inhibit the protein kinase B pathway and eliminate STAT3 (Signal Transducer and 
Activator of Transcription 3) activity. Protein kinase B/Akt (PKB/Akt) is a serine/threonine 
kinase involved in various cellular processes such as glucose metabolism, cell proliferation, 
apoptosis, transcription and cell migration. Activation of PKB/Akt occurs downstream of PI3K 
and is regulated via cytokine receptors and as earlier mentioned, calcium signalling (259). 
STAT3 is a transcription factor and mediator of the switch from survival to death signalling 
activated by certain cytokines and growth factors including G-CSF and IL-6 (2). Since OdDHL 
completely inhibits STAT 3 activity in BC cells and partially inhibit PI3K signalling this may 
explain OdDHL’s ability to induce apoptosis in BC cells (196).  
 
Although the various studies report on different and at times contradicting observations on 
OdDHL’s effects on mammal signalling systems, it is worth  remembering that MAP kinases, 
calcium signalling, PKB/Akt and PI3K pathways, and STAT3 are all entangled systems which 
interact with eachother: Calcium signalling is involved in MAP kinase and PI3K pathways, 
with PI3K being an activator of PKB/Akt, while PI3K/Akt and STAT3 are two parallel 
pathways both induced by IL-6 (41). Moreover, results obtained by the use of one type of cells 
may not correspond to observations achieved by using a totally different cell system. 
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ODDHL AND CELLS OF THE IMMUNE DEFENCE 
DiMango et al., 1995 first reported on immunomodulatory properties of OdDHL and showed 
that OdDHL stimulate respiratory epithelial cells to produce IL-8 (79). Also Smith et al., 2001 
demonstrated that OdDHL promotes IL-8 production by human lung fibroblasts and epithelial 
cells (358). IL-8 is a neutrophil attracting chemokine released by macrophages and other cell 
types such as epithelial cells. In the early stages of an inflammatory response neutrophils are 
the predominant cells at the site of infection. Neutrophils are attracted to the site of an infection 
by chemokines (e.g. IL-8) and by complement split products, prostaglandins and leukotrienes. 
Also certain PAMPs such as formyl peptides are chemotactic for neutrophils (reviewed by 
(422)). Neutrophils are important phagocytes and when activated, they produce biocidal 
oxygen radical species including superoxide anions (O2-), hydrogen peroxide (H2O2) (produced 
via the NADPH-oxidase complex) and hypochlorous acid (HOCl) and chloramines, via 
myeloperoxidase. Though neutrophils are mostly known for their central role in phagocytosis 
and production of oxidative burst, these cells also make vital contributions to the recruitment, 
activation and programming of APCs e.g. by proteolytical activation of prochemerin to 
generate chemerin, a dendritic cell attracting chemokine. Neutrophils also influence whether 
macrophages differentiate to a predominantly pro- or anti-inflammatory state (250). As 
neutrophils represent the first line of defence against bacterial infections, the interaction 
between neutrophils and P. aeruginosa has attracted some attention. In a recent study by 
Wagner et al., 2007 it was demonstrated that OdDHL works as an attractant on neutrophils; 
moreover the expression of the immunoglobulin receptors CD16 and CD64 and the adhesion 
protein CD11b were increased by the presence of OdDHL (400). In another article, the authors 
further investigated OdDHL as a neutrophil chemoattractant and found that neutrophils bind 
radioactivity labelled OdDHL in a specific and saturable fashion, suggesting that neutrophils 
express a receptor which OdDHL is able to bind to (444). Based on inhibition of signalling 
pathways it was further demonstrated that OdDHL induces neutrophil chemotaxis via a 
pathway involving tyrosine kinase, phospholipase C, protein kinase C and ERK as specific 
inhibition of each of these factors impeded OdDHL-induced chemotaxis (444). Inhibition of 
several factors crucial for IL-8-promoted chemotaxis however, did not interfere with OdDHL-
induced chemotaxis indicating that OdDHL attracts neutrophils via a pathway at least in part 
different than that of IL-8. It is indeed quite intriguing that OdDHL both induces production of 
the neutrophil chemokine IL-8 while functioning as a neutrophil attractant per se.  
 
In an attempt to further identify factors affected by P. aeruginosa signalling, I have (in a 
preliminary study) investigated the effects of pure AHL signal molecules and sterile filtered 
supernatants from P. aeruginosa PAO1 on the transcriptome of human neutrophils by the 
application of the GeneChip Human Genome U133 Plus 2.0 Array from Affymetrix. In brief, 
neutrophils were purified from peripheral blood, resuspended in RPMI buffer and incubated for 
1 hour either with 5 µM BHL and 5µM OdDHL or mixed with 50 % supernatant from P. 
aeruginosa exponentially growing cultures (either from the wild-type or from the lasI-rhlI 
mutant). Following this the neutrophils were subjected to DNA microarray analysis. Both 
treatments had a profound effect on the expression of the PI3K gene. In neutrophils, PI3K is 
involved in various activities such as actin assembly and events leading to phagocytosis, 
chemotaxis and cytokine synthesis (94, 228). Neutrophils which had been challenged with pure 
AHL molecules showed a 12.6 fold decreased PI3K expression, while PI3K was 3.6 fold 
down-regulated by addition of wild-type supernatant compared to treatment with supernatant 
from the lasI-rhlI mutant. The wild-type supernatant differs from the lasI-rhlI mutant 
supernatant in several ways. One difference is that the wild-type supernatant contains 
significantly higher levels of various quorum sensing regulated products such as phenazines 
and proteases than the supernatant from the lasI-rhlI mutant. Another important difference is 
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that only the wild-type supernatant contains quorum sensing signal molecules. Thus the 
decrease in PI3K imposed by the wild-type supernatant may be caused by signal molecules in 
the supernatant.  
Calcineurin, a central element in calcium signalling and the target for the immunosuppressant 
cyclosporin, was down-regulated 4.42 times by pure AHLs and down-regulated 3.5 times by 
the wild-type supernatant. As PI3K is in part controlled by calcium signalling, the effect on 
PI3K is likely to be a down stream effect of the decreased expression of calcineurin. 
Expression of genes involved in actin assembly, COX-2 regulation, phagocytosis and 
chemotaxis were also altered by exposure to pure AHLs and P. aeruginosa wild-type 
supernatant.  
In eukaryotes, many environmentally induced changes take place at a post-transcriptional level, 
such as gene silencing by microRNAs. It has been estimated that mRNA concentrations only 
determine the concentration of the corresponding protein by 20%–40% (36, 384). Thus 
conclusions should not be based on transcriptome analyses only. The above mentioned 
transcriptome analyses were mainly performed to guide further investigations on the effect of P. 
aeruginosa quorum sensing regulated products - including signal molecules - on neutrophil 
activities. I am currently investigating the effects of AHLs on neutrophil protein expression by 
Fluorescence 2-D Difference Gel Electrophoresis (DiGE) proteomics in collaboration with 
Cambridge Centre for Proteomics. Phenotypic tests, e.g. the Boyden migration chamber test 
and phagocytosis tests could also be used to further explore the effect of AHL signal molecules 
and quorum sensing regulated products on neutrophil activities involved in the elimination of 
bacteria.  
 
ODDHL AND THE TH1/TH2 CONTROVERSY  
Most CD4+ T cells (T helper cells) belong to one of the two functional subsets TH1 and TH2, 
and can be classified on the basis of their cytokine profiles. TH1 cells are characterized by the 
production of IFN-γ, TNF-β and IL-2, and are pivotal in the cell-mediated immunity, while 
TH2 cells are characterized by the production of IL-4, IL-5 and IL-13 and play an important 
role in antibody-mediated humoral immunity (reviewed in (118, 332)). TH1 cytokines 
antagonise development of the TH2 subset and vice versa. Cytokines produced by other cell 
types than TH cells have also been assigned to belong to either the TH1 or the TH2 response. For 
instance IL-1, IL-8 and TNF-α are associated with the TH1 subset, and IL-6 with the TH2 
subset (75, 332). While Shiner et al., 2006 found that OdDHL induces expression of IL-6, 
indicating that OdDHL supports a TH2 type response, the observation that OdDHL induces 
production of IL-8 (79, 358) suggests that OdDHL imposes a TH1 subset. This exemplifies that 
in vitro investigations and in particular the conclusions drawn are often contradicting with 
respect to the effect of OdDHL on the immune system. The studies and conclusions can be 
divided in two groups; A) studies suggesting that OdDHL will shift the host protective TH1 
response into a TH2 response potentially leading to less bacterial clearance and B) studies 
indicating that OdDHL might support a proinflammatory TH1 response likely to lead to 
uncontrolled and prolonged inflammation and subsequent destruction of host tissue and 
pathogen dissemination. Among the reports supporting that OdDHL promotes the TH2 subset is 
the study by Telford et al., 1998 showing that OdDHL in vitro decreases the production of the 
TH1 cytokines IL-12 and TNF-α by LPS stimulated macrophages (378). Lymphocyte 
proliferation was also found to be hindered by the presence of OdDHL, while immunoglobulin 
E production was promoted by OdDHL, collectively suggesting that OdDHL influences the 
balance between TH1-TH2 to the advantage of the TH2 subset.  
Contrary to these findings, OdDHL has been shown to induce proinflammatory responses in 
human lung fibroblasts and epithelial cells e.g. by mediating an induced IL-8 transcription as 
earlier mentioned (358). Moreover, OdDHL has been demonstrated to induce production of 
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INF-γ by antigen and APC activated T cells, promoting a TH1 response (359).  The latter study 
also showed that OdDHL, but not BHL, injected into the skin of C57BL/6 mice caused 
extensive inflammation (infiltrating cells and edema) and tissue destruction (359).  
Studies have shown that the immune response to chronic P. aeruginosa lung infection in CF 
patients is predominantly of the TH2 type response; it seems however, that the TH1 type 
response is associated with an enhanced bacterial clearance, milder lung inflammation, and 
improved survival (33, 123, 235-238). Considering that these studies conclude that a TH2 
response is associated with more persistent inflammation, a TH1 response mediated by OdDHL 
should lead to a better prognosis for CF patients. 
 
PQS has recently been shown to exert antiproliferative effects on hPBMCs (human Peripheral 
Blood Mononuclear Cells) in a ConA driven T cell proliferation assay (144). Moreover, PQS 
and OdDHL also decreased the release of the TH1 cytokine IL-2 by mitogen stimulated PBMCs 
(144). However, only OdDHL had an effect on the release of IL-2 by T cells activated via the 
T cell receptor (stimulation via anti-CD3/anti-CD28 antibodies). While OdDHL in doses above 
50 µM suppressed secretion of TNF-α of E. coli LPS treated hPBMCs, high doses of PQS 
(above 25 µM) induced TNF-α expression (144). Thus, also PQS seems to have the capacity to 
modulate the immune response in both the TH1 and the TH2 direction. This is also reflected in 
manuscript “Pseudomonas aeruginosa Quorum Sensing Signal Molecules interfere with 
dendritic cell induced T cell proliferation” which reports on the effect of BHL, OdDHL and 
PQS on activities and functions of murine bone marrow derived dendritic cells. OdDHL and 
PQS both decreased the IL-12 production by dendritic cells, however expression of T cell 
stimulatory and maturation related surface markers by LPS-stimulated dendritic cells were 
impeded by OdDHL but seemed to be promoted by PQS. OdDHL and PQS both decreased the 
capacity of dendritic cells to induce T cell proliferation, whereas BHL was found not to 
interfere with DC functions (Article 4).  
Though the TH1 response is crucial for cell-mediated immunity, misregulation of the TH1 
response is the cause of several severe diseases. Multiple sclerosis, type 1 diabetes, rheumatoid 
arthritis and scleroderma are all TH1-driven autoimmune diseases. In type 1 diabetes (insulin-
dependent diabetes mellitus, IDDM) autoaggressive T helper cells (CD4+) and cytotoxic T 
cells (CD8+) infiltrate the pancreas and induce islet β-cell destruction and insulinitis. Studies 
showing that OdDHL down-regulate immune responses in an apparent TH1 selective manner 
suggest that OdDHL may function as a therapeutic in TH1 driven diseases. In an interesting 
study, female non-obese diabetic (NOD) mice were treated with OdDHL, OHHL and OtriDHL 
(N-3-oxo-tridecanoyl homoserine lactone), PBS and DMSO and evaluated for the onset of 
diabetes by test of glycosuria. OdDHL prophylaxis was shown to significantly retard the 
cumulative incidence of diabetes, while OHHL and OtriDHL had no significant effect (312). 
(Refer to figure 24 showing the effect of OdDHL on pancreatic islet morphology compared to 
placebo treatment).  
Whether OdDHL may have applications as a pharmaceutical agent in IDDM and other 
autoimmune diseases remains to be established. 
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Figure 24. The morphology of pancreatic islets treated with vehicle (dimethyl sulphoxide; DMSO) (left) and with 
OdDHL (3-oxo-C12-HSL) (right). The DMSO treated control shows the mononuclear insulitis characteristics of 
NOD mice (311, 312). 
Ritchie et al., 2003 investigated the effect of OdDHL on C57BL/6 mice (TH1-biased) and 
BALB/c mice (TH2-biased) and found that the cytokine profile was altered depending on the 
underlying immune bias of the mouse strain used.  Mice of the C57BL/6 strain showed a 
relative increase of the TH1 cytokine IFN-γ as response to OdDHL, while BALB/c mice 
exhibited a relative increase of the TH2 cytokine IL-4 (331). Moreover, a similar pattern was 
seen with T lymphocytes from the two strains. The authors thus suggested that the effect of 
OdDHL on T-cell cytokine production is mostly non-specific and accentuates an underlying 
immune response bias rather than specifically altering either TH1 or TH2 responses (331). In 
another study the authors demonstrated that OdDHL in vitro inhibits differentiation of both 
TH1 and TH2 cells and that the balance of cytokine production by TH cells stimulated in the 
presence of OdDHL varies with both the antigen concentration and its affinity for the T cell 
receptor (329). Thus the use of different systems may be the source of conflicting observations 
on the effect of OdDHL on the TH1/TH2 equilibrium. Another related explanation on the 
contradicting reports is proposed by Pritchard, 2006 (311), who suggests that the effect of 
OdDHL on the TH1/ TH2 balance is determined by the OdDHL concentration. High 
concentration of OdDHL (100 µM) is mainly used in studies pointing at a TH1 directing effect 
of OdDHL such as Smith et al., 2001-2 while low concentrations of OdDHL (>10 µM) have 
been applied in studies demonstrating promotion of the TH2 response such as Telford et al., 
1998 (358, 359, 378). Among the observations which contradict this hypothesis is that OdDHL 
decreases IL-12 production by LPS stimulated macrophages in concentrations ranging from 0.1 
to 100 µM, moreover production of the TH1 supporting cytokine TNF α by LPS stimulated 
macrophages has been shown to be down-regulated by OdDHL in concentrations above 40 µM 
(378). Thus, while there is growing evidence that OdDHL possesses immunomodulatory 
properties, the effects of OdDHL on elements of the immune response in vivo as well as in 
vitro still call for further investigations. 
 
THE CONCENTRATION OF QUORUM SENSING SIGNAL MOLECULES IN CULTURES AND IN VIVO 
Although virulence factor production by P. aeruginosa, as well as the clinical relevance of 
immunomodulatory effects of quorum sensing signal molecules may depend on their 
concentration, only a very limited number of studies have sought to quantify the concentration 
of signal molecules in P. aeruginosa liquid cultures and biofilms. This may be partly due to the 
problems of measuring heat labile 3-oxo-AHLs such as OdDHL by the use of GC-MS (44). 
The concentration of OdDHL in PAO1 cultures have been reported to be in the order of 5 µM 
(288). Concentrations of BHL and OdDHL in exponentially growing P. aeruginosa PAO1 
cultures have been quantified by HPLC-(UV) and the concentration of BHL was determined to 
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be in the range of 0.12 µM to 2.01 µM, while OdDHL under the same conditions was found to 
be 0.45 µM to 1.16 µM (325). In biofilms the concentration of OdDHL has been found to be 
surprisingly higher; 632 µM (± 381 µM) (52).  
The concentrations of PQS and the related 2-heptyl-4-hydroxyquinoline N-oxide (HQNO ) in 
overnight cultures of P. aeruginosa PAO1 and PA14 have been measured to be 17.0-17.4 µM 
and 32.8-35.8 µM for PQS and HQNO, respectively (191). PQS, HQNO and the two main 
AHLs of P. aeruginosa BHL and OdDHL have all been found in lung tissue and sputum of CF 
patients (60, 207, 352). The concentration of PQS in CF sputum has been estimated to be 
around 2 µM, and the concentration of OdDHL in sputum and lung tissue of CF patients have 
been found to be in the pico- to nanomolar range (60, 92, 352). Thus the PQS level in sputum 
is roughly 10 % of the PQS concentration in liquid P. aeruginosa cultures, whilst the 
concentration of OdDHL is 1000 fold lower in CF sputum compared to liquid cultures and 
drastically lower compared to biofilm samples. The reason for the immense difference between 
the OdDHL levels in liquid cultures and in sputum could be that the P. aeruginosa strains 
infecting the CF lung produce less OdDHL than the laboratory strains used for quantifying 
AHLs in liquid cultures. The low concentration of OdDHL found in the CF sputum could also 
be caused by continuous degradation of OdDHL by host paraoxanases, perhaps even after 
sampling (58, 433).  
It thus seems that further measurements of the OdDHL concentration in medical settings such 
as in burn wounds and in acute and chronic lung infections are still needed in order to define a 
biologically relevant OdDHL concentration. 
WHAT IS THE MECHANISM(S) BEHIND ODDHL’S IMMUNOMODULATORY EFFECTS? 
In order to determine which structural key features of OdDHL is essential for its 
immunosuppressive activity Chhabra et al., 2003 investigated a range of AHLs and analogues 
and showed that the optimal structures in regard to immunosupression were AHLs with 11-13 
carbon acyl chains containing either a 3-oxo or a 3 hydroxy group and a high lipophilicity of 
the molecule (53). This is supported by several studies where short and middle chain AHLs 
were investigated along with OdDHL, but not found to possess immunomodulatory activity 
(144, 377, 378). Since the hydrophobicity seems to be involved in the immunomodulatory 
activity of OdDHL, it has been suggested that insertion of the signal molecule within the lipid 
bilayer is the cause of OdDHL’s effects on cells of the immune defence including its ability to 
induce apoptosis. While it is still unknown whether PQS is also capable of crossing the 
eukaryotic cell membrane, several studies have demonstrated that AHLs (e.g. BHL, OdDHL 
and N-(3-oxooctanoyl)-L-homoserine lactone, OOHL) are able to cross the cell membrane of 
various cell lines and to function in mammalian cells; thus the target of OdDHL may be an 
intracellular factor (253, 330, 347, 417).  
 
IL-8 secretion is transcriptionally upregulated by binding of the transcription factor NF-κB to 
its promoter (351) and OdDHL increases NF-κB leading to the induced IL-8 transcription 
found by (79, 358). Production of the MAP kinase p42/44 MAPK (ERK1/2) by human 
epithelial cells has also been reported to be induced by the presence of OdDHL (395). Addition 
of a specific MAP kinase inhibitor abolished the OdDHL mediated induction of IL-8 
transcription, thus it seems that MAP kinases are also involved in the OdDHL induced 
activation of NF-κB leading to increased IL-8 secretion (358). OdDHL also induces expression 
of genes encoding Activator Protein 2 (AP-2), cyclooxygenase 2 (COX-2) and prostaglandin 
E2 (PGE2). COX-2 can be induced by a wide variety of inflammatory stimuli (360) and a 
number of pathways have been described to be involved in transcriptional regulation of COX-2 
in response to inflammatory mediators, among these NF-κB and factors being a part of MAP 
kinase cascades (72, 108). COX-2 has long been regarded as a mediator of proinflammatory 
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responses as this enzyme converts arachidonic acid to prostaglandin H2, the precursor of 
thromboxane and the series-2 prostanoids e.g. PGE2 which promote inflammation, fever, and 
pain (391). However, recent studies suggest that COX-2 also plays an important role in the 
process of resolving inflammation and in healing by mediating production of cyclopentenone 
prostaglandins including 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) (111, 161, 233). This 
naturally occurring eicosanoid displays a broad spectrum of biological activities, including 
regulation of apoptosis and cell proliferation, suppression of IL-6-induced STAT3 
phosphorylation, stimulation of ERK (p42/44 MAP kinases) via H-Ras, and induction of anti-
inflammatory effects (91, 167, 273, 343, 428). (See figure 25). 
It has been proposed that 15d-PGJ2 exerts its anti-inflammatory activity through the activation 
of peroxisome proliferator-activated receptor-γ (PPAR-γ) and also via the inactivation of NF-
κB by directly inhibiting its effector kinase I B kinase (IKK) or the p50 subunit (47, 156, 328, 
333). PPAR-γ is a phosphoprotein and its activity is regulated by ligand binding and 
phosphorylation. The phosphorylation is presumed to be accomplished by MAPKs, particularly 
ERK (146, 441). Ligand-activated PPAR-γ mediates its anti-inflammatory effects on various 
immune cells. PPAR-γ has been shown to inhibit IL-2 production by T cells, down-regulate 
dendritic cells’ IL-12 production and maturation, and attenuate endothelial cells’ production of 
T cell-active CXC chemokines which play an important role in T cell recruitment to the site of 
inflammation (170, 218, 435). Thiazolidinediones, a group of PPAR-γ agonists, are routinely 
applied to treat patients with non-insulin-dependent diabetes mellitus (NIDDM, Type 2 
diabetes mellitus), moreover PPAR-γ agonists have been shown to reduce the incidence of 
diabetes in NOD mice (19, 23, 24).  
 
Figure 25. Pro-inflammatory and anti-inflammatory 
actions of 15d-PGJ2. The prostacyclin 15d-PGJ2, 
derived from PGD2, may interact with the PGD2 
receptors DP1, DP2  (the latter also known as 
Chemoattractant Receptor-homologous molecule 
expressed on TH2 cells (CRTH2)) to activate protein 
kinase A (PKA) (anti-inflammatory) and stimulate 
Ca2+ influx (inflammatory). In the cytosol, PGJ2 may 
directly activate the Ras/Erk pathway, and bind to 
and inhibit IκB kinase (IKK), the activator of NF-κB. 
dditionally, 15d-PGJ2 may inhibit NF-κB activity 
dDHL may also interact directly with PPAR-γ. Structural overlap between OdDHL and an 
array of agonists and antagonists (including 15d-PGJ2 and the thiazolidinedione Rosiglitazone) 
A
either by directly blocking NF-κB DNA binding sites 
in the nucleus, or activating PPAR-γ to stimulate 
synthesis of the NF-κB inhibitory subunit IκB. 
(Adapted from (343)) .  
 
As mentioned earlier, OdDHL also has the 
capacity to prevent autoimmune diabetes in 
NOD mice, by inhibiting IL-2 production in 
T cells and, as shown in article 4, decreasing I
of dendritic cells. Moreover, OdDHL has als
(p42/44 MAP kinase), suppress STAT3 and 
events, activities also carried out by 15d-PGJ2. 
mechanisms exerted by OdDHL could be that O
proinflammatory prostaglandins such as PGE2 promoting a proinflammatory response, or 
mediates generation of prostacyclins such as 15d-PGJ2, which in turn mediates an anti-
inflammatory effect via PPAR-γ and NF-κB. 
 
L-12 production in dendritic cells and maturation 
o been shown to induce MAPKs such as ERK 
induce calcium influx leading to inflammatory 
Thus one hypothesis for the immunomodulatory 
dDHL induces COX-2, which either generates 
O
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Rerank 
suggests that OdDHL may have the capacity to bind to the PPAR-γ receptor. Moreover, in 
silico docking of OdDHL against the x-ray crystallographic structure of PPAR-γ bound to its 
agonist BPR1H036 ligand 3EA (212) shows that OdDHL has high affinity for PPAR γ. See 
table 2 and figure 26. 
 
Table 2. Docking of OdDHL and known agonists to PPAR γ and mean of random molecules. 
 Molecule MolDock 
 
a BPR1H036  -144.5 -62.2
b OdDHL -104.0 -89.7
c 15dPGJ2 -84.5 3.3
d Rosiglitazone -5
y mean 
-81.3 4.6
e PGD2 -65.9 57.9
*Diversit 116.8 51.4
T phic stru  the li n
[5 luoromet zo[d] ol-6 xypropoxy]indol-1-yl]ethanoic acid) (RCSB PDB 
 
Figure 26.  A. The PPAR γ dimer bound to its agonist BPR1H036. From www.rcsb.org/pdb Protein Databank of 
the Research Collaboratory for Structural Bioinformatics RCSB PDB code 2ath, ligand 3EA. (PDB Si ple 
ediated by 15dPGJ2. This could be due to direct interaction between OdDHL and 
 
he x-ray crystallogra
-[3-[7-propyl-3-(trif
cture of
hyl)-ben
gand bi
isoxaz
di g domain of  PPAR-γ bound to its agonist BPR1H036 (2-n
-yl]o
code 2ATH, ligand 3EA) was used for docking of OdDHL and PPAR-γ agonists using the Template Docking 
Model with default settings (Molegro Virtual Docker (MVD2007) (382)). The PPAR-γ agonist BPR1H036 was 
set as the template ligand. Ligands were ranked by using the MVD MolDock score. The re-rank scoring is also 
shown. Positive scores indicate low affinity.  
*Diversity mean is the average score of 25 random molecules from NCI Diversity Set of small molecules. 
 
m
viewer).  B.  OdDHL (carbon atoms grey, oxygen atoms red and nitrogen atom blue) superimposed in the LBD of 
PPAR γ with BPR1H036 (red) as template. (Molegro Virtual Docker, MVD2007). 
 
It is intriguing that the effect of OdDHL on various mammalian pathways resembles those 
m
transcription factors (activation of PPAR-γ and/or inhibition of IKK and thus NF-κB) or 
because OdDHL interacts with a factor upstream of 15dPGJ2, such as COX-2, thereby inducing 
production of 15dPGJ2 or another prostanoid with similar effects. The possibility however, that 
OdDHL either directly or indirectly interacts with PPAR-γ remains to be investigated by 
experimental studies.    
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ere in the beginning of the 21st century, P. aeruginosa has definitely emerged as a serious 
opportunistic pathogen. This prevalent bacterium has multiple ways to escape the antagonistic 
actions of the immune defence; P. aeruginosa readily forms biofilms and the biofilm matrix 
confers physiological protection against aggressive host factors. Moreover, this microbe 
produces an array of cell destructive and toxic virulence products which weaken the host 
barriers and fortification against this intruder. Just to mention a few examples on the harsh 
armament of this bacterium: P. aeruginosa produces rhamnolipids which can impose 
immediate lysis of neutrophils and other mammalian cells, and also generates several tissue 
degrading enzymes such as lipases, elastases and proteases. Additionally this pathogen is 
capable of producing hydrogen cyanide which is a true chemical warfare agent, as it inhibits 
mitochondrial cytochrome oxidase and P. aeruginosa hydrogen cyanide has been shown to 
rapidly paralyse and kill nematodes. P. aeruginosa is being found at an increasing frequency in 
connection to serious infections and with its inherent high tolerance to antimicrobial agents, 
together with its ability to constantly evolve new resistance mechanisms, emphasize the 
clinical problems associated with this organism. Collectively, there is an urgent need for the 
development of new drugs targeting the various protective and aggressive survival mechanism 
of this bacterium. 
One attractive strategy is to target its “line of command” which the bacterium uses to 
coordinate and regulate complex activities involved in biofilm formation, immuno-modulation, 
and virulence factor production. The concept of treating noxious activities by interfering with 
signal pathways is commonly used in many endogenous diseases to treat the condition or 
alleviate symptoms, for instance Selective Serotonin Reuptake Inhibitors (SSRIs) are used to 
treat depression by increasing the level of serotonin in the synapses, and Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs) are used to ease the pain in rheumatoid arthritis by 
counteracting COX-2’s production of inflammatory prostaglandins. To reassign this concept 
and use it to treat bacterial infections is however, novel. Microbial diseases are traditionally 
defeated by the use of bactericidal or bacteriostatic agents although, as outlined previously, this 
strategy has major disadvantages due to the selective pressure for development of resistance 
and tolerance to the drugs used. Pharmaceuticals designed to interfere with bacterial 
communication can be developed based on structured design using known inhibitors or using 
the recently solved LBD of the LasR crystal. Another option is to screen natural libraries for 
antagonists of bacterial communication as described in articles 1 and 2.  
Natural libraries are valuable in the development of novel drugs because they provide a vast 
array of bioactive compounds. And in many cases natural selection is superior to combinatorial 
chemistry for discovery of novel substances with drug potential.  Natural sources are very rich 
on diverse secondary metabolites. Plants have been reported to produce more than 100,000 
small-molecule compounds and this high diversity is -at least in part- caused by an 
evolutionary process driven by selection for improved defence against microbial attack or 
insect/animal predation (80). Another important feature of naturally derived drugs is that 
besides being biologically active, they have also evolved to function in the target organism. 
Antibiotics derived from natural sources (for example, aminoglycosides, tetracycline and 
chloramphenicol) are able to bypass the dual barrier-extrusion mechanism of Gram-negative 
bacteria, while synthetic compounds optimised to inhibit e.g. DNA gyrase may be excluded by 
the membrane or omitted by the Mex pumps and thereby fail. 
Natural products are, on average, sterically more complex, with more rings and chiral centres, 
incorporate fewer nitrogen, halogen, or sulphur atoms but more oxygen atoms and have higher 
molecular weights than combinatorial compounds (132). Thus screening of natural libraries is a 
very strong alternative or supplement to combinatorial chemistry.  
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I CTION TO TH PERIMENTAL WORK 
 for quorum sensing inhibitors in a library consisting of microfungi. 
 quorum sensing inhibitors and 23 % of the extracts were found to be active. 
vealed that the three 
NTRODU E EX
Article 1 entails a screening
Crude extracts of different isolates of Penicillium sp. were tested for the presence of quorum 
sensing inhibitory compounds by the use of the bacterial screening systems Quorum Sensing 
Inhibitor Selector (QSIS) 1 and 2. Two mycotoxins, patulin and penicillic acid were identified 
as strong inhibitors of quorum sensing, and their effect on P. aeruginosa gene expression was 
further investigated by whole genome transcriptomics. This analysis revealed that quorum 
sensing inhibitory genes were highly overrepresented among the genes down-regulated by the 
two mycotoxins. Patulin was shown to enhance biofilm susceptibility to tobramycin treatment, 
moreover both patulin and penicillic acid allowed neutrophils to develop oxidative burst when 
exposed to P. aeruginosa biofilms, while the activation of neutrophils was hindered by the 
untreated wild-type. Patulin was also shown to function in vivo; in a mouse pulmonary 
infection model P. aeruginosa was cleared faster from the mice treated with patulin compared 
with the placebo group. 
 
Article 2 describes the screening of 284 marine organisms collected at the Great Barrier Reef, 
Australia. Using the luxI-luxR-based QSIS1 system, extracts of marine organisms belonging to 
various taxonomic groups (algae, ascidians, hard coral, soft corals and sponges) were screened 
for the presence of
About half of the active extracts were also positive in the lasB-lasR-based QSIS2 system. 
Extracts of the sponge Luffariella variabilis proved active in both systems. The secondary 
metabolites manoalide, manoalide monoacetate and secomanoalide isolated from this sponge 
were tested using a quorum sensing regulated biomonitor system, and the three manoalides 
were found to have strong quorum sensing inhibitory properties. Interestingly, the manoalides, 
patulin, penicillic acid (in the predominant lactone form) and the halogenated furanones all 
share the 2,5-dihydro-2-furanone (or 2-buten-1,4-olide) structure suggesting that this 
substructure is important for their quorum sensing inhibitory properties e.g. via interaction with 
the LuxR(-homologue). Also protoanemonin, a toxic by-product formed during the 
biodegradation of some chloroaromatic compounds, e.g. polychlorinated biphenyls, contain the 
2(5H)-furanone and exhibit tremendous quorum sensing inhibitory activity. (Article in 
preparation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Quorum sensing inhibitors sharing the 2,5-dihydro furanone structure. A) Penicillic acid (lactone and 
acid in tautomeric equilibrium) B) Patulin C) C30 D) Secomanoalide E) Protoanemonin 
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The submitted manuscript (article 3) describes the screening of 12 antibiotics using the QSIS1 
selector system. Three of the antibiotics screened; azithromycin (AZM), ceftazidime (CFT) and 
ciprofloxacin (CPR) exhibited strong quorum sensing inhibitory activities and were further 
studied by transcriptomics and phenotypic tests. These investigations re
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nsing regulated virulence factors of P. 
 Cephalosporium acremonium (synonymous with Acremonium 
P. aeruginosa quinolones have been reported to have antibacterial activity 
s well as being involved in quorum sensing. It is thus likely that antibiotics may, beside their 
aditional bactericidal applications, have the potential to be used to regulate cell to cell 
ommunication in bacteria.    
hile a range of compounds produced by eukaryotic organisms such as the mycotoxins patulin 
nd penicillic acid, as well as the three manoalide compounds produced by the sponge L. 
ariabilis seem to interact with quorum sensing in P. aeruginosa there is also evidence that the 
ommunication goes the other way round. The final manuscript (article 4) describes the effect 
f P. aeruginosa quorum sensing signal molecules on the development and maturation of 
timulated dendritic cells. Interestingly it seems that PQS and especially OdDHL are able to 
hange the pro-inflammatory TH1-directing response elicited by the dendritic cells to an anti-
flammatory TH2-directing response. Other studies have also shown that P. aeruginosa 
nsing signal molecules possess the ability to shape cellular proces
 of the immune defence – of eukaryotic cells. 
antibiotics efficiently down-regulated several quorum se
aeruginosa. However, in contrast to most other quorum sensing inhibitors identified until now, 
AZM, CFT and CPR most likely do not interact directly with LasR as in silico docking shows 
that the antibiotics have low affinity for the LBD of the LasR protein due to spatial effects. The 
transcriptome analysis suggests that the quorum sensing inhibitory properties of the 
investigated antibiotics at least in part is mediated by a change in membrane permeability 
influencing the OdDHL flux. 
 
Most antibiotics developed until today are of natural origin or are derivatives of natural 
products. In the last 25 years (1981-2006) 64 out of the 109 antibacterials introduced to the 
market, have been based on natural compounds or derivatives thereof (254). This is also 
reflected in the three antibiotics investigated; AZM is a azalide derivative of erythromycin, a 
metabolic product of a Streptomyces erythreus strain (designation changed to 
"Saccharopolyspora erythraea") (407). Ceftazidime belongs to the group of cephalosporins 
riginally purified fromo
chrysogenum) (3). The fluoroquinolone ciprofloxacin is a derivative of nalidixic acid, a 
synthetic inhibitor of DNA gyrase, synthesised as a precursor of the antimalarial agent quinine.  
The knowledge that naturally occurring quinolones possess antibacterial properties, dates a 
long way back: In 1889 P. aeruginosa (at that time named Bacillus pyocyaneus) cultures were 
shown to prevent anthrax in rabbits, and later on in 1952 the active compounds responsible for 
the prophylactic effect were identified as quinolones (31, 76, 126, 409).  
 
It has been widely accepted that the function of antibiotics in nature is as weapons targeted 
against competitors however, a recent article questions this assumption (199). Using a focused 
subgenomic array (555 genes) and phenotypic tests, the authors demonstrated that tobramycin, 
tetracycline, and norfloxacin (structurally very similar to ciprofloxacin) applied in subMIC 
concentrations activated expression of virulence determinants in P. aeruginosa, for instance 
expression of the type III secretion system (TTSS) was induced by the presence of tetracycline. 
These findings prompted the authors to suggest that the ecological role of antibiotics are not 
only to slay competitors but also - in low concentrations – to function as signalling molecules 
regulating the homeostasis of microbial communities (199), and the reverse may also be the 
ase: As mentioned, c
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ge of the host immune response.  
Thus to sum up; P. aeruginosa applies quorum sensing signal molecules to control virulence 
factors important for its infectious capacity, including rhamnolipids capable of lysing 
phagocytes and enzymes with host tissue and complement degrading activities. These signal 
molecules also seem to be capable of directly changing the immune response of the host, while 
host factors such as INF γ affect P. aeruginosa quorum sensing. The key to successful control 
may lie in the obstruction of the capability of this pathogen to sense, modulate and cripple the 
immune defense. As outlined in articles 1 and 2, eukaryotes such as fungi and marine 
organisms produce compounds which interfere with bacterial cell-to-cell signalling. These 
quorum sensing inhibitory compounds have the potential to be used to target P. aeruginosa 
virulence and thereby decrease tissue and host cell destruction as well as the quorum sensing 
signal molecule mediated chan
 
Thus the ability of P. aeruginosa to respond to host factors and manipulate actions of the 
immune response may contribute to the success of this pathogen. At the same time eukaryotic 
organisms may offer a solution for overcoming P. aeruginosa infections by providing us with 
inhibitors of bacterial communication.  
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Quorum sensing (QS) communication systems are thought to afford bacteria with a mechanism
to strategically cause disease. One example is Pseudomonas aeruginosa, which infects
immunocompromised individuals such as cystic fibrosis patients. The authors have previously
documented that blockage of the QS systems not only attenuates Ps. aeruginosa but also
renders biofilms highly susceptible to treatment with conventional antibiotics. Filamentous fungi
produce a battery of secondary metabolites, some of which are already in clinical use as
antimicrobial drugs. Fungi coexist with bacteria but lack active immune systems, so instead rely
on chemical defence mechanisms. It was speculated that some of these secondary metabolites
could interfere with bacterial QS communication. During a screening of 100 extracts from 50
Penicillium species, 33 were found to produce QS inhibitory (QSI) compounds. In two cases,
patulin and penicillic acid were identified as being biologically active QSI compounds. Their
effect on QS-controlled gene expression in Ps. aeruginosa was verified by DNA microarray
transcriptomics. Similar to previously investigated QSI compounds, patulin was found to enhance
biofilm susceptibility to tobramycin treatment. Ps. aeruginosa has developed QS-dependent
mechanisms that block development of the oxidative burst in PMN neutrophils. Accordingly,
when the bacteria were treated with either patulin or penicillic acid, the neutrophils became
activated. In a mouse pulmonary infection model, Ps. aeruginosa was more rapidly cleared from
the mice that were treated with patulin compared with the placebo group.
INTRODUCTION
The 20th century initially offered the promising prospect of
penicillin and other antibiotics to fight bacterial infections,
but ended with the gloomy scenario of emerging multi-
resistant bacteria. The efficiency of conventional antibiotics
in preventing bacterial proliferation is the source of their
success, but at the same time is also the cause of their
failure. In many cases, selective pressure imposed by the use
of conventional antibiotics leads to increased expression
of degrading enzymes and development of drug-efflux sys-
tems which operate with increased efficiency and therefore
actively reduce the internal concentration of the anti-
biotics. Furthermore, research over the last two decades
has revealed that bacteria in the biofilm mode exhibit a
higher tolerance to antimicrobial treatments (Anwar et al.,
1990). The biofilm mode of growth also protects oppor-
tunistic pathogens, such as Pseudomonas aeruginosa, against
the action of the host immune system, which in turn
facilitates establishment of chronic infections (Costerton
et al., 1999).
Abbreviations: AHL, N-acylated homoserine lactone; 123-DHR,
dihydrorhodamine 123; GFP, green fluorescent protein; PMN, poly-
morphonuclear leukocyte; QS, quorum sensing; QSI, QS inhibitor(y).
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The prospect of the 21st century as a post-antibiotic era
highlights the importance of novel strategies to control
bacterial diseases (Camara et al., 2002). Many Gram-
negative bacteria utilize N-acylated homoserine lactones
(AHLs) to coordinate expression of virulence in response
to the density of the surrounding bacterial population in a
process termed quorum sensing (QS). The AHL molecules
are produced by LuxI homologues and constitute, in
complex with LuxR homologues, transcriptional regulators.
AHLs consist of a conserved homoserine lactone ring with
a variable N-acyl chain. The predominant AHL variations
include presence or absence of a keto or hydroxy group on
the C-3 carbon atom, as well as the length and saturation
of this chain (Fuqua et al., 1994; Salmond et al., 1995). A
number of recent publications have pointed to QS as a
new drug target. Fighting bacteria by interfering with
their command language and thereby disrupting virulence
expression instead of inhibiting growth could serve as an
alternative to the conventional ways of combating bac-
terial infections (Finch et al., 1998; Habeck, 2003; Smith
& Iglewski, 2003; Hentzer & Givskov, 2003). The strategy
would be based on small molecules with variations in their
chemical composition that would allow them to block the
AHL receptor site of the LuxR homologues or alternatively
block the formation of active dimers that are required for
binding to and expression of target genes. A number of
studies have identified several molecules that function as
QS inhibitors (QSI) (Smith et al., 2003a, b; Reverchon
et al., 2002; Olsen et al., 2002; Hentzer & Givskov, 2003).
Much effort has been spent on synthesis of AHL analogues
which antagonize the cognate signal molecules. Varying
the length of the acyl side chain was found to be impor-
tant; for example AHLs with extended side chains generally
caused inhibition of the LuxR homologues (Chhabra et al.,
1993; Passador et al., 1996; Schaefer et al., 1996; Zhu et al.,
1998). Other modifications to the AHLs included altera-
tion of the acyl chain by introducing ramified alkyl,
cycloalkyl or aryl/phenyl substituents at the C-4 position,
resulting in both inducers (analogues with non-aromatic
substitutions) and antagonists (analogues with phenyl
substitutions) (Reverchon et al., 2002). Modification of
the lactone ring of AHLs by adding substituents to C-3 or
C-4 did not give rise to strong QSI activity (Olsen et al.,
2002). However, exchanging the homoserine ring with a
five- or six-membered alchohol or ketone ring, Smith et al.
(2003a, b) generated a number of activators and inhibitors,
some of which blocked of Ps. aeruginosa QS in vitro. Their
target specificity for the QS regulon was not verified by
transcriptomics.
In nature, eukaryotes live closely associated with virulent
prokaryotes. This has forced mammals to evolve different
defence systems. Plants and fungi, however, do not possess
active immune systems; instead they have to rely on physical
and chemical defences. A well-studied example of this is
the production of halogenated furanone compounds by
the Australian alga Delisea pulchra (Givskov et al., 1996).
This species produces the compounds in the central vesicle
of gland cells, from which they are released to the surface
of the plant (Dworjanyn & Steinberg, 1999), where they
prevent extensive surface growth by bacteria and higher
fouling organisms (Steinberg et al., 1997; Maximilien et al.,
1998). The halogenated furanones have been shown to
inhibit several QS-controlled phenotypes, including swarm-
ing motility of Serratia liquefaciens, toxin production of
Vibrio harveyi and bioluminescence of Vibrio fischeri
(Givskov et al., 1996; Kjelleberg et al., 1997; Manefield
et al., 2000; Rasmussen et al., 2000). In a more clinical
context, a synthetic derivative of the furanones (C-30) was
found to downregulate expression of more than 80% of
the QS-regulated genes found in Ps. aeruginosa, many of
which encode known virulence factors. This effect is not
limited to planktonic bacteria: it also applies to biofilm-
dwelling Ps. aeruginosa. Biofilms developed in the presence
of furanone compounds become more susceptible to treat-
ments with antibiotics and disinfectants (Hentzer et al.,
2002, 2003). This is highly interesting given that Ps.
aeruginosa is an opportunistic pathogen often found in
people with compromised immune systems, such as cystic
fibrosis patients, where it is responsible for persistent,
chronic infections probably caused by biofilm formation
within the host (Hoiby & Koch, 2000; Hoiby, 2000; Van
Delden & Iglewski, 1998). Attenuating this bacterium
with respect to virulence and persistence is undoubtedly
desirable; the first proof of this concept was delivered by
Hentzer et al. (2003), who were able to attenuate and
eradicate bacteria colonizing mouse lungs.
In the present study, selected members of the filamentous
fungal genus Penicillium were investigated for production
of QSI activity. Microfungi produce a huge variety of
secondary metabolites, including complex molecules such
as alkaloids and polyketides. Some of these are myco-
toxins, compounds which can cause disease and sickness
in vertebrates at fairly low concentrations. The b-lactam
antibiotics, which include penicillin G and cephalosporin,
were originally isolated from Penicillium species. The
immunosuppressants cyclosporin and tacrolimus used in
connection with organ transplants also originate as fungal
metabolites. The ability to produce a wide variety of bio-
active compounds makes the microfungi obvious candid-
ates to screen for QSI products. Using a recently published
screening system consisting of bacteria that will grow only
when the growth medium is supplemented with a QSI
compound (Rasmussen et al., 2005), extracts of 50 mem-
bers of the genus Penicillium have been screened. Several
fungi were found to produce QSI activities and two of the
compounds were identified and examined for their speci-
ficity for the Ps. aeruginosa QS regulon, and their effects
on both biofilm tolerance to antimicrobial treatments and
pulmonary infections.
METHODS
Bacterial strains. The two QSI selector strains, QSIS1 (Apr, luxI–
phlA) and QSIS2 (Apr Gmr, lasB–sacB) were described by Rasmussen
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et al. (2005). We also used a quorum-sensing reporter strain such as
Ps. aeruginosa PAO1 harbouring a lasB–gfp fusion (Hentzer et al.,
2002). The Ps. aeruginosa PAO1 used for the in vitro experiments
was obtained from the Pseudomonas Genetic Stock Center (www.
pseudomonas.med.ecu.edu, strain PAO0001). This PAO1 isolate has
served as DNA source for the Pseudomonas Genome Project (www.
pseudomonas.com) and, subsequently, as template for design of the
Ps. aeruginosa GeneChip (Affymetrix, Inc.). The DlasI rhlI mutant
and the DlasR rhlR mutant were constructed using previously des-
cribed knock-out systems (Beatson et al., 2002a, b). The knock-out
mutants were verified by Southern blot analysis and by screening for
absence of AHL production. When green fluorescent protein (GFP)
was employed as a bacterial tag, we used a constitutively expressed
stable GFP version encoded by a gene present on the plasmid
pMRP9 (Davies et al., 1998).
The Ps. aeruginosa used for in vivo experiments was obtained from
B. Iglewski, University of Rochester, Medical Center, Rochester, NY,
USA. The DlasR rhlR mutant of the Iglewski PAO1 was constructed
using the same knock-out systems as for PAO0001 (Beatson et al.,
2002a, b). The knock-out mutants were verified by Southern blot
analysis and by screening for absence of AHL production.
Growth medium and conditions. ABT minimal medium (AB
medium of Clark & Maaløe, 1967, plus 2?5 mg thiamine l21) sup-
plemented with 0?5% glucose and 0?5% Casamino acids was used.
Media were supplemented with antibiotics where appropriate, and
unless stated otherwise, all strains were incubated at 30 uC.
Fungal strains. Fungal isolates (Table 1) were obtained from the
IBT Culture Collection at BioCentrum-DTU, Technical University
of Denmark. The cultures were inoculated in triplicate on Czapek
yeast (autolysate) agar (CYA) (Pritt, 1979) and yeast extract sucrose
agar (YES) (Frisvad & Filtenborg, 1983) and incubated at 25 uC for
7 days in the dark.
Preparation of fungal extracts. Procedures for micro-extraction
of fungal secondary metabolites were similar to those given by
Smedsgaard (1997) with the following modifications. Plug extracts
were prepared from nine plugs and extracted with 2 ml ethyl acetate/
methylene chloride/methanol (3 : 2 : 1, by vol.) containing 50 p.p.m.
trifluoroacetic acid.
Screening for QSIs. The screening assays using QSIS1 and QSIS2
were performed as described by Rasmussen et al. (2005). QSIS1 is
an E. coli lac+ strain harbouring pTBR2iB, which encodes an AHL-
induced killing system. QSIS2 is a Ps. aeruginosa lasI rhlI double
mutant harbouring pLasB-SacB1, encoding an AHL-induced killing
system; this strain also harbours pSU2007, encoding constitutively
expressed luxCDABE, giving rise to bioluminescence (Rasmussen
et al., 2005).
Microfractionation of extracts. An Agilent 1100 series HPLC
with fraction collector coupled to a G2250A Micro plate sampler
was used for microfractionation. Samples were fractionated on a
Phenomenex Luna II C18 column (100 mm64?6 mm, 5 mm) at
40 uC with a flow rate of 1 ml min21 and the following H2O/
CH3CN solvent gradient: 2 min at 10% CH3CN/H2O; a linear
gradient to 70% CH3CN/H2O for 12 min; isocratic at 70% for
another 10 min; a linear gradient for 2 min to 100% CH3CN,
followed by isocratic at 100% CH3CN for 4 min then returned to
10% CH3CN/H2O in 2 min and re-equilibrated for 8 min. Solvents
were HPLC-grade acetonitrile and MilliQ water, both with 50 p.p.m.
trifluoroacetic acid added. HPLC eluate was collected into Nunculon
polystyrene microtitre plates (Nunc) for HPLC samples containing
less than 70% acetonitrile. Solvent-resistant U96 PP 0?5 ml poly-
propylene plates (Nunc) were used for collection of HPLC eluate
containing more than 70% acetonitrile.
Identification of active compounds by LC-DAD-MS. Fungal
metabolites were analysed using an Agilent HP 1100 liquid chro-
matograph with a DAD system (Waldbronn) coupled to an LCT
oaTOF mass spectrometer (Micromass) using a Z-spray ESI source
and a Lock Spray probe. A Phenomenex Luna II C18 column
(100 mm62 mm, 3 mm) at 40 uC and a flow rate of 0?3 ml min21
was used for separation. Solvents were HPLC-grade acetonitrile and
MilliQ water. The water was buffered with 10 mM ammonium for-
mate (analytical grade) and 20 mM formic acid, and the acetonitrile
with 20 mM formic acid.
Dose response. To establish a dose–response relationship of
patulin and penicillic acid, dilution rows were made with growth
medium (ABT with 0?5% Casamino acids) in a microtitre dish.
Each well contained 100 ml diluted QSI and 200 ml of a 1 : 100
diluted overnight culture of PAO1 lasB-gfp(ASV) (Hentzer et al.,
2002), grown in ABT with 0?5% Casamino acids, was added.
Growth was monitored as OD450 over a time-course of 14 h, and
GFP expression was measured at 515 nm.
DNA array analysis. ABT minimal medium supplemented with
0?5% Casamino acids (200 ml) was inoculated with exponentially
growing Ps. aeruginosa PAO1 cells (OD600<0?5) at an OD600 of
0?05. At an OD600 of 0?7, the culture was split into two 100 ml
cultures, which were grown on in 500 ml conical flasks on an orbital
air shaker operating at 200 r.p.m. at 37 uC. To one culture QSI com-
pound was added (at a non-growth-inhibitory concentration); the
second culture served as an untreated control. Patulin was added to
8 mM and penicillic acid was added to 147 mM, with both treated
and untreated cultures showing similar growth rates. Samples were
retrieved at OD600 2?0, mixed with 2 vols RNA Later (Ambion) and
stored at 280 uC until RNA extraction. RNA extraction was per-
formed with the Qiagen RNeasy Purification kit, using the bacterial
protocol. To remove all DNA, the purified RNA was treated for 1 h
with 11 U DNase I; RNA was then retrieved by using the Qiagen
RNeasy Purification kit. cDNA was synthesized by mixing 10 mg
RNA with 250 ng random primers (Invitrogen Life Technologies) in
a total volume of 30 ml. The rest of the assay was performed accord-
ing to the protocol supplied by Affymetrix.
Preparation of polymorphonuclear leukocytes (PMNs). Human
blood samples were obtained from normal healthy volunteers by
venous puncture, and collected in BD Vacutainers coated with heparin
and lithium (Becton-Dickinson, 388330). The blood was mixed with
dextran (T-500), 1 : 5, and the erythrocytes were sedimented for
40 min. The supernatant was applied to Lymphoprep (Axis-Shield
Poc.) and centrifuged at 800 g for 15 min at 5 uC. The supernatant
was discarded and the PMN neutrophils were treated with 2 ml 0?2%
NaCl in order to lyse remaining erythrocytes. Lysis was terminated by
adding 2 ml 1?6% NaCl and 6 ml Eagle-MEM (Bie & Berntsen). The
cells were centrifuged at 350 g for 10 min at 5 uC, the supernatant
was discarded and the PMNs were resuspended in Eagle-MEM.
Biofilm assays. Biofilms were grown in continuous culture, once-
through flow chambers, perfused with sterile ABtrace minimal
medium containing 0?3 mM glucose. Patulin (1?2 mg ml21) or peni-
cillic acid (1?2 mg ml21) was added to the medium when appro-
priate. Biofilm development was examined by confocal scanning
laser microscopy (CSLM) using a Zeiss LSM 510 system (Carl Zeiss)
equipped with an argon laser and a helium-neon laser for excitation
of fluorophores. Bacterial viability in biofilm cultures was assessed
by using the BacLight live/dead staining kit (Molecular Probes) as
described elsewhere (Huber et al., 2001).
PMN treatment of biofilms. In order to inoculate PMNs into the
biofilm chambers, the flow was stopped and the flow cells were
http://mic.sgmjournals.org 1327
QSIs produced by Penicillium spp.
clamped off. PMNs in the order of 1?56106 were inoculated in each
flow channel. The flow cells were incubated top down in a 37 uC
water bath with shaking, until microscopic inspection.
Monitoring the oxidative burst of PMNs. Isolated PMNs were
incubated for approximately 30 min in Eagle-MEM (36107 cells
ml21) with 10% normal human AB serum, 5 mM SYTO 62
(Molecular Probes) to stain the nuclei (dsDNA). For detecting the
oxidative burst of the PMNs 0?1 mg dihydrorhodamine 123 (123-
DHR) ml21 (D-1054, Sigma) was added to the PMNs in order to
stain the H2O2 in the phagosomes (Bassoe et al., 2003). One
hundred microlitres of the PMN mixture was added to each biofilm.
Experimental animals. Female BALB/c mice were purchased from
M&B Laboratory Animals at 10–11 weeks of age. The mice were of
equal size and were maintained on standard mouse chow and water
ad libitum for 1 week before challenge. All animal experiments were
authorized by the National Animal Ethics Committee.
Immobilization of Ps. aeruginosa in seaweed alginate
beads. Ps. aeruginosa was immobilized in seaweed alginate beads as
described by Pedersen et al. (1990). The suspension was adjusted to
2?56108 c.f.u. ml21 and confirmed by colony counts; 0?04 ml of
the suspension was inoculated into the left lung of each mouse.
Challenge procedure. The mice were anaesthetized by subcutaneous
injection of 0?2 ml Hyp/Mid [2?5 mg Hypnorm ml21 (Janssen) and
1?25 mg midazolam ml21 (Roche) in sterile water]. Sedated mice were
immobilized and the trachea was exposed and penetrated with an 18G
needle. The inoculum was introduced into the left lung approximately
11 mm from the tracheal penetration site with a bead-tipped needle
(Moser et al., 1997). The incision was sutured with silk and healed
without any complications. Pentobarbital (DAK), 2?0 ml per kg body
weight, was used to kill the animals, 5 days after infection.
Bacteriology. Lungs from mice were prepared for bacteriological
examination as described by Moser et al. (1997). Isolated lungs were
(a) (b)
(c) (d)
Fig. 1. QSIS1 (top rows) and QSIS2 (bottom rows) assays on extracts from four Penicillium spp.: (a) P. olsonii, (b) P.
roqueforti, (c) P. hordei and (d) P. carneum. The fungi were grown on two media, CYA (left columns) and YES (right columns).
For QSIS1, a blue ring indicates presence of QSI compound(s). QSIS2 indicates presence of QSI by emitting light visualized
by a photosensitive CCD camera.
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homogenized on ice. A serial dilution of the lung homogenate was
performed and plated on blue agar plates (Statens Serum Institut,
Copenhagen, Denmark), selective for Gram-negative bacilli, for
colony counting (Hoiby, 1974).
RESULTS AND DISCUSSION
Screening of Penicillium extracts
Extracts of the fungi (Table 1) were prepared as described in
Methods. As an initial, promiscuous screen, we employed
the QSIS1 selector, which identifies inhibitors of the lux
QS system. The selector bacterium harbours a QS-controlled
gene that causes cell death when expressed. In the assay, the
QSIS bacteria are cast into agar along with signal molecules
that activate the killing gene. A well is made in the agar in
which the test sample is placed. The sample diffuses into
the agar from the well, creating a concentration gradient
allowing for screening of several concentrations of the
sample. Presence of a QSI is signalled by growth of the
selector bacteria; therefore only non-toxic compounds are
identified. The QSIS2 selector was employed as a second
screen for inhibitors of the Ps. aeruginosa QS systems. It is
based on a QS-controlled sacB gene which leads to cell
death when expressed in the presence of sucrose (Rasmussen
et al., 2005). By means of these two screens, a number of
QSI-producing Penicillium species were identified (Fig. 1,
Table 1).
Fractionation of extracts and identification of
active compounds
In order to identify the individual fungal metabolites
inhibiting the QS systems of Ps. aeruginosa, Penicillium
radicicola (IBT 10696) and Penicillium coprobium (IBT
6895) were selected for further studies using microfrac-
tionation and LC-DAD-MS. QSIS1 screening of IBT 6895
showed a single active well in the microtitre plate assay of
the collected fractions (Fig. 2), whereas IBT 10696 extract
resulted in activity in five wells (data not shown).
The corresponding UV data from the microfractionation
samples suggested that the QSI compounds from P.
radicicola and P. coprobium were penicillic acid and patulin
respectively (Fig. 3). This was confirmed by LC-DAD-MS
analysis of the remaining contents of the active fractions
and by comparison with authentic samples. This is believed
to be the first report of these two well-known fungal
metabolites (Frisvad et al., 2004) acting as QSI compounds.
The identification and presence of these two compounds
Table 1. Fungal extracts tested for QSI content
+, QSI activity, 2, no activity. Extracts were prepared from fungi cultured on CYA and YES media (see Methods).
Penicillium species IBT no. CYA YES Penicillium species IBT no. CYA YES
P. aethiopicum 21721 2 2 P. gladioli 14699 2 2
P. albocoremium 22521 2 2 P. griseofulvum 21530 2 2
P. allii 21503 2 2 P. herqui 24483 2 +
P. atramentosum 11801 2 2 P. hirsutum 10623 + +
P. aurantiogriseum 22509 2 2 P. hordei 15999 2 +
P. brasilianum 12951 2 2 P. italicum 21533 2 +
P. brevicompactum 4342 2 2 P. janczewskii 16238 2 2
P. carlsbadiense 18341 2 2 P. johanii 24550 2 2
P. carneum 19478 2 + P. manginii 19538 2 2
P. chrysogenum 14462 2 + P. miczynskii 14839 + +
P. clavigerum 18977 2 + P. nalgiovense 15040 + 2
P. commune 17345 2 2 P. neoclavigerum 19355 2 +
P. concentricum 5623 2 2 P. neocoprobium 24375 2 2
P. coprobium 6895 + + P. neogriseofulvum 16848 2 2
P. coprophilum 5551 2 + P. neovulpinum 18360 2 +
P. decumbens 21919 2 2 P. nordicum 22024 2 +
P. digitatum 13068 2 2 P. novae-zelandiae 21935 2 2
P. dipodomyicola 16571 2 + P. olsonii 21538 2 +
P. dipodomyis 17759 + + P. paneum 11839 + +
P. discolor 21523 2 2 P. paxilli 16202 2 +
P. echinulatum 7000 2 2 P. radicicola 10696 2 +
P. marinum 16712 2 2 P. roqueforti 21543 + +
P. expansum 21525 2 + P. smithii 6647 2 +
P. fennelliae 19338 + + P. tulipae 3458 2 2
P. glabrum 17691 + 2 P. venetum 21549 2 +
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probably explains why several of the other species also
showed QSI activity. Recently the following terverticillate
Penicillium species were reported as penicillic acid pro-
ducers: P. aurantiogriseum, P. carneum, P. cyclopium, P.
freii, P. melanoconidium, P. neoechinulatum, P. polonicum,
P. radicicola, P. tulipae, P. viridicatum. The following
species were reported as patulin producers: P. carneum,
P. clavigerum, P. concentricum, P. coprobium, P. dipodomyi-
cola, P. expansum, P. glandicola, P. gladioli, P. griseofulvum,
P. marinum, P. paneum, P. sclerotigenum, P. vulpinum
(Frisvad et al., 2004). However, extracts prepared from
some of these fungi did not appear active in the QSI screens
used in the present study. One likely explanation is that
some of the fungal strains produce only trace amounts of
either patulin or penicillic acid, which is therefore below
the detection limit of the QSI screen. The search for com-
pounds other than patulin and penicillic acid is in progress
on other fungal species known as non- producers of patulin
and penicillic acid.
Dose–response analysis of penicillic acid and
patulin
Pure penicillic acid and patulin were tested in the QSIS1 and
QSIS2 systems and found to be positive (data not shown).
To examine the effects of these two fungal metabolites more
closely, we employed a lasB–gfp(ASV) fusion harboured by
Ps. aeruginosa PAO1 as a QS monitor (Hentzer et al., 2002).
Being a type IV QS gene, lasB is induced in late exponential/
early stationary phase (Whiteley et al., 1999). Induction by
the addition of C4 HSL and 3-oxo-C12 HSL caused a burst
of GFP production. Conversely, if a QSI is present the burst
of GFP expression will be reduced (Hentzer et al., 2003).
As the QSIS systems only provide a crude estimation of the
optimal concentration of the QSI, a dilution series of the
compounds was incubated with the QS monitor. Growth
and green fluorescence were recorded over a period of
14 h. Upon induction, the untreated cultures increased
GFP production approximately 10-fold. Addition of either
penicillic acid or patulin reduced the induction of fluor-
escence in a concentration-dependent manner. At the
highest concentrations tested (40 mM and 80 mM for
patulin and penicillic acid, respectively) the induction of
the QS-controlled lasB promoter was abolished. These
concentrations did not affect growth rate of the cultures
(Fig. 4). This suggests that the two compounds specifically
block bacterial QS.
Definition of the QS regulon
The QS regulon was previously identified by means of
DNA microarray analysis of gene expression (Hentzer et al.,
2003). Briefly, the QS regulon was defined as genes induced
by the addition of C4 HSL and 3-oxo-C12 HSL to a lasI rhlI
double mutant. It is possible, however, that the presence
of high, exogenous AHL concentrations during the entire
growth cycle could influence the expression profile of genes
in a non-natural manner, which would then affect mapping
of the QS regulon. To pursue this particular problem we
chose to define the QS regulon as consistently down-
regulated (>5-fold) genes in both a lasI rhlI and a lasR rhlR
mutant as compared to their parent wild-type (Table 2).
Fig. 3. Structures of penicillic acid (left), patulin (middle) and a general Delisea pulchra furanone structure (right).
Fig. 2. Screening of 96 fractions of P.
coprobium (IBT6895) extract. The wells
marked C contain a positive control (fura-
none C-30).
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In addition, the expression profiles of a lasR and a rhlR
mutant were determined (Table 2). The 172 genes of this
alternative QS regulon can be divided into four groups
on the basis of their expression pattern within the four
mutants. Group A contains 34 genes which require lasR
for expression, i.e. they are downregulated in both the lasR
and the lasR rhlR mutants. The 23 genes responsive to rhlR
are located in group B. Group C consists of 92 genes which
are downregulated in all three mutants. Finally, group D
comprises the 23 genes that are downregulated only in the
lasR rhlR double mutant; if only one of lasR or rhlR was
mutated, no effect was observed. Remarkably, the genes in
group D generally exhibited a lower degree of regulation
(less average fold change) than those in group C. We
speculate that the group D genes are only partially regulated
by QS. Of the 172 genes in the alternative QS regulon, 99
are in common with the previous QS regulon defined by
Hentzer et al. (2003). It must be emphasized that the
previous QS regulon was based on several sample points
throughout the growth cycle whereas the present QS
regulon was based on a single sample point at OD600 2,
where the majority of QS genes are being expressed
(Hentzer et al., 2003).
Target specificity
Next, DNA microarray analysis was performed to deter-
mine the target specificity of the two QSI compounds
towards the QS-regulated genes in Ps. aeruginosa. Cultures
of Ps. aeruginosa PAO1 were grown to exponential phase,
then split into subcultures at OD600 0?5. These cultures
were either not treated or treated with 8 mM patulin and
147 mM penicillic acid, respectively (concentrations at which
growth was not affected). Samples for DNA microarray
analysis were taken at OD600 2?0. Absolute expression values
from treated cultures or QS mutant cultures were compared
with values from untreated cultures; changes in expression
are reported as simple fold changes (Table 2). Genes found
‘not present’ by the Affymetrix Micro Array Suite software
were excluded from the calculations. According to Hentzer
et al. (2003) and Wagner et al. (2003) changes in expression
below 5-fold are disregarded.
In total, patulin and penicillic acid targeted 157 and 300
genes, respectively. According to the above QS definition,
49% of the 157 genes targeted by patulin and 34% of the
300 targeted by penicillic acid were QS controlled. Since
the number of chromosomal genes is approximately 5600,
Fig. 4. Dose–response curves of patulin (a) and penicillic acid (b). Dilution series were incubated with the QS monitor PAO1
(lasB–gfp) (Hentzer et al., 2002). Growth (top panels) and specific fluorescence (bottom panels, expressed as relative
fluorescence units per OD450 unit) were followed over 14 h. Patulin was tested at 40 mM (X), 10 mM (m), 3 mM (&), 0?6 mM
($) and 0 mM (+). Penicillic acid was tested at 80 mM (X), 20 mM (m), 5 mM (&), 1 mM ($) and 0 mM (+).
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Table 2. Genes downregulated in the four QS mutants and by treatment with patulin (Pat) and penicillic acid (PA)
Pa gene Gene Regulation* Product nameD Change in expression (fold)d
Pat PA lasR rhlR lasR rhlR lasI rhlI§
PA0059 osmC las+rhl Osmotically inducible protein OsmC –8 –18 –23 –26 –32 –22
PA0105 coxB las+rhl Cytochrome c oxidase, subunit II –9 –86 –10 –8 –14 –12
PA0107 las+rhl Conserved hypothetical protein –13 –18 –6 –11 –14 –17
PA0108 coIII las+rhl Cytochrome c oxidase, subunit III –12 –14 –5 –6 –8 –28
PA0122 las+rhl Conserved hypothetical protein –4 –11 –6 –6 –26 –45
PA0188 las+rhl Hypothetical protein –3 –3 –13 –9 –21 –8
PA0355 pfpI las+rhl Protease PfpI –2 –4 –14 –12 –22 –12
PA0567 las+rhl Conserved hypothetical protein –4 –8 –17 –10 –25 –250
PA0572 las Hypothetical protein –1 –2 –8 –1 –14 –10
PA0737 las+rhl Hypothetical protein –2 –2 –53 –6 –8 –9
PA0843 plcR las Phospholipase protein PlcR precursor –3 –14 –14 –5 –6 –7
PA0852 cpbD las+rhl Chitin-binding protein CbpD precursor –12 –27 –28 –8 –74 –64
PA0990 lasrhl Conserved hypothetical protein –5 –1 –4 –4 –20 –6
PA0996 pqsA las Prob. coenzyme A ligase 2 –1 –36 3 –21 –7
PA0997 pqsB las Homologous to b-keto–AACP synthase 2 1 –62 3 –15 –13
PA0998 pqsC las Homologous to b-keto-AACP synthase 3 1 –32 3 –14 –8
PA0999 pqsD las 3-Oxoacyl-[ACP] synthase III 2 –1 –21 3 –10 –8
PA1000 pqsE las Quinolone signal response protein 3 2 –33 4 –12 –8
PA1001 phnA las Anthranilate synthase component I 2 –1 –21 3 –10 –7
PA1002 phnB las Anthranilate synthase component II 3 1 –7 5 –5 –7
PA1131 rhl Prob. MFS transporter –3 –3 –2 –7 –11 –6
PA1168 las Hypothetical protein –2 1 –28 –4 –19 –22
PA1190 las+rhl Conserved hypothetical protein –12 –43 –8 –10 –12 –15
PA1242 rhl Hypothetical protein –5 –16 –3 –9 –21 –20
PA1249 aprA lasrhl Alkaline metalloproteinase precursor –3 –4 –4 –3 –8 –7
PA1250 aprI lasrhl Alkaline proteinase inhibitor AprI –1 –1 –3 –1 –6 –10
PA1323 las+rhl Hypothetical protein –3 –12 –44 –15 –39 –25
PA1324 las+rhl Hypothetical protein –4 –16 –30 –17 –27 –22
PA1431 rsaL las Regulatory protein RsaL –2 –2 –2766 –2 –3394 –3646
PA1432 lasI las Autoinducer synthesis protein LasI 1 2 –37 –1 –133 –97
PA1471 las+rhl Hypothetical protein –3 –4 –8 –10 –6 –8
PA1625 rhl Conserved hypothetical protein –6 –3 –3 –6 –9 –7
PA1657 las+rhl Conserved hypothetical protein –2 –2 –17 –5 –15 –13
PA1662 lasrhl Prob. ClpA/B-type protease –4 –5 –2 –4 –9 –6
PA1664 las+rhl Hypothetical protein –7 –4 –18 –9 –11 –5
PA1665 las Hypothetical protein –6 –2 –17 –3 –47 –6
PA1667 lasrhl Hypothetical protein –2 –1 –5 –3 –5 –6
PA1669 rhl Hypothetical protein –6 –52 –2 –10 –13 –29
PA1784 las Hypothetical protein –3 –5 –8 –1 –11 –9
PA1869 las+rhl Prob. acyl carrier protein –6 –3 –27 –25 –288 –137
PA1870 rhl Hypothetical protein –7 –77 –5 –14 –13 –22
PA1871 lasA las+rhl LasA protease precursor –9 –17 –25 –7 –148 –105
PA1874 las Hypothetical protein –8 –15 –7 2 –6 –8
PA1875 lasrhl Prob. outer-membrane protein precursor –7 –29 –3 1 –9 –34
PA1901 phzC2 las+rhl Phenazine biosynthesis protein PhzC –7 –9 –19 –51 –25 –22
PA1902 phzD2 las+rhl Phenazine biosynthesis protein PhzD –7 –77 –105 –91 –132 –134
PA1903 phzE2 las+rhl Phenazine biosynthesis protein PhzE –6 –46 –20 –20 –24 –17
PA1904 phzF2 las+rhl Prob. phenazine biosynthesis protein –6 –13 –82 –45 –62 –134
PA1905 phzG2 las+rhl Prob. pyridoxamine 59-phosphate oxidase –6 –19 –22 –30 –33 –14
PA1914 las Conserved hypothetical protein –17 –6 –84 –1 –15 –93
PA2021 las+rhl Hypothetical protein –8 –5 –9 –13 –12 –9
PA2046 las+rhl Hypothetical protein –3 –11 –20 –46 –22 –32
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Table 2. cont.
Pa gene Gene Regulation* Product nameD Change in expression (fold)d
Pat PA lasR rhlR lasR rhlR lasI rhlI§
PA2067 lasrhl Prob. hydrolase –6 –18 –5 –4 –6 –6
PA2068 las+rhl Prob. MFS transporter –7 –8 –18 –25 –19 –9
PA2069 las+rhl Prob. carbamoyltransferase –22 –529 –25 –27 –73 –29
PA2137 las+rhl Hypothetical protein –114 –9 –16 –71 –16 –11
PA2139 rhl Hypothetical protein –32 –25 –3 –24 –10 –9
PA2141 las+rhl Hypothetical protein –42 –61 –33 –69 –46 –6
PA2142 las+rhl Prob. short-chain dehydrogenase –9 –15 –6 –27 –16 –13
PA2143 las+rhl Hypothetical protein –15 –11 –101 –84 –60 –67
PA2144 glgP lasrhl Glycogen phosphorylase –10 –4 –5 –5 –21 –7
PA2146 las+rhl Conserved hypothetical protein –9 –147 –12 –10 –11 –7
PA2148 lasrhl Conserved hypothetical protein –3 –3 –4 –4 –8 –8
PA2149 las+rhl Hypothetical protein –6 –9 –25 –11 –7 –6
PA2151 las+rhl Conserved hypothetical protein –6 –64 –23 –31 –125 –39
PA2153 glgB las+rhl 1,4-a-Glucan branching enzyme –14 –18 –10 –9 –11 –7
PA2158 las+rhl Prob. alcohol dehydrogenase (Zn-dependent) –5 –17 –19 –52 –10 –65
PA2163 rhl Hypothetical protein –4 –54 –4 –5 –8 –8
PA2165 rhl Prob. glycogen synthase –6 –12 –4 –8 –5 –9
PA2166 las+rhl Hypothetical protein –16 –8 –19 –19 –38 –15
PA2167 rhl Hypothetical protein –6 –12 –4 –15 –8 –9
PA2170 rhl Hypothetical protein –7 –18 –3 –6 –14 –8
PA2171 las+rhl Hypothetical protein –6 –86 –31 –22 –110 –28
PA2176 las+rhl Hypothetical protein –5 –103 –16 –12 –25 –19
PA2178 lasrhl Hypothetical protein –7 –37 –2 –5 –6 –11
PA2184 las+rhl Conserved hypothetical protein –6 –250 –10 –21 –14 –16
PA2190 las+rhl Conserved hypothetical protein –13 –10 –5 –7 –15 –17
PA2193 hcnA rhl Hydrogen cyanide synthase HcnA –1 –3 –4 –9 –254 –260
PA2194 hcnB rhl Hydrogen cyanide synthase HcnB –1 –3 –3 –8 –43 –123
PA2195 hcnC rhl Hydrogen cyanide synthase HcnC –1 –6 –3 –7 –39 –21
PA2300 chiC las+rhl Chitinase –39 –133 –66 –34 –67 –34
PA2302 las Prob. non-ribosomal peptide synthetase –2 –2 –10 –1 –18 –13
PA2303 las Hypothetical protein –1 –3 –57 –1 –214 –88
PA2304 las Hypothetical protein –1 –2 –9 1 –23 –18
PA2305 las Prob. non-ribosomal peptide synthetase –1 –2 –9 1 –17 –6
PA2414 las+rhl L-Sorbosone dehydrogenase –7 –11 –9 –8 –18 –32
PA2415 las+rhl Hypothetical protein –4 –10 –7 –5 –9 –14
PA2423 las Hypothetical protein –1 –1 –7 2 –6 –6
PA2433 las+rhl Hypothetical protein –9 –43 –53 –33 –67 –26
PA2485 las+rhl Hypothetical protein –3 –4 –12 –12 –18 –12
PA2486 rhl Hypothetical protein 1 –2 –5 –6 –11 –9
PA2566 lasrhl Conserved hypothetical protein –2 –2 –4 –2 –7 –10
PA2570 pa1L las+rhl PA-I galactophilic lectin –19 –9 –21 –30 –49 –45
PA2587 pqsH las Prob. FAD-dependent monooxygenase –2 –1 –20 1 –36 –46
PA2588 las Prob. transcriptional regulator –5 –3 –77 –2 –34 –7
PA2591 lasrhl Prob. transcriptional regulator –2 –1 –2 1 –15 –7
PA2592 lasrhl Prob. periplasmic spermidine/putrescine-binding
protein
–2 –1 –4 –2 –18 –7
PA2708 las+rhl Hypothetical protein –3 –4 –5 –13 –8 –6
PA2747 las+rhl Hypothetical protein –6 –7 –29 –10 –37 –33
PA2751 las+rhl Conserved hypothetical protein –3 –5 –8 –6 –7 –8
PA2754 las+rhl Conserved hypothetical protein –2 –3 –7 –5 –7 –12
PA2777 las+rhl Conserved hypothetical protein –5 –79 –6 –9 –6 –8
PA2873 lasrhl Hypothetical protein –2 2 –1 –1 –6 –13
http://mic.sgmjournals.org 1333
QSIs produced by Penicillium spp.
Table 2. cont.
Pa gene Gene Regulation* Product nameD Change in expression (fold)d
Pat PA lasR rhlR lasR rhlR lasI rhlI§
PA2937 las+rhl Hypothetical protein –5 –17 –7 –5 –9 –7
PA2939 las Prob. aminopeptidase –4 –6 –12 2 –9 –40
PA3231 las+rhl Hypothetical protein –11 –17 –9 –10 –13 –34
PA3273 las+rhl Hypothetical protein –11 –13 –7 –27 –13 –13
PA3274 las+rhl Hypothetical protein –6 –18 –58 –17 –37 –45
PA3326 lasrhl Prob. Clp-family ATP-dependent protease –2 –2 –3 –4 –11 –12
PA3327 rhl Prob. non-ribosomal peptide synthetase –2 –6 –4 –10 –13 –5
PA3328 rhl Prob. FAD-dependent monooxygenase –1 –13 –4 –12 –26 –7
PA3329 las+rhl Hypothetical protein –1 –4 –10 –69 –174 –55
PA3330 las+rhl Prob. short chain dehydrogenase –2 –4 –7 –19 –178 –62
PA3331 las+rhl Cytochrome P450 –2 –7 –5 –24 –62 –20
PA3332 las+rhl Conserved hypothetical protein –2 –18 –6 –18 –19 –10
PA3333 fabH2 las+rhl 3-Oxoacyl-[ACP] synthase III –2 –5 –5 –10 –33 –17
PA3334 las+rhl Prob. acyl carrier protein –3 –3 –7 –11 –17 –43
PA3335 lasrhl Hypothetical protein –2 –3 –3 –4 –9 –18
PA3336 rhl Prob. MFS transporter –7 –3 –4 –23 –9 –8
PA3361 lecB las+rhl Fucose-binding lectin PA-IIL –7 –11 –11 –15 –29 –22
PA3369 las+rhl Hypothetical protein –8 –9 –28 –14 –42 –20
PA3370 las+rhl Hypothetical protein –17 –19 –45 –31 –66 –39
PA3371 las+rhl Hypothetical protein –12 –18 –36 –26 –52 –24
PA3460 las Prob. acetyltransferase –2 –11 –6 –5 –6 –5
PA3476 rhlI lasrhl Autoinducer synthesis protein RhlI –3 –2 –2 –2 –41 –19
PA3478 rhlB las+rhl Rhamnosyltransferase chain B –13 –17 –17 –53 –123 –120
PA3479 rhlA las+rhl Rhamnosyltransferase chain A –14 –27 –13 –55 –196 –320
PA3520 las+rhl Hypothetical protein –10 –6 –12 –7 –18 –28
PA3581 glpF las+rhl Glycerol uptake facilitator protein –19 –39 –6 –35 –89 –61
PA3584 glpD las+rhl Glycerol 3-phosphate dehydrogenase –9 –10 –7 –8 –20 –6
PA3691 las+rhl Hypothetical protein –2 –7 –23 –12 –19 –12
PA3692 las+rhl Prob. outer-membrane protein precursor –3 –9 –29 –12 –17 –31
PA3724 lasB las+rhl Elastase LasB –7 –12 –13 –5 –224 –167
PA3734 rhl Hypothetical protein –5 –31 –4 –9 –21 –7
PA3788 lasrhl Hypothetical protein –3 –8 –5 –4 –6 –9
PA3819 las+rhl Conserved Hypothetical Protein –2 –4 –8 –7 –7 –6
PA3888 las Prob. permease of ABC transporter –2 –2 –8 –5 –10 –6
PA3890 las+rhl Prob. permease of ABC transporter –2 –34 –36 –32 –88 –18
PA3904 las Hypothetical protein –3 1 –212 –1 –41 –68
PA3906 las Hypothetical protein –3 –2 –9 –1 –177 –7
PA3907 las Hypothetical protein –1 1 –7 1 –13 –6
PA3908 lasrhl Hypothetical protein –2 1 –4 1 –50 –6
PA4078 lasrhl Prob. nonribosomal peptide synthetase –6 –44 –3 –5 –11 –6
PA4130 lasrhl Prob. sulfite or nitrite reductase –2 1 –3 2 –6 –10
PA4133 las Cytochrome c oxidase subunit (cbb3-type) –5 1 –6 2 –13 –57
PA4134 las Hypothetical protein –27 –1 –12 –1 –6 –12
PA4139 las Hypothetical protein –1 1 –6 –4 –10 –6
PA4141 las+rhl Hypothetical protein –5 –6 –25 –58 –105 –73
PA4142 las+rhl Prob. secretion protein –5 –12 –24 –26 –72 –27
PA4143 las+rhl Prob. toxin transporter –9 –6 –8 –9 –15 –8
PA4171 las+rhl Prob. protease –3 –6 –11 –9 –15 –5
PA4175 prpL las Pvds-regulated endoprotease, lysyl class –6 –9 –28 –2 –47 –28
PA4209 phzM las+rhl Prob. phenazine-specific methyltransferase –3 –4 –13 –7 –19 –10
PA4210 phzA1 las+rhl Prob. phenazine biosynthesis protein –115 -50 –89 –20 –123 –65
PA4211 phzB1 las+rhl Prob. phenazine biosynthesis protein –9 -226 –62 –46 –61 –51
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patulin and penicillic acid affected the expression of 3–5%
of all genes. QS-controlled genes are overrepresented among
the genes downregulated by the compounds, indicating
that they have specificity for QS-regulated genes. Of the
QS regulated genes, 45% and 60% were affected by patulin
and penicillic acid respectively. Interestingly, patulin down-
regulated 43% of the group B genes, 58% of the group C
genes and 26% of the group D genes, but only 15% of the
group A genes. This suggests that RhlR-controlled genes
are preferentially targeted by patulin. Similarly, penicillic
acid downregulated 65%, 80% and 30% of groups B, C
and D, respectively, whereas only 21% of group A genes
were downregulated. Once again this suggests that RhlR-
controlled genes are preferentially targeted by penicillic acid.
Hentzer et al. (2003) found an 80% target specificity of
furanone C-30 to QS-regulated genes. However, when the
same analysis was performed according to the QS regulon
described above, it was found that C-30 exhibits a target
specificity of 64%. Thus, the QS target specificity of the
QSIs identified in the present study is comparable to that
of C-30.
Among the genes repressed by patulin and penicillic acid
treatment, many encode virulence factors which had pre-
viously been reported to be controlled by QS (Hentzer et al.,
2003; Schuster et al., 2003; Wagner et al., 2003; Whiteley
et al., 1999). These include the genes encoding LasA pro-
tease (lasA, PA1871), LasB elastase (lasB, PA3724), chitinase
(chiC, PA2300) and chitin-binding protein (chiD, PA0852),
and the genes encoding phenazine biosynthesis proteins
(phzC–G, PA1901–PA1905), the rhamnosyl transferase AB
operon (rhlAB, PA3478–PA3479), fucose-binding lectin
(lecB, PA3361) and PA-I galactophilic lectin (pa1L,
PA2570). Pyoverdine production seems to be unaffected
by patulin and penicillic acid, and the expression level of
pvd genes was unaltered in the QS mutants; however, the
PvdS-regulated endoprotease gene encoding PrpL (PA4175)
was downregulated by both patulin and penicillic acid as
well as in the QS mutants. PrpL is able to cleave lactoferrin,
transferrin, elastin and casein, and may potentially play a
role in virulence (Wilderman et al., 2001). Nouwens et al.
(2003) found reduced levels of PrpL in culture supernatants
of Ps. aeruginosa strains containing a las mutation, but
not in rhl mutants (Nouwens et al., 2003). The expression
of prpL in a lasI rhlI mutant is restored by the addition
of 3-oxo-C12 HSL, which further supports the idea that
expression of prpL is primarily LasR regulated (Hentzer
et al., 2003; Schuster et al., 2003). It is not known if this
is by direct regulation by the las QS system or via an
intermediary regulator such as PvdS. The significant down-
regulation of chiC by patulin and penicillic acid was not
unexpected considering that the major structural com-
ponent of fungal cells is chitin. This suggests that the QSI
properties of some mycotoxins are not just coincidental,
but are instead a strategy used by some fungi to minimize
damage caused by bacteria producing chitinase. A number
Table 2. cont.
Pa gene Gene Regulation* Product nameD Change in expression (fold)d
Pat PA lasR rhlR lasR rhlR lasI rhlI§
PA4217 phzS las+rhl Flavin-containing monooxygenase –6 –22 –9 –11 –13 –11
PA4290 rhl Prob. chemotaxis transducer –20 –24 –4 –16 –6 –7
PA4345 rhl Hypothetical protein –4 –4 –4 –7 –9 –11
PA4377 lasrhl Hypothetical protein –13 –7 –4 –3 –7 –10
PA4677 las Hypothetical protein –2 –4 –15 –1 –40 –17
PA4738 las+rhl Conserved hypothetical protein –6 –16 –45 –17 –54 –40
PA4739 las+rhl Conserved hypothetical protein –5 –12 –34 –17 –34 –34
PA4876 osmE las+rhl Osmotically inducible lipoprotein OsmE –3 –7 –8 –7 –9 –18
PA4880 las+rhl Prob. bacterioferritin –2 –7 –8 –13 –30 –6
PA5099 las+rhl Prob. transporter –252 –66 –10 –40 –15 –16
PA5212 las+rhl Hypothetical protein –1 –4 –9 –6 –9 –9
PA5220 rhl Hypothetical protein –3 –23 –4 –7 –9 –8
PA5235 glpT rhl Glycerol-3-phosphate transporter –5 –3 –2 –14 –32 –15
PA5297 poxB lasrhl Pyruvate dehydrogenase (cytochrome) –2 –1 –3 –3 –6 –18
PA5480 rhl Hypothetical protein –2 –16 –1 –6 –20 –14
PA5481 las+rhl Hypothetical protein –8 –16 –74 –23 –51 –46
PA5482 las+rhl Hypothetical protein –5 –16 –62 –12 –43 –60
*las+rhl, downregulated in both single mutants (lasR and rhlR); lasrhl, downregulated only in the double lasR rhlR mutant.
DProb., probable.
dThese data are included in those presented by Hentzer et al. (2003).
§Downregulation values >5 are shown in bold.
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of other genes, including osmC (PA0052, osmotically
inducible protein) coxA and coxB (PA0105 and PA106,
cytochrome c oxidase subunit I and II) and several genes
encoding hypothetical proteins previously identified as
being QS regulated (such as the operon at PA3326–PA3336)
were also found to be downregulated in the presence of
patulin and penicillic acid. One of these genes, fabH2,
encodes a 3-oxoacyl-ACP synthase, probably involved in
synthesis of the 3-oxo-C12 HSL signal molecule. This sug-
gests that one of the modes of action by which penicillic
acid inhibits QS is by preventing signal molecule synthesis.
It should be noted that the QSIS1 and 2 screens select
molecules which interfere with the LuxR homologue pro-
teins; thus inhibition of AHL synthesis is just an additional
feature of penicillic acid as QSI rather than its primary
activity.
Genes encoding central parts of the QS circuit, such as lasR,
rsaL, lasI, rhlR and rhlI (PA1430–PA1432, PA3437 and
PA3476), and genes involved in the synthesis of PQS (pqsA–
E, pqsH, PA0996–PA1000, PA2587) were almost unaffected
by treatment with the two QSI compounds. This suggests
that patulin and penicillic acid do not directly interfere
with the regulatory systems controlling transcription of the
lasRI and rhlRI genes, but instead act on these QS regulators
at the post-transcriptional level. This suggests that the two
QSI compounds interfere with the RhlR and LasR proteins.
Patulin accelerates LuxR turnover
Patulin was selected for more thorough analysis of its effect
on bacterial phenotypes related to pathogenicity since it
was found to actively inhibit Ps. aeruginosa QS at a con-
centration substantially lower than the LD50 (Hayes, 1981).
Manefield et al. (2002) demonstrated the ability of furanone
compounds to cause instability of the LuxR QS regulatory
protein.
LuxR was overexpressed from an IPTG-inducible pro-
moter in the presence of high concentrations of GroESL
in accordance with Manefield et al. (2002). After cells were
washed free of the inducer, they were treated with 3?5 mM
patulin (this concentration does not affect growth). The
amount of LuxR protein present in the samples was
visualized after 1 h of treatment by Western blotting with
a chemiluminescent LuxR antibody. Digital images of the
gel reported chemoluminescence with increasingly lighter
colours indicating higher band intensity. Treatment with
patulin markedly decreased the amount of LuxR present in
the samples (Fig. 5). As a reference, furanone C-2 was
included as a control (Manefield et al., 2002). The reduced
amount of LuxR correlated with the strong signal obtained
in the QSIS systems and with downregulation of the fluor-
escent signal from a LuxR-controlled luxI–gfp fusion (data
not shown). This is in accordance with a model where
patulin interacts directly with QS regulators. Interestingly,
a third LuxR homologue, designated QscR, has been
identified in the Ps. aeruginosa chromosome (Chugani
et al., 2001). This protein is a negative regulator of several
QS-controlled virulence factors and is able to form
multimers and heterodimers with both LasR and RhlR
(Ledgham et al., 2003). No effect of the QSIs on QscR
transcription was observed in our DNA array experiments
(Table 2). Whether the inhibitors interact directly with
QscR, as is the case for LuxR, is presently unknown. Another
member of the LuxR family of transcriptional regulators,
VqsR, has also been found in Ps. aeruginosa. This protein is
a major virulence factor regulator and has been found to
positively affect expression of QS-controlled genes (Juhas
et al., 2004). Again, we have not investigated whether the
QSIs interact directly with this regulator, but there is no
effect on transcription of vqsR when Ps. aeruginosa is
treated with penicillic acid or patulin. Interestingly, vqsR is
significantly downregulated in both of the double mutants
(Table 2). As we speculate that the inhibitors mainly target
the RhlR protein, the lack of effect on vqsR transcription
from the QSIs is not a surprising result.
QSI effect on biofilm tolerance to tobramycin
It has previously been shown that Ps. aeruginosa biofilm cells
are highly tolerant to antibiotic treatments (Anwar et al.,
1990). Davies et al. (1998) demonstrated that a QS mutant
of PAO1 is more susceptible to antimicrobial treatments
than the wild-type counterpart. Furthermore, Hentzer et al.
(2003) showed that biofilms treated with the QSI com-
pound furanone C-30 became susceptible to both SDS and
tobramycin treatment. We tested whether patulin exhibited
a similar effect. Two sets of PAO1 biofilms were allowed to
form in flow chambers in which the medium contained
either no patulin or 8 mM patulin for 3 days. The biofilms
were then challenged with tobramycin (340 mg ml21) for
24 h. The effect of the antibiotic treatment was assessed by
means of live/dead staining (Fig. 6). In the biofilm treated
with tobramycin only a few cells, mainly localized in the
top layer, were dead, whereas almost all the cells in the
biofilm treated with both tobramycin and patulin were
A B C D
Fig. 5. Western blot analysis of LuxR content using a chemi-
luminescent LuxA antibody. LuxR-overproducing E. coli cells
were either untreated (A), or treated with 20 mM furanone C-2
(B), 100 mM furanone C-2 (C) or 3?5 mM patulin (D). Lighter
colours indicate higher band density.
1336 Microbiology 151
T. Bovbjerg Rasmussen and others
dead. Treatment with patulin alone did not affect develop-
ment of the biofilm (data not shown).
PMN activation is affected by a QS-controlled
mechanism
In recent work by Bjarnsholt et al. (2005) it was found that
the activation of neutrophile PMNs by Ps. aeruginosa is
controlled by QS. A lasR rhlR mutant activated PMNs
whereas the wild-type Ps. aeruginosa PAO1 failed to do so. In
addition, when the wild-type was treated with furanone C-
30, activation was observed. We wanted to investigate if the
QS inhibitory effect observed by patulin and penicillic acid
created a similar increase in activation of PMNs. Biofilms of
wild-type Ps. aeruginosa PAO1 were grown for 3 days with
and without 1?2 mg ml21 patulin and penicillic acid. PMNs
were injected into the biofilm flow chambers and develop-
ment of oxidative burst was recorded after 2 h by 123-DHR
staining (Fig. 7). A marked difference in green fluorescence
signal intensity was observed for the PMNs incubated on the
wild-type biofilms compared to the QSI-treated biofilms.
These experiments suggest that a QSI-treated biofilm, in
contrast to its untreated counterpart, fully activates the
PMNs to produce H2O2.
Ps. aeruginosa in mouse lungs is cleared
rapidly when treated with patulin
We have shown that a functional QS system plays a major
role in the persistence of a pulmonary infection in mice
with respect to both clearance of the bacteria and the onset
of the innate immune defence (Bjarnsholt et al., 2005). We
investigated whether patulin could promote a faster clearing
of bacteria in mice, as seen with other QSIs (Hentzer et al.,
2003; Wu et al., 2004; Rasmussen et al., 2005). BALB/c
mice were used to establish a pulmonary model of chronic
lung infection. The immune response of the BALB/c mice
is Th-2 dominated (Moser et al., 1999), resembling the
immune response of cystic fibrosis patients to Ps. aeruginosa
pulmonary infection (Moser et al., 2000). In order to study
the effect of patulin in a pulmonary infection model two
groups of 72mice were treated with either patulin or placebo
(saline). The treatments were given as a subcutaneous
injection every 24 h for 7 days, administering 2?5 mg per g
body weight (~16 mM; the average mouse volume is taken
as 20 ml). After 1 day of prophylactic treatment, the mice
were intratracheally challenged with alginate beads contain-
ing Ps. aeruginosa (Pedersen et al., 1990). After the challenge,
a higher mortality was observed for the placebo-treated
group on day 1: 12 died compared to 5 in the patulin-treated
group; however, the difference was not found to be
statistically significant.
Clearance of bacteria from the lungs was assessed on day
1 and day 3 after bacterial challenge. On day 1 there was
only a slight difference between the two groups, with the
patulin-treated group showing faster clearance. On day 3,
a 20-fold lower bacterial content was observed with the
patulin-treated group, suggesting that the treatment pro-
moted clearing compared to the placebo (P<0?04) This is
in accordance with the results of Rasmussen et al. (2005),
Hentzer et al. (2003) and Wu et al. (2004) using other QSI
compounds.
Conclusions
A recently published screening system, the QSI selector,
was used to screen extracts prepared from 50 Penicillium
Fig. 6. Biofilms formed by Ps. aeruginosa in the absence (left) or presence (right) of 1?2 mg patulin ml”1 and treated with
tobramycin for 24 h. The cells are stained with the Baclight live/dead kit, which stains live cells green and dead cells red.
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species. Approximately 33% of the extracts contained
potential QSIs. The extracts from P. radicicola and P.
coprobium were subjected to further analysis, which showed
that the QSI produced by P. radicicolawas penicillic acid and
the QSI produced by P. coprobium was patulin. The ability
to inhibit QS was verified by DNA array analysis, which
suggested that penicillic acid and patulin targeted the RhlR
and the LasR proteins. Ps. aeruginosa biofilms formed in the
presence of patulin were susceptible to tobramycin treat-
ment, whereas control biofilms were tolerant. Furthermore,
the wild-type Ps. aeruginosa biofilms formed in the presence
of patulin induced oxidative burst in PMNs that settled
on top of the biofilm bacteria. The reduction in virulence
factor expression and activation of PMN oxidative burst
may explain why patulin accelerated the clearance of Ps.
aeruginosa from the lungs of infected mice. Even though
the two mycotoxins are not currently drug lead com-
pounds, this work demonstrates that fungi produce QSIs.
Ongoing work in our laboratories is aimed at identifying
non-toxin QSIs produced by fungi.
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Abstract
With the global emergence of multiresistant bacteria
there is an increasing demand for development of
new treatments to combat pathogens. Bacterial cell–
cell communication [quorum sensing (QS)] regulates
expression of virulence factors in a number of
bacterial pathogens and is a new promising target
for the control of infectious bacteria. We present the
results of screening of 284 extracts of marine organ-
isms from the Great Barrier Reef, Australia, for their
inhibition of QS. Of the 284 extracts, 64 (23%) were
active in a general, LuxR-derived QS screen, and of
these 36 (56%) were also active in a specific Pseudo-
monas aeruginosa QS screen. Extracts of the marine
sponge Luffariella variabilis proved active in both
systems. The secondary metabolites manoalide,
manoalide monoacetate, and secomanoalide isolated
from the sponge showed strong QS inhibition of a
lasB::gfp(ASV) fusion, demonstrating the potential
for further identification of specific QS antagonists
from marine organisms.
Keywords: Luffariella variabilis — manoalide —
marine natural products — quorum sensing —
quorum sensing inhibitors
Introduction
More than half of all prescribed drugs have their
origin in natural sources (Newman and Cragg
2004a, 2004b), and the diversity of chemical struc-
tures produced by marine organisms provides a
potential source of novel pharmaceuticals (Harper
et al. 2001; Paterson and Anderson 2005; Marris
2006). While there are few natural products derived
from marine organisms in clinical use, the poten-
tial applications of these compounds are broad
(Proksch et al. 2002; Marris 2006). Marine natural
products are in clinical or preclinical evaluation
against severe pain, cancers, allergy/asthma, in-
flammation, Alzheimer_s disease, HIV, and tuber-
culosis (reviewed in Proksch et al. 2002; Newman
and Cragg 2004a, 2004b), with the majority of these
natural products being sponge or tunicate derived
(Newman and Cragg 2004a, 2004b). They also have
potential application as anti-infective therapies
(Fenical and Jensen 2006). The development of
novel anti-infectives is particularly critical because
of the increasing number of multidrug resistant
bacteria (Tenover and Hughes 1996; Reacher et al.
2000). One strategy to develop new mechanisms to
combat bacterial infections is through the develop-
ment of antipathogenic drugs that function by
attenuating the bacteria with respect to virulence.
Because this can be achieved without affecting the
growth of bacteria, this principle is less likely to
impose a selective pressure for resistance (Hentzer
and Givskov 2003; Hentzer et al. 2003). Many
pathogenic bacteria synchronize their expression
of virulence genes by cell-to-cell communication
systems. This phenomenon, quorum sensing (QS),
enables bacteria to monitor cell density. QS relies
on low molecular weight signal molecules that are
capable of activating transcriptional regulators in
order to couple gene expression with population
density. In gram-negative bacteria, QS is mediated
mostly by N-acyl homoserine lactones (AHLs). QS
systems function by means of two proteins: the
AHL synthetase (the LuxI-homologue) responsible
for the AHL signal generation and the LuxRCorrespondence to: Michael Givskov; E-mail: immg@pop.dtu.dk
DOI: 10.1007/s10126-007-9036-y & Volume (&), 1–8 (2007) & * Springer Science + Business Media, LLC 2007
homologue, which is a dual-function receptor-re-
sponse protein recognizing and binding the AHL
molecules, allowing interactions with QS-controlled
promoter sequences. The signal molecules are pro-
duced constitutively at a basal low level by the LuxI
homologue and are distributed in the cell and the
surrounding environment either actively or by diffu-
sion. The concentration of AHL molecules increases
with increasing cell density, and reaching a certain
critical level (when the populations are Bquorate^)
they bind to the LuxR homologues, creating active
LuxR–AHL complexes. This complex functions as a
transcription factor that binds to the promoter region
of the QS-regulated genes, where it triggers gene
expression (Fuqua et al., 1994), including virulence
traits (Toder et al. 1991; Gambello et al. 1993) It has
been proposed that for some opportunistic patho-
gens, such as Pseudomonas aeruginosa, it is essen-
tial to stay Bsilent^ and delay production of virulence
factors until the cell population has reached a level
sufficient to overwhelm the host_s defenses. There-
fore, QS offers the invading bacteria with an advan-
tage during the establishment of infections. A
strategy for the development of novel anti-infectives
is to block the bacterial communication pathway. In
contrast to the sophisticated mammalian immune
system plants, fungi and marine invertebrates rely
on physical and chemical defense strategies to
protect them against bacterial pathogens. This pro-
vides a logical source to search for natural products
with the ability to inhibit QS in natural libraries of
chemically rich organisms. A proof of this concept is
the halogenated furanones derived from the marine
macro alga Delisea pulchra (Givskov et al. 1996),
which inhibits QS in vitro as well as in vivo
experimental settings (Manefield et al. 2000; Hent-
zer et al. 2003; de Nys et al. 2006). The treatment of
the opportunistic pathogen P. aeruginosa in a mouse
pulmonary infectious model with furanone-derived
drugs greatly accelerates eradication of the pathogen
(Hentzer et al. 2003). Furanones also reduce the
mortality of vibriosis in rainbow trout challenged
with pathogenic Vibrio anguillarum (Rasch et al.
2004). The use of QS inhibitors (QSIs) has a wide
range of applications, from veterinary treatment in
aquaculture to medical treatments in humans. In
this study we present the results from a screening of
284 marine samples from the Great Barrier Reef for
the inhibition of QS using high-throughput QSI
screens demonstrating the broad scale presence of
QSI activity in this marine habitat. We also demon-
strate specific QS inhibition for the marine natural
products manoalide, secomanoalide, and manoalide
monoacetate from the active extract of the sponge
Luffarilla variabilis.
Materials and Methods
Sample Collection: Identification of Marine
Organisms. Samples were collected in duplicate on
SCUBA at depths of 1 to 10 m from several locations
at the inner and mid-shelf reefs of the Central Great
Barrier Reef in the vicinity of (18- 35¶ 37µ S 146- 29¶
07µ E) in the Palm Islands, Queensland, Australia
(Collection permit number G03.8695.1).
Organisms were identified to the lowest taxo-
nomic level using field guides and specific taxonom-
ic keys for sponges (Hooper and Van Soest 2002),
ascidians (Goslinger et al. 1996), corals (Veron 1993;
Fabricius and Aldersdale 2001; Erhardt and Knop
2005), and algae (Huisman 2000).
Extract Preparation. After collection, samples
(n=2 for each species collected) were crushed or cut
into small pieces and extracted with ethyl acetate
(1 ml per gram of sample) for 24 h. Subsequently, the
ethyl acetate fraction was removed and evaporated
to almost complete dryness and samples were
redissolved in 96% ethanol (in 10% of the volume
ethyl acetate used) for use in QSI assays.
Purification of Manoalides from Luffariella
variabilis . A frozen sample of the sponge
Luffariella variabilis was freeze-dried (65 g dry
weight) and extracted with dichloromethane
(3200 ml) at room temperature. The combined
dried extracts (358 mg) were dissolved in methanol
and chromatographed using preparative reversed-
phase HPLC [Phenomenex, Luna C18 (2), 5 mm,
25021 mm; gradient of acetonitrile–water 70:30 to
100:0 over 60 min as eluent, flow rate 10 ml/min; UV
detection at 254 nm]. Fractions containing
secomanoalide and manoalide and manoalide
monoacetate were further puri f ied using
semipreparative HPLC [Phenomenex, Luna C18 (2),
5 mm, 25010 mm; gradient of acetonitrile-water.
73:27 to 81:21 over 25 min as eluent, flow rate 4 ml/
min; UV detection at 254 nm]. Manoalide, manoalide
monoacetate, and secomanoalide (see Fig. 1 for
structures) were identified by comparison of their
nuclear magnetic resonance (NMR) data with
literature data (Tsuda et al. 2002).
Bacterial Screens for QS Inhibition. As an
initial, promiscuous screen for QSI activity we
employed the screening system QSIS1. The quorum
sensor element is derived from the Vibrio fischeri
LuxR-regulated QS system and cloned in E. coli,
where it responds to a broad range of AHLs and QS
inhibitors (Andersen et al. 2001; Rasmussen et al.
2005a, 2005b). Samples that screened positive with
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the QSIS1 were further screened by means of QSIS2,
a P. aeruginosa QS specific screen. The general
concept of both selector systems implies a QS
regulator (luxR homologue) gene and a QS-
controlled promoter fused to a suicide gene. In the
presence of signal molecules, the gene under QS
control is transcribed, causing cell death. However,
in the presence of a QSI compound production of the
toxic gene product will be switched off, and the
bacteria will be rescued and able to grow normally.
The suicide gene product of the QSIS1 selector system is
the cytolytic phospholipase A originating from Serratia
liquefaciens MG1 (Givskov et al. 1988; Givskov and
Molin 1993). QSIS2 bacteria harbor the QS regulated
promoter for elastase B fused to sacB, which encodes
the secretory levansucrase of Bacillus subtilis. SacB
catalyses a transfructosylation reaction by which
sucrose is hydrolyzed, thereby contributing to the
production of the bactericidal polymer levan (Gay et
al. 1983).
The quorum sensing inhibitor selectors 1 and 2
(QSIS1 and QSIS2) have been described in detail by
(Rasmussen et al. 2005a). QSIS1 harbors the plasmid
pUC18Not-luxR-PluxI-RBSII-phlA T0-T1, Ap
r main-
tained in CSH37 (Miller 1972), an Escherichia coli
strain constitutively expressing b-galactosidase.
QSIS2 is maintained in P. aeruginosa JP2 (a lasI,
rhlI mutant unable to produce AHL signals) and
contains the plasmid pUCP22NotI-PlaclasR PlasB-sacB
GmR, CarR. The QS reporter strain Tn5-LAS, which
harbors the fragment PlasB-gfp(ASV) along with Plac-
lasR as a mini-Tn5-Gm chromosomal insert in the
wild type P. aeruginosa strain PAO1-ATCC (Hentzer
et al. 2002), was also used.
In brief, preparation of QSIS screens were per-
formed as follows: QSIS1: BT medium [B medium
(Clark and Maaloe, 1967) plus 2.5 mg of thiamine
per liter] containing 2% agar (wt/vol) was melted,
10% A10 was added (Clark and Maaloe, 1967), and
the mixture was cooled to 45-C. N-3-oxo-hexanoyl-
L-homoserine lactone (Sigma-Aldrich, Germany),
ampicillin (Ap, VepiDan, Denmark), X-Gal (5-bromo-
4-chloro-3-indoxyl-b-D-galactopyranoside, Apollo
Scientific, UK), and 1-methyl-2-pyrrelidone (Merck,
Germany) were added in final concentrations of 100
nM, 100 mg/ml, 40 mg/ml, and 0.2% (vol/vol) respec-
tively and the medium was supplemented with 0.5%
(wt/vol) glucose and 0.5% (wt/vol) casamino acid.
QSIS1 overnight culture [grown in ABT media
supplemented with 0.5% (wt/vol) glucose and 0.5%
(wt/vol) casamino acid and 100 mg/ml ampicillin]
was added to a final concentration of 0.4%.
Preparation of QSIS2 media. LB agar (Bertani,
1951) containing 2% agar (wt/vol) was melted, 10 %
A10 was added, and the mixture was cooled to 43-C,
whereupon sucrose, sodium citrate, OdDHL (N-3-
oxododecanoyl-L-homoserinlactone), BHL (N-
butanoyl-L-homoserine lactone, Sigma-Aldrich),
gentamicin (Gm; gentamicin sulfate, Biochrom AG,
Berlin, Germany) were added to final concentrations
of 60 mg/ml, 40 mM, 200 nM, 200 nM, and 80 mg/
ml, respectively. QSIS2 overnight culture [grown in
ABT media supplemented with 0.5% (wt/vol)
glucose and 0.5% (wt/vol) casamino acid and 80 mg/
ml of gentamicin] was added to a final concentration
of 2.0%.
The QSIS media were prepared as described
above and plates for the screening assay were
subsequently made by pouring the mixture into
boxes, giving an agar thickness of 0.5 cm. Wells with
a diameter of 5 mm were made in the agar plates
using a mould. On solidification, 50 ml of the
redissolved extracts (see Extract preparation) or
solutions of pure compounds dissolved in ethanol
(10 mg/ml) were added to the wells. The plates were
then incubated at 30-C for 16 h. Appearance of a
circular zone of growth around the well indicates
the presence of QSI-active compounds in the sample
added. In case of QSIS1, a blue zone emerged along
with growth due to the presence of hydrolyzed X-
Gal in the plate. To visualize growth of QSIS2, a
0.1% solution of tetrazolium red (2,3,5-triphenylte-
trazolium chloride, Sigma) dissolved in 0.9% NaCl
was poured on top of the plates (0.1 ml/cm2) and the
plates were incubated for 30 min at 30-C. After
incubation, non-bound color was washed off. Most
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Figure 1. Structures of manoalide, manoalide monoacetate
and secomanoalide. (A) secomanoalide. (B) R=H; manoa-
lide, R=Ac; manoalide monoacetate.
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bacteria, including P. aeruginosa, are capable to
Table 1. Marine organisms extracted and tested positive in
the QSIS screen(s)
QSIS1 QSIS2
Source of extract – identification of
marine organisms
+ – Algae – Caulerpa sp. (Caulerpaceae)
++ – Algae – filamentous red – pearl line
(Rhodomelaceae)
+ + Algae – Laurencia sp I – pearl line
(Rhodomelaceae)
+ + Algae – Liagara sp. or Galaxaura
sp. lightly calcified (Galaxauraxeae)
++ – Ascidian – colonial –
encrusting – dark purple
(Polycitoridae)
++ ++ Ascidian – colonial – encrusting –
dark purple Polysyncraton sp.
(Didemnidae)
+ – Ascidian – colonial – encrusting –
dark red (Didemnidae)
++ – Ascidian – colonial – encrusting –
green Didemnum sp.(Didemnidae)
++ + Ascidian – colonial – encrusting
(Didemnidae)
+ – Ascidian – Didemnum sp. (Didemnidae)
+ + Ascidian – solitary – crimson – Acropora
(Didemnidae)
++ + Ascidian – solitary – Polycarpa aurata
(Polycitoridae)
+ + Chlorodesmis fastigiata (Turtle weed)
(Udotaceae)
+ – Fan – gorgonian – white – fine
branching (Gorgoniidae)
+ + Hard coral – Acropora sp. (Acroporidae)
+ – Hard coral – Acropora sp.(Acroporidae)
+ – Hard coral – Favites sp.(Faviidae)
+ – Hard coral – Fungia simplex (Fungiidae)
++ + Hard coral – Fungia sp.(Fungiidae)
+ – Hard coral – massive – Barbattoia
sp.(Poritidae)
+ – Hard coral – massive (Mussidae)
+ + Hard coral – Millipora sp.(Milleporidae)
++ + Hard coral – Turbinaria sp.
(Dendrophyllidae)
++ ++ Soft coral – encrusting – yellow Dampia
sp. (Alcyoniidae)
+ ++ Soft coral – hard skeleton – Goniopora
sp. (Poritidae)
+ ++ Soft coral – Sarcophyton sp. – small
individual – yellow (Alcyoniidae)
+ – Soft coral – Sarcophyton sp. (Alcyoniidae)
+++ + Soft coral – Sarcophyton sp.– solitary
(Alcyoniidae)
++ ++ Soft coral – Sinularia sp. – (Alcyoniidae)
+ + Soft coral – Sinularia sp. – cream
(Alcyoniidae)
+++ +++ Soft coral – Sinularia sp. – yellow
branches – weeping (Alcyoniidae)
+ – Soft coral – Sinularia sp. (Alcyoniidae)
++ + Soft coral – solitary – Sinularia sp.
(Alcyoniidae)
(continued)
Table 1. Continued
QSIS1 QSIS2 Source of extract – identification of
marine organisms
+++ + Soft coral – solitary – small Sarcophyton
(Alcyoniidae)
+ + Sponge – brown – intertidal
++ ++ Sponge – Coscinoderma n.sp.
(Thorectidae)
++ – Sponge – encrusting – grey Dysidea sp.
(Dysideidae)
+ – Sponge – encrusting – light
yellow – Ircinia ramosa (Irciniidae)
+ – Sponge – encrusting – yellow – brittle
+ + Sponge – encrusting orange – large –
unique Agelas sp. (Agelasidae)
++ ’+ Sponge – encrusting orange Agelas sp.
(Agelasidae)
++ – Sponge – erect – Ianthella sp.
(Ianthellidae)
+ + Sponge – erect – lattice forming –
yellow Ircinia sp. (Irciniidae)
+ – Sponge – erect – orange – unique shape
(Axinellidae)
+ – Sponge – erect – tubes – yellow –
(Callyspongidae).
+ + Sponge – erect – white – small –
Dysidea sp. (Dysideidae)
+ + Sponge – Golf ball – purple Cinachrya sp.
(Tetillidae)
+ + Sponge – grey solitary Hyrtios sp.
(Thorectidae)
+ – Sponge – Ircinia gigantea (Irciniidae)
+ – Sponge – lilac solitary – soft (possibly
Niphatidae)
+ + Sponge – massive – black –
(Thorectidae)
+ +++ Sponge – massive – erect – red–brown –
Jaspis sp. (Jaspidae)
+++ + Sponge – massive –black – Luffariella
variabilis (Thorectidae)
+++ ++ Sponge – orange (lobate)
++ + Sponge – Rhopaloeides odorabile
(Spongiidae)
+ – Sponge – solitary – erect – Acanthella sp.
(Axinellidae)
+ – Sponge – solitary – erect – yellow
+ – Sponge – solitary – erect
++ – Sponge – solitary – erect – light
pink Dysidea sp. (Dysideidae)
+ + Sponge – solitary – orange – Acanthella
sp.(Axinellidae)
++ +++ Sponge – Tetillidae
++ ++ Sponge Ircinia n. sp. (Irciniidae)
+ – Sponge– lobed – Carteriospongia
(Thorectidae)
+ – Sponge– lobed – Carteriospongia
or Phyllospongia (Thorectidae)
+, Low activity; ++, medium activity; +++, strong activity; –, no
activity.
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reduce tetrazolium red to the red-colored triphenyl
formazan (TPF) by using tetrazolium red as an
electron acceptor. Thus growth of QSIS2 was seen
as a red zone of triphenyl formazan around the wells
containing QSI-active compounds.
Dose–Response Relationship. To investigate the
efficiency of a putative inhibitor of QS in P. aeruginosa
the QS reporter strain Tn5-LAS was applied as
follows: 150 ml of ABT medium supplemented
with 0.5% casamino acids were added to wells in a
microtiter dish (Black Isoplate\, Perkin Elmer). A
twofold serial dilution series of the extract or pure
compound was made, leaving the last well for
reference (concentration of the tested agent=zero).
Finally 150 ml 50 diluted o.n. culture of Tn5-LAS
(OD450 of diluted culture=0.1) was added to the
wells. The Gfp(ASV)-expression (measured as
fluorescence; excitation and emission wavelength
485 and 535 nm, respectively) was measured every
15 min during the following 18 h by the use of the
multilabel plate reader Wallac 1420 VICTOR2 i
(Perkin Elmer). The OD450 was also determined as a
measure for growth. During the assay the
temperature was held at a constant 34-C.
Results and Discussion
Screening of Marine Organisms. All specimens
collected were sampled, extracted, and screened with
the QSIS1 and QSIS2 screens. A high proportion of the
samples demonstrated QSI activity, with 23% (64 out
of 284) of the samples testing positive in the QSIS1
screen. A further 56% of these (36 out of 64) were also
active in the specific P. aeruginosa based selector
system QSIS2 (Table 1). The high frequency of
organisms that produced QSI compounds may
reflect that soft-bodied, sessile, or slow-moving
marine invertebrates are rich in bioactive me-
tabolites that might serve as defense against
potential predators, competitors, and infectious
microorganisms (reviewed in Paul et al. 2006).
Sponge extracts provided the greatest number of
active extracts (47%; Table 2), however, they were
also the most common source of extracts (38.3%;
Table 3). In terms of proportion of active extracts,
soft corals provided the highest levels of relative
activity, with 31.4% of soft coral extracts being
active in QSIS1 and 25.7% in QSIS2 (Table 3).
Sponges were the next most active group, with
28.8% of sponge extracts being active in QSIS1 and
15.4% in QSIS2 (Table 3). However, all major groups
including the algae had some selective QSI activity
(Table 3). This suggests that the ability to produce
inhibitors of bacterial signaling is either inherited
from a common ancestor or that this mechanism has
evolved convergently.
Natural Products from Luffariella variabilis. The
sponge Luffariella variabilis showed strong positive
activity in both selector systems and was selected for
a further study of a dose–response relationship using
the QS reporter strain Tn5-LAS. L. variabilis
produces the sesterterpenoids manoalide and
secomanoalide as its major metabolites (Ettinger-
Epstein et al. 2007). Manoalide and its related
compounds are potent anti-inflammatory agents
and irreversibly inactivate vertebral phospholipase
A2 (Bianco et al. 1995; Potts et al. 1992). Because the
strong activity of the L. variabilis extract could be
caused by inhibition of bacterial phospholipase in
the QSIS1 system, secomanoalide, manoalide, and
manoalide monoacetate were also tested in QSIS2. A
phospholipase inhibitor may provide a false positive
in QSIS1, but not in QSIS2. All three compounds
were positive in both selector systems. To further
investigate the activity of secomanoalide, manoa-
Table 2. Percentage (and number) of active extracts in
QSIS1 (n=64) and QSIS2 (n=36) reporter systems for each
major taxonomic group
QSIS1 QSIS2
Algae 7.8 (5) 8.3 (3)
Ascidians 12.5 (8) 11.1 (4)
Hard corals 14.1 (9) 11.1 (4)
Soft corals 17.2 (11) 25 (9)
Sponges 46.9 (30) 44.4 (16)
Others 1.6 (1) 0 (0)
Table 3. (A) Proportion (%, and number) of the total number of extracts for each major taxonomic group, (B) percentage
(and number) of QSIS1 active extracts relative to the number in each taxonomic group, and (C) percentage (and number)
of QSIS2 active extracts relative to the number in each taxonomic group
(A) Total extracts (B) QSIS1 (C) QSIS2
Algae 12.6 (35 of 284) 14.3 (5 of 35) 8.6 (3 of 35)
Ascidians 16.6 (45 of 284) 17.8 (8 of 45) 8.7 (4 of 45)
Hard corals 15.2 (42 of 284) 21.4 (9 of 42) 9.5 (4 of 42)
Soft corals 7.6 (35 of 284) 31.4 (11 of 35) 25.7 (9 of 35)
Sponges 38.3 (104 of 284) 28.8 (30 of 104) 15.4 (16 of 104)
Others 12.6 (23 of 284) 4.3 (1 of 23) 0 (0 of 23)
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lide, and manoalide monoacetate, we employed a QS
reporter system harboring the lasB-gfp(ASV) fusion
Tn5-Las in a P. aeruginosa PAO1 background (Hentzer
et al. 2002). In this construction, the expression of
unstable Gfp(ASV) is regulated by the QS-controlled
lasB-promoter. This reporter strain produces signal
molecules that during growth accumulate in the
medium. Expression of lasB will be induced, leading
to increased fluorescence after 8 h, demonstrating
that Bquorate^ conditions were reached. The pres-
ence of an exogenous QSI compound will decrease
expression of fluorescence proportional to the con-
centration and efficacy of the inhibitor. To establish
a dose–response relationship, dilution series of the
manoalide, secomanoalide, and manoalide monoace-
tate were incubated with the QS reporter, and grow-
th and fluorescence were recorded over 18 h. The
OD450 and fluorescence expressed by the QS reporter
Figure 2. OD and relative fluorescence units (RFU). The QS reporter strain PAO1 TN5_LAS was incubated with different
concentrations of (a) manoalide monoacetate and (b) secomanoalide: D, 20 mM; r, 10 mM; ), 5 mM; +2.5 mM; >, 1.3 mM; &, 0.7
mM; Ì, 0.4 mM; Í, reference, no compound added and (c) manoalide: D, 10 mM; r, 5 mM; ), 2.5 mM+1.3 mM; >, 0.7 mM; &, 0.4 mM;
Ì, 0.2 mM; Í, reference, no compound added. These graphs represent the results of one out of several similar experiments.
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in response to manoalide monoacetate, manoalide,
and secomanoalide ranging from 0.2 mM to 20 mM are
shown in Fig. 2. The slope of the resulting curves rep-
resents the synthesis rates (DRFU/Dtime) and is there-
fore a measure of gene expression of the QS controlled
lasB::gfp fusion. The maximal slope for each concen-
tration of the compounds is plotted as a function of
the concentration of manoalide, manoalide monoace-
tate, and secomanoalide. The slope is calculated for
each time point as
P
xacxð Þ yacyð ÞP
xacxð Þ2 where xa is the time
before xb, xb is the time for which the slope is calcul-
ated and xc is the time after xb. Likewise ya is the RFU
(relative fluorescence unit) at time xa, yb is the RFU at
the time xb, and yc is the RFU at time xc. x is the
average of xa, xb, and xc and y is the average of ya, yb ,
and yc. Reduction in synthesis rate (slope) is a measure
of QS inhibition. As seen in Fig. 3, addition of mano-
alide monoacetate, manoalide, and secomanoalide r-
educed the slope in a dose-dependent manner. The
efficacy of manoalide, secomanoalide, and manoalide
monoacetate as QSIs can be calculated as IC50 [the
concentration needed to reduce expression of the las-
B::gfp (ASV) fusion to 50%] based on the logarithmic
equation for synthesis rate as a function of the conce-
ntration of compound. The IC50 values are 0.658 mM,
1.110 mM, and 1.123 mM for manoalide, secomanoa-
lide, and manoalide monoacetate, respectively.
The 2(5H)-furanone moiety, which is present in
all three manoalide derivatives (Fig. 1), is conserved
among many QSIs of natural origin such as the
furanones, patulin, and penicillic acid (Givskov et
al. 1996; Rasmussen et al. 2005b). Strawberries and
peas (Medicago truncatula), which also possess QS
inhibitory activity, produce compounds with a
furanone moiety (Gao et al. 2003). Slaughter (1999)
raised the hypothesis that over an evolutionary time
scale some furanones, due to their properties, were
utilized as interorganism signaling molecules, in-
ducing a range of responses. The QSI activities of
furanones produced by eukaryotes may represent a
conserved mechanism for communication between
eukaryotes and prokaryotes.
Conclusion
Two QSIS systems were used to screen 284 extracts
of marine organisms collected on the central Great
Barrier Reef, Australia. QS inhibitory activity was
exhibited by 64 extracts (23%) from a range of hard
and soft corals, algae, sponges, and seaweed. The
presence of QSIs in all of the major groups of
organisms collected indicates the importance of
QS among marine living organisms and supports
further investigations of the potential of marine
derived QS inhibitors. This was further demonstrat-
ed by the QSI specific activity of the three related
C25 sesterterpene metabolites—manoalide, manoa-
lide monoacetate, and secomanolaide—from the
sponge Luffariella variabilis. QSI active compounds
have broad potential veterinary and biomedical
applications (Rasmussen and Givskov 2006), and
the screening of natural libraries with maximum
diversity will increase the probability for providing
new candidates for drug development.
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Abstract   
During the infectious process Pseudomonas aeruginosa employs bacterial communication (quorum sensing, 
QS) to coordinate expression of tissue damaging factors. QS controlled gene expression plays a pivotal role
in the virulence of P. aeruginosa and QS deficient mutants cause less severe infections in animal infection 
models. Treatment of chronically P. aeruginosa infected Cystic Fibrosis (CF) patients with the macrolide
antibiotic azithromycin (AZM) has been demonstrated to improve clinical outcome. Several studies indicate
that AZM may accomplish its beneficial action in CF patients by impeding QS, thereby reducing 
pathogenicity of P. aeruginosa. This led us to investigate whether QS inhibition is a common feature of
antibiotics. Here we present the results of a screening of 12 antibiotics for QS inhibitory (QSI) activity using 
the previously published QS Inhibitor Selector 1 (QSIS1). Three tested antibiotics: AZM, ceftazidime (CFT)
and ciprofloxacin (CPR) were very active in the assay and were further examined for their effects on QS 
regulated virulence factor production in P. aeruginosa. The three antibiotics administered in sub-inhibitory 
concentrations were investigated by use of DNA microarrays. Although all three antibiotics down-regulate a 
significant proportion of QS regulated genes, the target specificities for QS controlled gene expression are
lower than the QS inhibitor furanone C-30. However, consistent results from the virulence factor assays and 
DNA microarray support that AZM, CFT and CPR decrease expression of a range of QS regulated virulence
factors. Our data suggest that these three antibiotics may, beside their traditional bactericidal and 
bacteriostatic applications, find use as quorum sensing inhibitors.   
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quorum sensing inhibition, subMIC antibiotics 
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Introduction 
The opportunistic pathogen Pseudomonas 
aeruginosa causes severe infections, particularly in 
immunocompromised individuals and cystic 
fibrosis (CF) patients.  The progressive 
deterioration of the lungs caused by chronic P. 
aeruginosa infections, and thus persistent 
inflammation, is currently the main reason for the 
morbidity and mortality in patients with CF (54). 
Intensive anti-pseudomonal treatment 
(maintenance therapy) has greatly improved the 
prospects for CF patients (25, 29, 71). A serious 
side-effect of antibiotic therapy is the development 
of resistance to the antibiotics used (2, 14, 28, 53). 
P. aeruginosa forms biofilms during the infection 
process which adds to the difficulties of 
eradicating infections by antibiotic intervention, 
since bacterial cells living as biofilms are much 
more tolerant to antibiotics than their planktonic 
counterparts (3, 13, 16). When the infection enters 20 
a chronic state the mucoid, alginate-overproducing 
phenotype dominate (21). Macrolides such as 
erythromycin, clarithromycin and the 
erythromycin derivative, azithromycin (AZM), 
have been shown to inhibit the enzymatic activity 
of guanosine diphospho-mannose dehydrogenate 
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in the alginate biosynthetic pathway of mucoid P. 
aeruginosa strains at concentrations well below the 
MIC (Minimal Inhibitory Concentration) value 
(42, 48). Alginate induces a continuous antigen–
antibody reaction locally in the small airways. 
Thus a lowered alginate production will not only 
reduce the viscosity of the sputum, but may also 
lead to less inflammation and thus improved lung 
function (7, 39, 48). Several clinical studies have 
shown that long term treatment with AZM 
improves lung function and body weight in CF 
patients (27, 41, 75). AZM is not usually 
considered to exhibit anti-pseudomonal activity 
due to a MIC against P. aeruginosa in the range of 
128-512 µg/mL (41). The highest concentrations 
of AZM found in the sputum of patients receiving 
high dose therapy (250 mg AZM daily) is 0.6-79.3 
µg/mL, with the median AZM concentration being 
9.5 µg /mL (5). It has been suggested that AZM 
treatment inhibits neutrophil recruitment to the 
lung by reducing proinflammatory cytokine 
expression and inhibition of neutrophil migration, 
resulting in a significant reduction in airway-
specific inflammation (87). Macrolide antibiotics 
such as erythromycin, josamycin and AZM have 
been shown to change the cytokine profile and the 
phagocytic activity of splenocytes and peritoneal 
cells in in vitro experiments (63). It has been 
demonstrated that AZM reduces the production of 
the Th1 subset inducing cytokine IL-12 while 
slightly increasing IL-4. IL-4 induces 
differentiation of CD4+ T cells into Th2 cells and 
thus it seems that AZM treatment has the capacity 
to modulate the Th1/Th2 balance in the Th2 
direction (63). The Th2 subset is dominated by 
antibody mediated defense systems while the Th1 
subset involve the cell mediated immunity. The 
Th1 type response is  especially important in 
defending the host in the early stage of an 
infection, but is also associated with tissue 
destruction in chronic infections due to prolonged 
release of inducible nitric oxide synthase (iNOS), 
reactive oxygen species (ROS) and elastases (26).  
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It has also been suggested that inhibition of cell-
cell communication is the mode of action by which 
AZM exerts its activity in P. aeruginosa infections 
(59, 83). In Gram-negative bacteria cell-cell 
communication, also known as quorum sensing 
(QS), relies upon small diffusible signal molecules 
(N-acyl L-homoserine lactones, AHLs), which 
interact with transcriptional activators to couple 
gene expression with cell population density. The 
QS system of P. aeruginosa is organized 
hierarchically with the RhlI-RhlR components 
being subordinate to the LasI-LasR components. 
LasI directs synthesis of OdDHL (N-3-oxo-
dodecanoyl-L-homoserine lactone) whereas RhlI 
synthesizes BHL (N-butanoyl-L-homoserine 
lactone). P. aeruginosa cells are permeable to 
BHL which freely diffuses over the cell membrane 
whereas active efflux is required for transportation 
of OdDHL (66). Besides the AHL signal 
molecules BHL and OdDHL, a third intercellular 
signal; 2-heptyl-hydroxy-4-quinolone (designated 
the Pseudomonas quinolone signal; PQS) has been 
found to be part of the QS regulon in P. 
aeruginosa (70). They all function in concert to 
control the expression of an array of genes, 
including genes encoding tissue damaging 
exoproducts (31, 50, 61, 65). Besides controlling 
production of virulence factors, the QS signal 
molecules PQS and OdDHL have been reported to 
possess immunomodulatory effects, and in this 
way contribute directly to the pathogenesis of P. 
aeruginosa (23, 40, 84). Several authors have 
shown the effects of AZM on expression of QS 
regulated virulence genes in vitro (59, 83). We 
have recently demonstrated by means of a CF-
mouse model that AZM treatment, despite having 
no effect on growth of infecting bacteria, 
significantly improved clearance of pulmonary 
bacteria, reduced the extents of lung abscesses and 
decreased the severity of lung pathology and 
reduced alginate production in vitro and in vivo 
(38). Since QS seems to play a key role in the 
expression of virulence and interaction with host 
protection, inhibitors of QS have been suggested as 
important components of future anti-pseudomonal 
therapy (35). Examples of compounds that can 
block QS in P. aeruginosa are the halo-furanones 
(32, 36) originating from a benthic macroalgae and 
the fungal metabolites patulin and penicillic acid 
(73). Furanone C-30 inhibits QS at a concentration 
range from 1 to 10 μM but administered in excess 
i.e. in concentrations 10 fold higher, the compound 
impairs growth and exhibit antibiotic properties. In 
addition to QSI activity, the bioactive halo-
furanones exhibit a multitude of activities 
including antibiotic and anti-fouling properties and 
can therefore be considered as multifunctional 100 
compounds engaged in communication as well as 
competition (for a recent review see (20)). 
Recently it was demonstrated that subminimum 
inhibitory concentrations (subMICs) of antibiotics 
broadly affect patterns of transcription in bacteria 
and seems to function as signaling mediators, 
 rather than targeting growth of rivals (33). This 
raises the question whether other compounds 
previously identified for their antibiotic properties 
may turn out to possess communication interfering 
properties and potentially QS inhibitory (QSI) 
activity. In line with that, we present the results of 
a screening of 12 antibiotics for QSI activity, 
identifying three antibiotics; AZM, ciprofloxacin 
(CPR) and ceftazidime (CFT) exhibiting strong 
QSI activity in the assay. The effect of these three 
antibiotics was further investigated by means of 
transcriptome analysis and phenotype assays.  
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Results and discussion 
 
Screening for QSI activity 
AZM has been shown to inhibit expression of a 
subfraction of QS controlled genes (59, 83). Along 
with AZM, we have investigated 11 other 
antibiotics (including one antifungal compound; 
griseofulvin) for the ability to interfere with 
bacterial QS using a simple plate diffusion screen 
based on the Quorum Sensing Inhibitor Selector 
QSIS1 (72). By employing our standard conditions 
(72), we found that chloramphenicol, gentamicin, 
griseofulvin, kanamycin, piperacillin, 
spectinamycin, tetracycline, tobramycin and 
streptomycin showed low or no QSI activities 
whereas AZM, in accordance with previous 
investigations, was very active. Also the 
fluoroquinolone, ciprofloxacin (CPR) and the 
cephalosporin, ceftazidime (CFT) showed strong 
QSI activities in the QSIS1 assay (Fig. 1).  
 
Figure 1. Screening of antibiotics by the use of the 
CPR and CFT are employed in the clinic as anti-
pseudomonal treatments, whereas AZM exhibits 
low if any bactericidal or bacteriostatic effect on P. 
aeruginosa. CPR inhibits bacterial DNA synthesis, 
by targeting DNA gyrase (topoisomerase II), 
responsible for the supercoiling and uncoiling of 
the DNA. Uncoiling of the structure is the initial 
step for replication, transcription, and repair of the 
DNA, thus inhibition of this step will eventually 
lead to the death of the cell. CFT is a β-lactam and 
disrupts the synthesis of the peptidoglycan layer of 
bacterial cell walls. The mode of action of AZM is 
to bind the 50S subunit of the bacterial ribosome 
thereby inhibiting translation of mRNA. These 
three antibiotics therefore exhibit diverse 
mechanisms of antimicrobial action and they are 
structurally very different. We chose to further 
investigate the effects on P. aeruginosa QS 
regulated gene expression and virulence factor 
production with AZM, CPR and CFT as 
representatives for these widely diverse groups of 
antibiotics.  
35 
QSIS1 assay a) piperacillin b) azithromycin c) chlor-
amphenicol d) ciprofloxacin e) gentamicin f) spectina-
mycin, g) griseofulvin h) kanamycin i) tetracycline       
j) tobramycin k) ceftazidime l) streptomycin 
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AZM, CPR and CFT interfere with production of 
QS controlled virulence factors.  
 65 
Heat stable hemolysin 
First we investigated the effect of AZM, CPR and 
CFT on the production of heat stable hemolysin. P. 
aeruginosa produces at least two hemolysins; the 
heat-labile phospholipase C (PA0844, phlC) and 
the heat-stable rhamnolipid (PA3479, PA3478, 
PA1130 and PA3387, rhlA-C, G) (8, 45, 81). 
Besides being a hemolysin, rhamnolipid has also 
been reported to immediately lyse neutrophils, 
macrophages and various animal cells (44, 56, 80). 
Expression of rhamnolipid therefore contributes 
significantly to the virulence of P. aeruginosa. 
Rhamnolipid synthesis is turned on in early 
stationary phase of P. aeruginosa PAO1 cultures 
(61, 88). After 14-18 hours of growth (under the 
conditions outlined in the Materials and Methods 
section), the concentration of rhamnolipid in the 
supernatant exceeds 50 µg/mL, which is sufficient 
to lyse erythrocytes within 20 minutes (our 
observation). The lysis of erythrocytes by 
rhamnolipid can be used as a simple assay for 
detection of rhamnolipid by mixing autoclaved 
supernatant with blood and incubate the mixture at 
room temperature for 20 minutes. A clearing and a 
non-precipitating red coloring of the blood-
supernatant solution indicates rhamnolipid present 
at a concentration above 50 µg/mL, while lack of 
b ca d
e f g h
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 A hemolytic activity (characterized by the 
precipitation of intact blood cells) indicates that 
little or no rhamnolipid is present in the 
supernatant. Investigating supernatants from P. 
aeruginosa grown in the presence or absence of 
AZM, CPR and CFT and supernatants from the QS 
mutant ∆lasI-∆rhlI, we found that only the 
untreated wild-type produced enough rhamnolipid 
to cause rapid hemolysis of the red blood cell. 
However, treatment with CFT did not fully abolish 
hemolytic activity (Fig. 2).  
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Figure 2. Hemolysis of autoclaved supernatants from P. 
aeruginosa PAO1 cultures grown for 20 h. From left to 
right a) PAO1 grown without antibiotics, PAO1 grown 
in the presence of: b) 2 µg/mL AZM, c) 8 µg/mL AZM, 
d) 0.25 µg/mL CFT, e) 0.04 µg/mL CPR, and  f) the 
∆lasI-∆rhlI mutant of PAO1. 
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To quantify the effect of AZM, CFT and CPR on 
rhamnolipid production we determined the 
concentration of rhamnolipid in supernatants of 
treated and untreated P. aeruginosa by means of 
LC-MS. When grown in the presence of 8 µg/mL 
AZM, the concentration of rhamnolipid was 
reduced by 80% compared to untreated cultures, 2 
µg/mL AZM reduced the rhamnolipid content of 
the supernatants to 25% compared to the untreated 
controls, whereas CPR (0.04 µg/ml) and CFT 
(0.25 µg/ml) reduced the concentration of 
rhamnolipid to around 60% of the untreated 
cultures. The QS mutant ∆lasI-∆rhlI did not 
produce any measurable amount of rhamnolipid. 
(Fig 3). 
 
Protease 
The production of extracellular protease in P. 
aeruginosa PAO1 cultures grown in the absence or 
presence of AZM, CPR or CFT, as well as the 
∆lasI-∆rhlI mutant was assayed by adding sterile-
filtered supernatants from overnight cultures to 
wells made in agar plates containing 5% skimmed 
milk. Protease activity was significantly lowered 
by AZM, CPR and CFT.  (Fig. 4). 
 
 
 
Figure 3. Determination of the concentrations of 
rhamnolipid in supernatants from P. aeruginosa  
cultures grown for 16 h (A) and 20 h (B) in the presence 
of: 2 µg/mL AZM (dark grey bar), 8 µg/mL AZM (light 
grey bar), 0.25 µg/mL CFT (bar w. vertical lines), 0.04 
µg/mL CPR (bar w. horizontal lines), PAO1 grown 
without antibiotics (black bar) and ∆lasI-∆rhlI mutant 
of PAO1 (no measurable rhamnolipid production, thus 
not visible). 
 
Elastase  
Extracellular elastase activity in the supernatants 
of P. aeruginosa PAO1 cultures (untreated or 
grown with AZM, CPR or CFT) was quantified by 
the use of the procedure from (62) (slightly 
modified). The QS mutant ∆lasI-∆rhlI was assayed 
by the same procedure. AZM treatment reduced 
the elastase activity almost to the level of the 
∆lasI-∆rhlI mutant. CPR and CFT also reduced the 
elastase activity. (Fig. 5). 
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Chitinase  
Chitinase activity in the supernatants of P. 
aeruginosa PAO1 cultures (untreated or grown 
with AZM, CPR or CFT, or the QS mutant ∆lasI-
∆rhlI) was quantified by measuring degradation of 
 chitin azure. AZM and CPR reduced the 
chitinolytic activity almost to the level of the 
∆lasI-∆rhlI mutant. CFT did not decrease chitinase 
activity as much as AZM and CPR, although still 
having a significant effect. (Fig. 6). 
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Figure 4. Protease activity of supernatant grown 
without antibiotics a) or in the presence of b) 0.04 
µg/mL CPR, c) 8 µg/mL AZM, d) 2 µg/mL AZM e) 
0.25 µg/mL CFT and f) supernatant from the ∆lasI-
∆rhlI mutant of PAO1. (** P<0.01, Dunnett’s test). The 
experiment was performed as four replicates. Data are 
representative of two independent experiments.  
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Figure 5. Elastolytic activity of supernatants from 
PAO1 cultures grown to OD600 2.0 in the presence of:  
2 µg/mL AZM (dark grey bar), 8 µg/mL AZM (light 
grey bar), 0.25 µg/mL CFT (bar w. vertical lines), 0.04 
µg/mL CPR (bar w. horizontal lines), PAO1 grown 
without antibiotics (black bar) and ∆lasI-∆rhlI mutant 
of PAO1 (white bar). (* P<0.05, ** P<0.01, Dunnett’s 
test). The experiment was performed as triplicates. Data 
are representative of two independent experiments. 
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Figure 6 Chitinase activity of supernatants from PAO1 
cultures grown to OD600 2.0 in the presence of: 2 µg/mL 
AZM (dark grey bar), 8 µg/mL AZM (light grey bar), 
0.25 µg/mL CFT (bar w. vertical lines), 0.04 µg/mL 
CPR (bar w. horizontal lines), PAO1 grown without 45 
antibiotics (black bar) and ∆lasI-∆rhlI mutant of PAO1 
(white bar). (* P<0.05, ** P<0.01, Dunnett’s test). The 
experiment was performed as four replicates. Data are 
representative of two independent experiments. 
DNA microarray analysis of gene expression in the 
presence of AZM, CFT and CPR 
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In order to obtain knowledge of the mechanism by 
which virulence factor production was altered by 
presence of the three antibiotics we performed 
DNA microarray analyses on P. aeruginosa 
cultures treated with the three antibiotics AZM, 
CPR and CFT in concentrations not affecting 
growth. Our experience from screening large 
numbers of compound libraries is that toxic or 
growth inhibitory compounds may show QSI-like 
activity (unpublished observations). This is likely 
to be caused by pleiotropic effects rather than a 
“true” QSI activity (such as interaction with the 
QS receptor), since the effect on QS controlled 
gene expression disappears when the concentration 
of the compound is lowered to a level that allows 
the bacteria to attain the optimum growth rate in a 
given medium. Furthermore, since obstruction of 
QS (either by mutation or antagonistic drugs) will 
not inhibit growth, we consider it essential to 
investigate potential QSI activities of the three 
antibiotics under conditions not affecting growth.  
The medium of exponentially growing P. 
aeruginosa cultures was either supplemented with 
AZM (2 and 8 μg/mL), CFT (0.25 μg/mL) or CPR 
(0.04 μg/mL) at OD600 0.1 or left untreated as a 
control. These concentrations clearly did not affect 
growth. Growth curves for P. aeruginosa grown in 
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 AZM, CFT and CPR affect expression of QS 
regulated genes 
the presence or absence of AZM, CPR and CFT in 
different concentrations (including concentrations 
with slightly growth inhibiting effects) and the 
ΔlasIΔrhlI mutant are presented in Fig. 7. 
6 
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Figure 7. Growth curves for the ΔlasI-ΔrhlI mutant (□) 
and PAO1 grown without antibiotics (×) or PAO1 
grown in the presence of 2 µg/mL AZM (Δ), 8 µg/mL 
AZM (▲), 16 µg/mL AZM (▲), 0.04 µg/mL CPR (○), 
0.08 µg/mL CPR (●), 0.25 µg/mL CFT (◊) and 0.5 10 
µg/mL CFT (♦). 
Applying the growth conditions described in the 
Materials and methods section, OD600 2.0 
corresponds to the transition from exponential 
phase into stationary phase, and at this point a 
substantial fraction of QS regulated genes are 
maximally regulated (induced/repressed) (78). 
OD600 2.0 was therefore chosen as sample point for 
the transcriptomic analysis. Total RNA from the 
samples were extracted and subjected to cDNA 
synthesis. The absolute expression values from 
cultures grown in the presence of antibiotics were 
compared with untreated cultures and the changes 
in expression reported as simple fold. According to 
(36, 88) expression changes below 5 fold are 
disregarded. Only “present genes” – as validated 
by Affymetrix software GeneChip Operating 
System (GCOS) version 1.4 – were included in the 
analyses. (Table I).  
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The QS regulon has been defined by Rasmussen et 
al., 2005 (73). This particular study considers 
genes to be QS regulated if their expression are 
consistently altered >5 fold in both ΔlasI-ΔrhlI and 
ΔlasR-ΔrhlR mutants compared to their wild-type 
counterpart. The majority of all QS regulated 
genes defined this way are inducible with 
exogenous AHLs in a ΔlasI-ΔrhlI background. 
Only one gene (PA1556, a probable cytochrome c 
oxidase subunit) is consistently upregulated in both 
the ΔlasI-ΔrhlI and the ΔlasR-ΔrhlR mutant and 
thus QS repressible. Using this QS regulon we 
analyzed the fraction of QS regulated genes among 
the genes repressed by the three antibiotics. These 
analyses showed that AZM (8 μg/mL) repressed 
70% of the 174 QS regulated genes in P. 
aeruginosa PAO1 and that  28% percent of the 
total number of genes being repressed by AZM are 
members of the QS regulon. Lowering the 
concentration of AZM to 2 μg/mL caused a relief 
in inhibition of QS regulated genes (47% of all QS 
genes repressed) and the total number of genes 
down-regulated fell to 227 however, the specificity 
toward the QS regulon increased to 36%. CPR 
accounts for the highest specificity towards the QS 
regulon (40%) and targeted 51% of all QS genes in 
P. aeruginosa, whereas the specificity for CFT 
was 36% and CFT only repressed 28% of all QS 
genes. For comparison, the specificity of C30 is 
48% and it down-regulates 72% of all QS genes in 
P. aeruginosa (C30 data from (36), applied to the 
same data treatment and criteria). 
As outlined above, members of the QS regulon are 
overrepresented among the genes repressed by 
subMIC levels of AZM, CFT and CPR. This 
suggests that these antibiotics exhibit some 
specificity for QS regulated gene expression 
through interaction with, or effect on QS 
regulatory components.  Investigating the 
expression profile of LasR, RhlR or LasR-RhlR 
regulated genes, we further aimed to elucidate 
potential QS target(s) of the antibiotics. The QS 
regulated genes can be divided into 4 groups. 
Group A contains 44 LasR dependent genes, i.e. 
genes down-regulated in both a ΔlasR and a 
ΔlasR-ΔrhlR mutant. Group B consists of RhlR 
dependent genes (14 genes), genes down-regulated 
in both a ΔrhlR and a ΔlasR-ΔrhlR mutant. Group 
C comprises the main fraction of QS regulated 
genes (94 genes in total) and consists of genes 
which require both LasR and RhlR to be expressed  
According to these criteria, non-growth inhibitory 
concentrations of AZM altered the expression of 
488 (8 μg/mL) and 276 (2 μg/mL) genes, with 
most genes (427 and 227, respectively) being 
down-regulated. Non-growth inhibitory 
concentrations of CFT (0.25 μg/mL)  and CPR 
(0.04 μg/mL)  affected the expression of 146 (136 
repressed) and 281 genes (223 repressed), 
respectively. (Table II).  
90 
 
 Table I. The effect of subMIC of AZM, CFT, and CPR on P. aeruginosa genes belonging to the QS regulon defined 
by (73). This regulon consist of genes down regulated in both a ∆lasI-∆rhlI and a ∆lasR-∆rhlR mutant of PAO1. 
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 Text to table I. The effect of subMIC levels of AZM, CFT and CPR on genes belonging to the QS regulon defined by 
(73). This regulon consists of genes down-regulated in both a ∆lasI-∆rhlI and a ∆lasR-∆rhlR mutant of P. aeruginosa 
PAO1. Genes more than 5 times down regulated are marked grey and genes more than 5 times upregulated are marked 
black. 
The column pprB reports genes being more than 5 times upregulated (+) or 5 times down regulated (-) in a ∆pprB 
mutant of PAO1 according to (24). 
5 
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The column designated * reports genes previously reported to be upregulated (+) or down regulated (-) by AZM 
according to (59). 
The column Reg. assigns the genes into one of the four QS regulation groups. Group A; Las dependent genes, group B; 
Rhl dependent genes, group C; genes requiring both a functional Las and Rhl system and group D are Las-Rhl regulated 
genes. See further explanation in the text. 
 
Table II  
Description 
AZM  
8 μg/mL 
(11 µM) 
AZM  
2 μg/mL 
(2.7 µM) 
CFT 
0.25 μg/mL 
(0.4 µM) 
CPR 
0.04 μg/mL 
(0.1 µM) 
C30c
2.5 µg/mL 
(10 μM) 
No. of genes > 5 fold down-regulated 427 227 136 223 260
No. of genes > 5 fold up regulated 61 49 10 58 0
No. of QS genesa affected (> 5 fold) 121 81 49 89 125
Percent of QS genesa affected (> 5 fold) 70% 47% 28% 51% 72%
Specificity b 28% 35% 36% 40% 48%
a Genes belonging to the QS regulon as defined by (73) 
b Specificity; QS genesa repressed/total number of genes repressed 15 
20 
25 
30 
35 
40 
45 
c Data for the QSI furanone C-30 at OD600  2.0 included for comparison (Data presented in (36)) 
 
at normal levels, that is genes which are down-
regulated in all three types of mutants; either 
ΔlasR or ΔrhlR or ΔlasR-ΔrhlR. Finally, group D 
consists of 14 LasR-RhlR regulated genes, which 
are only down-regulated if both LasR and RhlR are 
knocked out as in the ΔlasR-ΔrhlR mutant. 
Interestingly it seems that AZM, CFT and CPR 
have a low preference for the group B genes (the 
RhlR specific genes), whereas they have a high 
specificity for the group C genes. (Fig. 8). 
Among the genes affected by AZM, CFT and CPR 
many encode previously identified QS regulated 
genes such as chitinase (chiC, PA2300) and chitin-
binding protein (cbpD, PA0852) (30, 78, 88). 
Other known QS induced genes such as the genes 
encoding the osmotically inducible protein (osmC, 
PA0059) and cytochrome c oxidase (coxA-B and 
coIII, PA0105-PA0108) are down-regulated by the 
presence of the three antibiotics (36, 78). The 
endoprotease gene piv (also known as prpL, 
PA4175) is also down-regulated by AZM, CFT 
and CPR. This protease is capable of degrading 
elastin, decorin and the transferrin family of 
proteins, including lactoferrin (91). The only QS 
repressed genes from the regulon; PA1556 
(cytochrome c oxidase) was upregulated by all 
three antibiotics together with PA1557.  
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Many genes from the PA2134 – PA2190 region of 
the genome were down-regulated by AZM, CFT 
and CPR. This region has been found to be 
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Figure 8. LasR, RhlR and LasR-RhlR specificity of 
AZM (white bars), CFT (black bars) and CPR (light 50 
grey bars) (and C30 (dark grey bars)). See definitions 
for group A, B, C and D in the text. 
associated with stationary growth and to be under 
QS/rpoS control (77, 78, 88, 89). Out of the 57 
genes in this 60.69 Kbp region, 46 were evaluated 
as present in the all arrays. Out of the 46 genes, 39 
genes were more than 5 fold repressed by AZM, 
CFT and CPR. The general stress protein PA2190 
was down-regulated in the presence of all three 
antibiotics along with genes involved in nutrient 
stress (glgA PA2165, glgB PA2153 and glgP 
PA2144). A glgA transposon insertion in 
Escherichia coli has been shown to cause the 
mutant to become severely defective in biofilm 
formation (43).  
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AZM and CPR seem to exhibit higher target 
specificity for QS genes than CFT which is in 
accordance with the virulence factor assays 
described earlier in this section. Many QS 
regulated virulence factors such as the alkaline 
metalloproteinase (aprA, PA1249), protease PfpI 
(pfpI, PA0355) LasA protease (lasA, PA1871) 
elastase B (lasB, PA3724) the cytotoxic 
galactophilic lectin  (PA-IL, lecA, PA2570) and 
rhamnolipid (rhlA, rhlB PA3478-3479) were more 
than 5 fold repressed by AZM and CPR but not by 
CFT. Investigations have shown that biofilms of P. 
aeruginosa QS mutants have reduced tolerance to 
antibiotics compared with their wild-type parent. 
In line with that, inhibition of QS have been shown 
to promote eradication by antimicrobial treatments 
and make the biofilm more susceptible to 
phagocytosis by neutrophils (19, 36, 72). Since 
rhamnolipid and the adhesive lectin LecA are both 
QS regulated and involved in biofilm maturation 
(18, 22, 51, 64) repression of these genes may 
contribute to the development of a less structured 
and more antibiotic sensitive biofilm seen in QS 
mutants. Agents targeting expression of 
rhamnolipid, lectins and other biofilm factors 
either via QS or by other pathways are desirable in 
clinical settings as biofilm formation complicates 
the eradication of bacterial infections. Moreover, 
rhamnolipid and lectin LecA have been reported to 
cause cytotoxic effects on mammalian cells, 
including neutrophils and macrophages, and are 
also important in the infectious process of P. 
aeruginosa (4, 44, 56, 57, 79, 80, 94). 
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AZM, CFT and CPR alter gene expression of a 
variety of genes  
A few genes were consistently upregulated by 
AZM, CFT and CPR. The QS repressed gene 
PA1556 (cytochrome c oxidase subunit) and 
PA1557 were more than 5 times induced. PA1673 
(unknown function, 44% similar to hemerythrin, 
used for oxygen storage/transfer by a marine, 
sipunculid worm) was >5 fold induced by AZM 
and CPR but only 4.1 fold by CFT treatment. 
PA2260 (hypothetical protein, identified by (88) to 
be QS repressed) was induced by AZM and CFT 
but not CPR.  
Several genes are solely induced by AZM. A high 
proportion of these genes have also been reported 
as AZM inducible by (59), and many encodes for 
ribosomal subunits such as PA3742 (rplS, 50S 
ribosomal protein L19) and PA4671 (probable 
ribosomal protein L25). The overexpression of 
ribosomal genes may be a mechanism to 
compensate for the effect of AZM which targets 
the 50S ribosomal subunit. The initiation factor 
infA (PA2619) was also induced in the presence of 
AZM in accordance with the findings by (59).  
In agreement with two recent studies (11, 52) we 
found that CPR induces the expression of the 
pyocin S genes (PA0985, pyocin S5, PA1150 
pyocin S2 and PA3866 pyocin S3 like). The S-type 
pyocins are protease sensitive bacteriocins and 
have colicin like structures and mode of actions; 
they contain an effector component possessing 
DNase and lipase activity as well as an immunity 
component.  
The ribosome modulation factor (rmf, PA4296) 
was repressed by AZM but not affected by 
treatment with CFT and CPR. The transcriptome 
analyses by (59) also shows that rmf is repressed 
by AZM. rmf of P. aeruginosa shows a high 
homology to rmf of E. coli  (similarity 66%). rmf 
mutants of E. coli have been shown to gradually 
lose viability in stationary phase cultures (60) 
however, a recent study concluded that rmf (in E. 
coli) may only be required under competitive 
growth conditions (12). 
 
AZM induces expression of genes related to Type 
III secretion 
In accordance with the findings by (59) we also 
found that AZM induced expression of genes 
involved in Type III secretion (T3S). P. 
aeruginosa uses its T3S system to secrete and 
translocate several cytotoxic products into the 
cytosol of eukaryotic cells. Expression of T3S 
increases pathogenicity of P. aeruginosa and is 
associated with more severe infections and higher 
mortality rate in animal models (1, 74, 76). QS has 
been shown to negatively modulate expression of 
the T3S system in P. aeruginosa (9), which means 
that the T3S system is down-regulated under high 
cell density conditions and thus presumably 
primarily plays a role in the early stages of the 
infection. Genes in the T3S system such as 
PA1700-1701 (conserved hypothetical proteins in 
T3S), pcrGV (PA1705 regulator in T3S and 
PA1706), exsB (PA1712, exoenzyme S synthesis 
protein B), exsD (PA1714, part of the pscB-L 
operon) and pscBCEO (PA1715, T3S export 
apparatus protein, PA1716, T3S outer membrane 
protein, PA1718, T3S export protein, PA1696 
translocation protein in T3S) were upregulated by 
AZM. Neither CFT nor CPR however, induced 
genes in the T3S system gene cluster PA1690-
 11 
PA1725. Interestingly, a study by (49) showed that 
treatment of P. aeruginosa with subMIC 
macrolides (AZM, clarithromycin, erythromycin) 
prior to intranasal challenge of mice significantly 
enhanced the mortality rate (from 0% to 80-100%)  
In the same study however, macrolide antibiotics 
were also administered to mice after inoculation of 
P. aeruginosa PAO1, and in this case the mortality 
of mice did not increase (49). Thus it seems that 
activation of genes by macrolides only causes 
enhanced virulence if the macrolides are applied 
prophylactically and not as a part of the treatment. 
Still the potential risk of inducing virulence and 
cytotoxicity through the T3S system should be 
considered along with the potential benefits when 
applying AZM (and possibly other macrolides) to 
patients infected by P. aeruginosa.  
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AZM, CPR, CFT and the two component regulator 
system pprA-B 
The QS induced chemotaxis transducer PA4290 
was down-regulated by AZM, CFT and CPR. 
AZM and CPR also repressed the main part of the 
genes in the region PA4290-PA4306. Many of 
these genes have been shown to be QS regulated in 
previous studies where QS genes were identified 
by mapping genes down-regulated in ΔlasI-ΔrhlI 
mutants and restored to wild-type levels by 
addition of signal molecules (36, 78, 88). The two 
component regulator system pprA-B (PA4293, 
PA4296) was down-regulated by AZM and CPR 
but not by CFT. pprA was down-regulated 30 and 
7.9 times by AZM and CPR, respectively, with 
pprB down-regulated 12.9 and 5.7 times by AZM 
and CPR, respectively. Expression of pprA-B has 
been shown to be QS regulated (78, 88), but the 
gene products have also been identified having QS 
modulatory activity, as yet another auto-feedback 
system of QS in P. aeruginosa (24). Knock out of 
pprB leads to reduced influx of the P. aeruginosa 
QS signal OdDHL thereby globally influencing the 
expression of QS regulated genes (24), but PprB is 
also involved in regulation of sensitivity to 
antibiotics. Overexpression of pprB results in an 
increased sensitivity to antibiotics, especially 
aminoglycosides, probably due to a decrease in 
membrane permeability (90). In vivo and in vitro 
studies have shown that P. aeruginosa develops an 
increasing tolerance to aminoglycosides following 
pre-treatment with these antimicrobials (17, 46, 
92). It is possible that a similar mechanism 
operates in the presence of other antibiotics such as 
AZM and CPR and perhaps also CFT thereby 
inducing an adaptive down-regulation of pprB to 
decrease membrane permeability and further 
causing decreased OdDHL influx, which results in 
a change in expression of QS regulated genes. 
Support for this hypothesis can found in the 
observation that the three antibiotics have higher 
specificities for las regulated genes than rhl 
regulated genes (group B). The rhl signal molecule 
BHL is capable of freely diffusing over the 
membrane and is – unlike OdDHL - not dependent 
on active transport.   
The study by (24) identified 53 genes more than 
five fold down-regulated by a Tn5 insertion in 
pprB. In comparison we found, as presented in this 
current study, that expression of 40 of those genes 
more than 5 fold reduced were down-regulated to 
half the level or less in the presence of AZM. This 
include 21 genes which were more than 5 fold 
down-regulated. We found that CPR down-
regulated 20 out of the 53 genes more than 2 fold, 
including 6 genes more than 5 fold down-
regulated. CFT caused a down-regulation of 14 of 
the 53 genes down-regulated by the pprB mutation 
with no genes being more than 4 times down-
regulated. Genes reported to be PprB regulated 
include virulence factor genes such as lasB, rhlAB, 
lecA, prpL (24) which are also down-regulated by 
AZM and CPR. The expression of the QS 
transcriptional regulator RhlR and the AHL 
synthetase genes lasI and rhlI are also decreased 
by the prpB knock out mutation (24). This is not 
surprising as rhl is subordinate to the las system 
and the AHL synthetase genes are under QS 
control, which may provide negative feedback that 
enhances the QS repressing effect of the pprB 
mutation. Only AZM however, causes a down-
regulation of rhlR, and none of the three antibiotics 
down-regulates the AHL synthetase genes. 
Additionally AZM decreased the expression of 
lasR 5 fold, which may also contribute to the QS 
inhibitory effect of AZM.  
 
Docking of AZM, CFT and CPR against the 
Ligand Binding Domain of the LasR protein. 
In order to explore the possibility that AZM, CFT 
and CPR directly interacts with the LasR protein, 
we performed an in silico docking of the three 
antibiotics against the recently published Ligand 
Binding Domain (LBD) of the LasR protein (10). 
None of the three antibiotics gave a high affinity 
score in the docking. In contrast to this, previously 
reported QSI compounds (e.g. C-30, patulin, 
furanone and 4-nitropyridine-N-oxide) exhibited 
 high affinity scores (Table III). Further the in silico 
analysis suggested that AZM, CFT and CPR do 
not fit inside the binding site cavity of LasR 
because they exhibit of steric clashes with the 
protein target. This suggests that AZM, CFT and 
CPR effects on QS may be pleiotrophic in nature.  
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Final comments 
In the present paper we present the screening 
results of 12 antibiotics for QSI activity using the 
QSI screening system QSIS1. Three of the 12 
antibiotics; AZM, CFT and CPR showed strong 
positive results in the screening system and were 
further investigated for their effect on production 
of virulence factors in P. aeruginosa. 
Administered in concentrations not affecting 
growth, AZM, CPR and CFT, inhibited production 
of the important virulence factors chitinase, 
protease, elastase and rhamnolipid production. Our 
recent data suggest that rhamnolipid functions as 
shield to protect biofilms against the predatory 
behavior of neutrophils, and rhamnolipid may thus 
be a pivotal virulence factor (44). DNA microarray 
analyses showed that QS genes were over-
represented among the genes down-regulated by 
AZM, CPR and CFT, suggesting that the three 
antibiotics possess QS inhibitory activity. 
Furthermore, the three antibiotics exhibited a 
higher specificity for LasR regulated genes than 
RhlR dependent genes.  
We speculate that the effect of AZM and CPR and 
perhaps also CFT is pleiotropic and channeled 
through the two component regulator system 
encoded by PprAB. Expression of this two 
component regulator system was down-regulated 
by AZM and CPR. PprB has been reported to 
control membrane influx of OdDHL and thereby 
affect QS in P. aeruginosa. pprB was first 
identified to be involved in sensitivity to 
antimicrobials by regulating membrane 
permeability in response to the presence of 
antibiotics. This suggests that the mechanism by 
which AZM and CPR affects QS is to lower influx 
of OdDHL over the P. aeruginosa membrane by 
down-regulating expression of PprB in response to 
the presence of antibiotics.  
QSIs constructed using AHL scaffolds are 
designed to bind to the LuxR homologue without 
activating it thereby blocking the binding and 
activation by AHLs. Thus, these QS antagonists 
have a high structural similarity to AHLs. Other 
QSIs all sharing the 2(5H)-furanone moiety such 
as the natural occurring halogenated furanones, 
and the mycotoxins patulin and penicillic acid 
seem to exert their effect by destabilizing LuxR 
and thereby inducing turnover of QS regulator 
proteins (55, 73). Structures of BHL and OdDHL 
and previously published QSI compounds are 
shown in Fig. 9.  
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Figure 9. Inhibitors and signal molecules of P. 
aeruginosa QS. a 4-nitropyridine-N-oxide (72), b C30 
(36), c 2-heptylthioacetyl homoserine lactone (69), d 3-
oxo-C12D10 (82), e BHL, f patulin (73), g OdDHL. 
The three antibiotics AZM, CFT and CPR are 
structurally very different from all until now 
published QSIs, moreover, as many other 
antibiotics they are very bulky molecules (Fig. 10). 
In silico docking of AZM CFT and CPR against 
LBD of the LasR protein showed a low affinity of 
the antibiotics to the LasR receptor site mainly due 
to spatial penalties. This supports the idea that 
these antibiotics may exert their QS regulatory 
effect through mechanisms different to the other 
QSI’s thereby opening new interesting 
perspectives for combination therapy with QSI’s 
having different modes of action. The usefulness 
of the combination of QSI’s and traditional 
bactericidal compounds has been proven by 
several in vitro experiments (19, 36, 73). The 
understanding of some antibiotics’ dual course of 
action may have the potential to further add to 
anti-pathogenic therapies of which the key element 
is attenuating rather than killing bacteria directly. 
This strategy allows the host defense system 
eliminate the attenuated bacteria.  
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Figure 10. Structures of the three antibiotics investigated for potential quorum sensing inhibitory activities.                  
A. Azithromycin, B. Ceftazidime and C. Ciprofloxacin 
C B A 
 
Most antibiotics originate from natural sources 
such as soil microorganisms, or are derivatives of 
compounds originating from nature. A general 
point of view has been that the ecological purpose 
of antimicrobials in the environment is to fight 
competitors. However, in soil the concentration of 
free antibiotics are likely to be well below MIC. 
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Table III. In silico docking 
Name of ligand    Rerank Score 
OdDHL (template) -107.3
3-oxo-C12D10 -94.5
2-heptylthioacetyl homoserine lactone -88.8
BHL -82.2
Patulin -69.8
4-nitropyridine-N-oxide -62.9
C30 -50.4
Ciprofloxacin 317.3
Ceftazidime 373.5
Azithromycin 3316.2
 
As described in this paper and by others (52, 93) 
subMIC antibiotics may have various effects on 
bacteria such as enhanced biofilm formation, 
altered motility patterns, increased cytotoxicity and 
changes in expression of virulence factors, effects 
which are totally different from the impact of high 
doses (37, 52, 59). The authors of (52) suggest that 
the function of antibiotics in nature may be 
intermicrobial signaling rather than bullets aimed 
to kill enemies in order to defend niches or food. 
This hypothesis offers an evolutionary explanation 
of why some antibiotics may be capable of 
interfering with QS controlled gene expression.  
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In line with the present report, it has recently been 
shown that OdDHL (and other 3-oxo AHLs) as 
well as its tetramic acid degradation product 
exhibit antibacterial activity against Gram positive 
bacteria (47) suggesting that the signal molecules, 
like some antibiotics, posses dual activity. 
Furthermore, our data suggest that antibiotics 
which function to down-regulate QS in P. 
aeruginosa may be administered in subMIC 
concentrations (where there is a reduced selection 
pressure for the development of resistance) to 
block QS and thereby attenuate the pathogen. Such 
interesting properties highlight the huge 
unexplored potential of using compounds derived 
from natural scaffolds in the search for new 
pharmaceuticals with a variety of targets (i.e. 
multifunctional antimicrobials). It seems that we 
have not fully explored and exploited the potential 
of the drugs we know today. 
35 
The dual activity of some antibiotics (e.g. AZM, 
CFT and CPR investigated here) may help 
explaining that  CFT has been shown to be 
superior to comparative anti-pseudomonal 
antibiotic regimes of CF patients in the Danish CF 
center (68). Caution must be taken however. The 
subsequent shift to CFT as the predominant anti-
pseudomonas antibiotic in the Danish CF center 
lead to an epidemic spread of a multi-resistant non-
mucoid strain (67). The study by (33) shows that 
subMIC concentrations of antibiotics may still 
modulate transcriptional patterns in members of 
the beneficial human flora causing a variety of 
unwanted effects. Likewise, it has been shown, 
that the long-term use of AZM in CF patients with 
chronic P. aeruginosa infection may lead to 
macrolide resistance in Staphylococcus aureus in 
these patients (86). This underlines the 
requirement for further development of QSIs 
without classical bactericidal or bacteriostatic 
activity. 
 
 
 
 
 14 
Materials and Methods 
 
Bacterial strains applied in this study:  
The sequenced P. aeruginosa PAO1 wild-type 
where obtained from the Pseudomonas Genetic 
Stock Center (www.pseudomonas.med.ecu.edu, 
strain PAO0001). The lasI-rhlI mutant was 
constructed using previously reported knock out 
system (6). The QSI selector strain QSIS1 were 
described by (72). 
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Bacterial screen for QS inhibition 
The Quorum Sensing Inhibitor Selector 1 (QSIS1) 
has been described in detail elsewhere (72). QSIS1 
harbors the plasmid pUC18Not-luxR-PluxI-RBSII-
phlA T0-T1, Apr maintained in CSH37 (58), an E. 
coli strain constitutively expressing β-
galactosidase. 
 
Briefly, preparation of QSIS1 screens were 
performed as follows: BT medium (B medium (15) 
plus 2.5 mg thiamine pr. liter) containing 2% agar 
(wt/vol) was melted, added 10% A10 (15) and 
cooled to 45°C. N-3-oxo-hexanoyl-L-homoserine 
lactone (Sigma-Aldrich, Germany), ampicillin (Ap, 
VepiDan, Denmark), X-Gal (5-bromo-4-chloro-3-
indoxyl-β-D-galactopyranoside, Apollo Scientific, 
UK) and 1-methyl-2-pyrrelidon (MERCK, 
Germany) were added in final concentrations of 
100 nM, 100 µg/mL, 40 µg/mL and 0.2% (vol/vol) 
respectively and the medium was supplemented 
with 0.5% (wt/vol) glucose and 0.5% (wt/vol) 
casamino acid. QSIS1 over night culture (grown in 
ABT media supplemented with 0.5% (wt/vol) 
glucose and 0.5% (wt/vol) casamino acid and 100 
μg/mL ampicillin) was added to final 
concentrations of 0.4%. Plates for the screening 
assay were subsequently made by pouring the 
mixture into a box giving an agar thickness of 5 
mm. Wells with a diameter of 5 mm were made in 
the agar plates. Upon solidification, 50 μL of a 1-
10 µg/mL solution of antibiotics to be tested for 
QSI activity was added to the wells. The plate was 
then incubated at 30°C for 16 hours. Appearance 
of a circular zone of growth (appearing blue due to 
the presence of hydrolyzed X-gal), indicates the 
presence of QSI active compounds in the sample 
tested.  
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Sample preparation for P. aeruginosa GeneChip® 
Analysis 
ABT medium supplemented with 0.5% cas amino 
acids were inoculated with exponentially growing 
P. aeruginosa PAO1 cells to an OD600 of 0.05 and 
grown at 37°C, 200 rpm in 5 x 500 mL flasks 
containing 100 mL each. At OD600 0.3 AZM 
(Zithromax®, Pfizer, 8 and 2 µg/mL 
Azithromycin), CPR (Fluka, 0.04 µg/mL 
Ciprofloxacin) and CFT (Fortum®, 
GlaxoSmithKline, 0.25 µg/mL ceftazidime) were 
added. These concentrations of antibiotics did not 
affect growth of P. aeruginosa. Samples were 
retrieved at OD600 2.0, and immediately transferred 
to two volumes RNAlater (Ambion) and stored at  
-80°C. RNA was isolated using the “RNeasy Mini 
Purification Kit” (QIAGEN) according to the 
provided protocol including the on-column DNase 
treatment. Synthesis of cDNA was performed with 
12 μg RNA, 300 ng/μL random primers 
(Invitrogen™), 1500 U SuperScript III Reverse 
Transcriptase (Invitrogen™) and 30 U 
SUPERase٠In™ Rnase Inhibitor (Ambion) 
according to Affymetrix’s Expression Analysis 
Protocol. Synthesized cDNA was purified using 
the QIAquick PCR Purification Kit (QIAGEN) and 
3-4 μg cDNA was fragmented using 0.2 U DNase 
I, FPLC pure™ (Amersham Bioscience) pr. μg 
cDNA. Fragmented cDNA was terminal labelled 
with biotin-ddUTP (Enzo Bioarray™ terminal 
labeling kit) and hybridised for 18 h at 55°C to P. 
aeruginosa genome microarray GeneChip® 
(Affymetrix).  The chips were washed and stained 
according to the Affymetrix protocol. The 
microarray hybridization signal intensity was 
scaled to an overall signal average of 2500, and 
present/marginal/absent (based on evaluation of 
PerfectMatch (PM) and MisMatch (MM) 
intensities) was evaluated by the use of the 
Affymetrix GCOS v1.4 software. Only expression 
value genes estimated being “Present” were 
included in the further analyses.  
DNA microarray data (CHP, CEL, EXP files) have 
been submitted to Gene Expression Omnibus 
(GEO) http://www.ncbi.nlm.nih.gov/geo/. 
Experiment series number GSE8953. 
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Virulence factor assays 
 
Supernatents for virulence factor assays 
P. aeruginosa PAO1 cultures were grown for 
either 16-20 hours (for hemolysis assay) or to 
OD600 2.0 (for protease and elastase assays) as 
described above with 8 or 2 µg/mL AZM, 0.04 
µg/mL CPR or 0,25µg/mL CFT and a control with 
no antibiotics added. The P. aeruginosa PAO1 QS 
mutant ∆lasI-∆rhlI was also grown along with the 
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treated and untreated P. aeruginosa PAO1 
cultures. Cells were harvested by centrifugation 
and the supernatants were sterile filtered (TPP 
syringe filter 0.22 µm, Switzerland). Supernatants 
were either used immediately or stored at -20°C. 5 
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Hemolysis assay 
Sterile filtered supernatants were autoclaved and 
mixed with venous blood from a healthy individual 
in volumetric ratio of 30:1 (supernatant:blood), 
observed for hemolysis after 20 minutes and left at 
room temperature for four hours to allow 
sedimentation of intact erythrocytes. Hemolytic 
activity was observed as a clearing and a non-
precipitating red coloring of the blood solution, 
while lack of hemolytic activity was characterized 
by the precipitation of intact erythrocytes. The 
experiment was performed four times with 
supernatants from four individual growth 
experiments. 
 
Protease assay 
Sterile filtered supernatants (300 µL each) were 
added to wells in ABT agar plates (ABT medium 
supplemented with 2% agar) containing 5% 
skimmed milk and incubated overnight at 37°C. 
Clearing zones were measured on photos of the 
plates by the use of a ruler. The experiment was 
performed twice as four replicates with 
supernatants from two individual growth 
experiments. 
 
Elastase assay 
Sterile filtered supernatants were mixed with 
phosphate buffer (0.1 M, pH 6.3) 2:1 and 2 mg/mL 
Elastin Congo Red (Sigma) was added.  The 
mixture was incubated at 37°C with shaking (200 
rpm) for 1 week.  After centrifugation, the 
absorbance of the supernatant at 495 nm was 
measured with a spectrophotometer zeroed on an 
elastin Congo-red sample incubated with media 
alone. Procedure modified from (62). The 
experiment was performed twice in triplicate with 
supernatants from three individual growth 
experiments. 
 
Chitinase assay 
Chitinase was measured using a modified chitin 
azure assay (30, 34). Sterile filtered supernatants 
were mixed with Na-citrate buffer (0.1 M, pH 4.8) 
2:1 and 0.5 mg/mL Chitin azure (Sigma) was 
added.  The supernatant-chitin azure mixtures were 
incubated at 37°C with shaking (200 rpm) for 1 
week.  The samples were then centrifuged at 
15,000 × g for 10 min, and the absorbance at 570 
nm was determined. Samples were compared to 
blanks incubated with media only. The experiment 
was performed twice as four replicates with 
supernatants from two individual growth 
experiments. 
 
Quantification of rhamnolipid 
A standard curve for rhamnolipid B (concentration 
vs. total ionisation current (TIC)) was calculated 
from LC-ESI-MS data.  To minimize potential 
differences in ionization levels of rhamnolipid 
between the samples the rhamnolipid standards 
used for calculating the concentration curve were 
analyzed immediately prior to, as well as after the 
samples undergoing analysis. The TIC level was 
determined on the [M+NH4]+ ion at 668.4, over 7 
seconds at which rhamnolipid B was eluted.  
HPLC-MS analysis was performed with an agilent 
1100 series HPLC connected to a micromass LCT 
TOF MS. 
 
Docking of AZM, CFT and CPR against the LBD 
of the LasR protein 
The x-ray crystallographic structure of the LBD of 
the LasR protein (PDB ID code 2UV0) was used 
for docking of AZM, CFT and CPR to the LasR 
receptor site using the Template Docking model 
with default settings, (Molegro Virtual Docker 
(MVD) (85)). OdDHL was set as the template 
ligand in the LBD of the LasR protein. Ligands 
were ranked using the MVD re-rank scoring 
function. 
 
Data analysis and statistics 
Statistical analyses; one-way analysis of variance 
(ANOVA) followed by Dunnett’s test were used to 
evaluate the effect of AZM, CFT and CPR 
treatment and the effect of the lasI-rhlI mutation 
on the expression of elastases, chitinase and 
protease compared to the untreated P. aeruginosa 
PAO1 wild-type. Tests were performed using 
InStat 3 from GraphPad (GraphPad Software, San 
Diego, CA). Differences were considered 
significant if P<0.05 or lower. 
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Further experiments to be carried out for the manuscript in progress (article 4): 
 
PSEUDOMONAS AERUGINOSA QUORUM SENSING SIGNAL MOLECULES 
INTERFERE WITH DENDRITIC CELL INDUCED T CELL PROLIFERATION 
 
Besides the analyses of the effect of quorum sensing signal molecules (QSSMs) on production of 
interleukin- (IL)-10 and IL-12 by bone marrow derived dendritic cells (BM-DCs), it would be 
relevant to investigate the influence of QSSMs on the production of the proinflammatory 
cytokines IL-6 and TNF α.  
 
IL-6 is secreted in response to specific microbial molecules and is an important mediator of the 
acute phase response. Even though IL-6 is a proinflammatory cytokine it has been shown to 
polarize naive CD4+ T cells to effector TH2 cells by inducing the initial production of IL-4 in 
CD4+ T cells and to impede TH1 induced response by pulmonary DCs (2, 3) Thus IL-6 may play 
an important role in the TH1/TH2 balance and for this reason it would be relevant to investigate the 
effect of QSSMs on DC IL-6 production. 
 
TNF α is another very important acute phase cytokine. TNF α production by peritoneal 
macrophages has been shown by (6) to be inhibited by OdDHL. As TNF α is a TH1 associated 
cytokine it would be relevant to investigate whether DCs’ TNF α production is affected by 
QSSMs. 
 
It would be interesting to investigate the effect of AHLs with varying acyl chain length and AHL 
like structures to elucidate which structural features are critical for the ability of these molecules 
to function as immunomodulators and induce cytokine profile changes in the model described in 
the manuscript.   
 
As C57BL/6 mice have been suggested to be TH1 biased (1, 5) it would be relevant to repeat the 
investigations of the effect of QSSM on the cytokine profile with BALB/c mice which has been 
reported to be TH2 biased (4, 5). 
 
The fate of PQS in cell culture media in the presence and absence of cells should also be 
investigated. This can be done by a recently constructed PpqsA::gfp(ASV) fusion. 
 
The investigation of surface marker expression (MHC II, CD40, CD80 and CD86) will be 
repeated with a lower concentration of Escherichia coli LPS. Hopefully this will give clarify the 
effect of BHL and PQS on the surface phenotypes of BM-DCs. 
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ABSTRACT  
Pseudomonas aeruginosa secretes a wide array of toxins and tissue degrading enzymes. The release of these 
malicious virulence factors is controlled by interbacterial communication in a process known as quorum
sensing. An expanding body of evidence indicates that the quorum sensing mediator N-(3-oxododecanoyl)-
L-homoserine lactone (OdDHL) has immune-modulating capacity. Recently was yet another quorum
sensing signal molecule; the Pseudomonas quinolone signal (PQS) shown to reduce the release of
interleukin-2 (IL-2) by mitogen stimulated human T cells (D. Hooi et al., Infect. Immun. 72:6463-6470, 
2004). In this article we demonstrate that OdDHL and PQS decrease the production of IL-12 by E. coli
lipopolysaccharide-matured bone-marrow-derived dendritic cells (BM-DCs) without altering the IL-10 
release. Moreover, BM-DCs exposed to PQS and OdDHL during antigen stimulation exhibit a decreased
ability to induce T cell proliferation in a syngeneic mixed leukocyte reaction. Collectively, this suggests that 
OdDHL and PQS change the maturation pattern of stimulated DCs away from a proinflammatory TH1 
directing response, thereby decreasing the antibacterial activities crucial for the eradication of an infection.
OdDHL and PQS thus seem to possess dual activities in the infection process; as inducers of virulence
factors as well as immune-modulators facilitating the infective properties of this pathogen. 
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ABBREVIATIONS: 
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lactone, BM-DC; Bone Marrow-derived Dendritic Cells, INF; interferon, IL; interleukin, LPS; 
lipopolysaccharide, MLR; Mixed Leukocyte Reaction OdDHL; N-(3-oxododecanoyl)-L-homoserine 
lactone, PBMC; Peripheral Blood Mononuclear Cell, PQS; Pseudomonas quinolone signal (heptyl-3-
hydroxy-4-quinolone); QS(SM); quorum sensing (signal molecules), TNF; Tumor Necrosis Factor 
 
INTRODUCTION 
Pseudomonas aeruginosa is an opportunistic 
pathogen, which often infects decubitus ulcers 
and burn wounds and thereby retards healing 
(10). Moreover, this versatile bacterium is a 
major cause of pneumonia in 
immunocompromised persons and in cystic 
fibrosis (CF) patients where chronic P. 
aeruginosa infections are the main cause of 
morbidity and mortality (2, 34). The persistent 
infection is dominated by an exaggerated host 
response causing tissue destruction. During the 
infectious process, P. aeruginosa expresses 
virulence factors and tissue damaging products in 
a cell number-dependent process termed quorum 
sensing (QS) (13, 28). Several in vivo surveys 
have demonstrated that QS is important for 
virulence and pathogenicity of P. aeruginosa (16, 
20, 29, 48, 49). The QS system of P. aeruginosa 
is mainly mediated by three signal molecules; the 
two N-acyl L-homoserine lactones; N-(3-
oxododecanoyl)-L-homoserine lactone (OdDHL) 
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and N-butanoyl-L-homoserine lactone (BHL) and 
the Pseudomonas quinolone signal, PQS (heptyl-
3-hydroxy-4-quinolone).  
The major P. aeruginosa QS signal molecule 
(QSSM) OdDHL has been shown to affect 
functions and activities of a range of mammalian 
cell types. OdDHL  inhibits contraction of arterial 
smooth muscle (19) and modulates expression of 
an array of cytokines in various cells of the 
immune system. OdDHL induces interleukin 
(IL)-8 production in respiratory epithelial and 
lung fibroblasts cells (11, 42) and inhibits tumour 
necrosis factor α (TNF-α)-production by lipo-
polysaccharide (LPS)-stimulated macrophages 
(45). Both OdDHL and PQS have been shown to 
inhibit cell proliferation of human peripheral 
blood mononuclear cells (PBMCs), PQS being 
far more potent than OdDHL (17). This study 
also showed differential immunomodulatory 
effects of PQS and OdDHL, as OdDHL but not 
PQS inhibits IL-2 release by T cells activated via 
anti-CD3/anti-CD28 antibodies (17).  
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Dendritic cells (DCs) are professional antigen 
presenting cells (APCs) and the principal 
stimulators of naïve T cells, and are thus 
important in the initiation and modulation of 
immune responses. The TH1 response, which 
promotes cell mediated immunity, is 
characterized by high interferon γ (IFN-γ)-
production by CD4+ T cells and thus an elevated 
IFN-γ/IL-4 ratio. The TH1 response is induced by 
APCs - in particular DCs - producing IL-12, but 
is also promoted by IFN-γ (22, 46). The TH2 type 
response is dominated by IL-4 production and 
low IFN-γ and promotes humoral immunity. 
These two TH responses are sustained by their 
representative cytokines, while they antagonize 
each other; for example, the cytokine IFN-γ is 
produced by TH1 cells and while this cytokine 
further enhances the TH1 responses it inhibits 
proliferation of the TH2 subset (26, 27). Another 
example of cross-regulation is the TH2 cytokine 
IL-10 which down-regulates IL-12 (50). 
OdDHL suppresses the production of the TH1 
cytokines IL-12 and TNF-α by macrophages, and 
hinders lymphocyte proliferation while 
promoting IgG1 production, thereby supporting 
the hypothesis that OdDHL pushes the TH1/TH2 
balance away from a TH1 dominated response 
(45). Clinical surveys have shown that the TH 
response in CF patients is predominantly of the 
TH2 type, and that patients with a TH1-dominated 
immune response have improved lung function 
and a better prognosis suggesting that a change 
from a TH2 to TH1 dominated response might 
improve the prognosis in these patients (24). 
Thus OdDHL may play a dual role in the 
pathogenesis of P. aeruginosa; 1) as mediator of 
bacterial communication by which it controls 
virulence and 2) as immunomodulator changing 
the milieu from the host-protecting 
proinflammatory TH1 response towards the TH2 
direction, thus favouring the establishment of 
bacteria within the host. 
Here we investigate the effect of the three P. 
aeruginosa QSSMs; OdDHL, BHL and PQS on 
DC functions and maturation pattern, in 
particular the effect on cytokine profile and 
activation of T cell proliferation. 
 
MATERIALS AND METHODS  
Mice 
Animal experiments were approved by the 
Danish Council of Animal Ethics (mice used for 
experiments with cytokine production and cell 
surface markers) and University of New South 
Wales (UNSW) Animal Care and Ethics 
Committee (ACEC 06/16A) (mice used for 
syngeneic Mixed Leukocyte Reaction, MLR). 
C57BL/6 mice were used for investigations on 
cytokine production and cell surface markers. 
Transgenic mice on a B10.BR genetic 
background bred in house at UNSW from 
homozygous breeding pairs (kindly provided by 
B. Fazekas de St. Groth) were used for syngeneic 
MLR. These mice overexpress a T cell receptor 
(TCR) specific for the COOH-terminal epitope of 
pigeon moth cytochrome c (MCC) on 50-80% of 
peripheral CD4+ T cells (3).  All mice used were 
8–12 wk old, kept under SPF conditions and 
given sterile mouse chow and water ad libitum. 
 
Quorum sensing signal molecules (QSSMs) 
The QSSMs applied were N-(3-oxododecanoyl)-
L-homoserine lactone (OdDHL), Pseudomonas 
quinolone signal (PQS, heptyl-3-hydroxy-4-
quinolone) and N-butanoyl-L-homoserine lactone 
(BHL). OdDHL was synthesized, purified and 
validated as described by (6), PQS was 
synthesized, purified and validated as described 
by (17, 31), and BHL was purchased from 
Sigma-Aldrich. 
 
Bone marrow cell culture  
Bone marrow cells were isolated and cultured as 
described by (21), with minor modifications. 
 Briefly, femora and tibiae from C57BL/6 and 
MCC TCR transgenic B10.BR mice were 
removed and stripped of muscles and tendons. 
After soaking the bones in 70% ethanol for 2 
min. and rinsing in PBS, both ends were cut and 
the marrow was flushed with PBS using a 27-
gauge needle. Cell clusters were dispersed by 
repeated pipetting. The resulting cell suspension 
(containing 5–7.5×107 leukocytes per mouse) was 
centrifuged for 10 min at 300 × g and washed 
once in PBS. Cells were resuspended in RPMI 
1640 (Sigma-Aldrich, St. Louis, MO) 
supplemented with 4 mM L-glutamine, 100 
U/mL penicillin, 100 µg/mL streptomycin, 50 µM 
β-mercapto ethanol and 10% (v/v) heat-
inactivated fetal bovine serum (Atlanta 
Biologicals, Norcross, GA). For cytokine 
production and cell surface markers, 15 ng/mL 
murine granulocyte-macrophage colony-
stimulating factor (GM-CSF) was added as 
culture supernatant (containing 550 ng/mL GM-
CSF) harvested from a GM-CSF-producing cell 
line (GM-CSF transfected Ag8.653 myeloma cell 
line) (54). The GM-CSF-producing cell line was 
kindly provided by Dr. R. Tisch (University of 
North Carolina, Chapel Hill, NC). For generation 
of DCs for syngeneic MLR, 15 ng/mL GM-CSF 
purchased from Peprotech, Rocky Hill, NJ was 
used. 
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BM-DC for cytokine production 
For cytokine production, 10 mL of cell 
suspension containing 2×106 leukocytes/mL was 
seeded per 100-mm bacteriological petri dish and 
incubated for 8 days at 37 °C in 5% CO2. An 
additional 10 mL of freshly prepared media was 
added to each plate on day 3. On day 6, 9 mL 
from each plate was withdrawn without removing 
cells and replaced with 10 mL fresh media. On 
day 8, nonadherent cells were gently harvested 
and used for investigations of cytokine release in 
the absence or presence of QSSM.  
 
BM-DC for induction of surface markers and 
MLR 
For Mixed Leukocyte Reaction (MLR) and 
investigation of surface markers, 0.7 mL of cell 
suspension containing 2×106 leukocytes/mL was 
seeded into wells in a 12 well plate (Nunc, 
Germany) at day 0. An additional 0.7 mL fresh 
media was added on day 3, and on day 6, 0.6 mL 
used media was carefully withdrawn and replaced 
with 0.7 mL fresh media. On day 8 cells were 
stimulated with LPS (Escherichia coli O26:B6 
LPS; Sigma-Aldrich) in the presence or absence 
of QSSM. 
 
Induction of cytokine release 
Cells from bone marrow-derived cell cultures 
were centrifuged for 5 min at 260 × g and 
resuspended in media supplemented with 10 
ng/mL GM-CSF. Cells were seeded in 48-well 
tissue culture plates at 1.2 × 106 pr. well in 500 
µl. 50 µl/well PBS containing QSSMs (1-30 µM 
final concentration, stock solution 50 mM in 
DMSO) were then added. Controls were PBS 
containing DMSO. All wells, except wells used 
for control of the effect of DMSO, were adjusted 
to contain 0.1% DMSO. 50 µl/well LPS (E. coli 
O26:B6; Sigma-Aldrich) at 1 µg/mL final 
concentration in PBS was added to induce 
maturation. After a stimulation period of 15 h at 
37°C in 5% CO2, culture supernatant was 
collected and stored at -80 °C until cytokine 
analysis. Viability of the cells was investigated 
by propidium iodide exclusion using a BD FACS 
array flow cytometer (BD Biosciences, San Jose, 
CA) and indicated that QSSM treated as well as 
untreated cultures contained 90% viable cells. 
The entire experiment (including analysis of cell 
viability and ELISA) was repeated 4 times. 
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Cytokine quantification in culture supernatants 
Culture supernatants were aliquoted and stored at 
-80 °C until they were analyzed for the presence 
of cytokines. Quantitative assays for IL-12, IL-10 
and TNF-α in the culture supernatants were 
performed using enzyme-linked immunosorbant 
assay (ELISA) kits (R&D Systems, Minneapolis, 
MN, USA) according to the manufacturer's 
instructions. Briefly, polystyrene microtitre plates 
(Nunc, Germany) were coated with the first 
antibody diluted in coating buffer overnight at  
4°C. Various concentrations of recombinant 
cytokines were added as external standards. 
Standards and supernatants were incubated for 2 
h in dilutions of 1:2 (for IL-10 and IL-12) and 
1:40 (for TNF α). Bound cytokine was detected 
with biotinylated second antibody, streptavidin-
peroxidase conjugate and 3,3′,5,5′-
Tetramethylbenzidine (TMB). The reaction was 
stopped after 20 min. incubation with 2 M H3PO4 
and absorbance was measured using a microplate 
reader (PowerWaveX Microplate 
Spectrophotometer, BioTek Instruments, 
Winooski, VT) wavelength 450 nm and 630 nm 
85 
 as reference. Cytokine concentrations were 
calculated using standard curves that were 
performed for each ELISA plate in order to 
minimize interassay variability. Results were 
expressed as the mean concentrations in duplicate 
culture supernatants. 
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Induction of surface marker expression 
0.7 mL of spent medium was carefully removed 
and discarded from 8-day old DC-enriched 
cultures in 12 well plates (described in the section 
BM-DC for induction of surface markers and 
MLR), each containing 1.4 mL. Then, 0.6 mL of 
media without GM-CSF was added to each dish. 
50 µl/well PBS containing QSSMs (5-30 µM 
final concentration, stock solution 50 mM in 
DMSO) were then added. Controls were PBS 
containing DMSO. All wells, except wells used 
for internal control of the effect of DMSO were 
adjusted to contain 0.1% DMSO. 50 µl/well LPS 
(E. coli O26:B6; Sigma-Aldrich) at 1 µg/mL final 
concentration in PBS was added to induce 
maturation. Cultures were incubated for 14 h at 
37°C in 5% CO2. At the end of the incubation 
period, 3 mL of PBS containing 1% (v/v) FBS 
and 0.15% (w/v) sodium azide (PBS-Az) was 
added to each well to prevent internalization of 
surface markers during subsequent handling of 
cells. Nonadherent cells were collected by gentle 
pipetting, centrifuged for 5 min at 300 × g, and 
subjected to surface marker staining for flow 
cytometric analysis as described below. Trypan 
blue and propidium iodide exclusion indicated 
that the QSSM-treated as well as untreated 
cultures contained 90% viable cells. Cell number 
pr. well was not affected by treatment with 
QSSMs. 
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Immunocytostaining and flow cytometry 
Centrifuged cells were resuspended in cold PBS-
Az and transferred to a round-bottom 96-well 
plate (4×105 cells/well). During all work, cells 
were kept at or below 4°C and at low light 
exposure. Cells were centrifuged and incubated 
10 min. in 50 µl/well PBS-Az containing anti-
mouse Fc RII/III (3 µg/mL; BD Biosciences, San 
Jose, CA) to block nonspecific binding of Ab 
reagents. After incubation, an additional 50 
µl/well of PBS-Az containing fluorochrome-
conjugated Abs in pre-optimized concentrations 
was added and incubated for 45 min. Cells were 
then washed twice in 200 µl/well PBS-Az and 
finally resuspended in 300 µl/well PBS-Az for 
flow cytometric analysis in a BD FACS Array 
flow cytometer (BD Biosciences, San Jose, CA). 
The analysis was based on counting of 30,000 
cells. The following Abs used for staining were 
purchased from eBioscience, San Jose, CA (eB) 
or Southern Biotech, Birmingham (SB): APC-
conjugated anti-mouse CD11c (SB), PE-
conjugated anti-mouse MHCII (SB), APC-
conjugated CD86 (SB), PE-conjugated anti-
mouse CD80 (eB) and PE-conjugated anti-mouse 
CD40 (eB). Non-viable cells were gated out by 
forward and side light scatter. The results were 
expressed as median fluorescence of cells. 
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Mixed lymphocyte reaction (MLR) 
Mixed lymphocyte reaction was performed in 
triplicate wells. 100 µl CD4+ T cells (1×106 
cells/mL) isolated from mouse splenocytes by 
positive selection with anti-CD4 microbeads 
(Miltenyi Biotec) were co-cultured with 100 µl 
sodium azide harvested syngeneic DCs (1.5×105, 
7.5×104 and 3.8×104 cells/mL) treated with 
QSSMs as described in Induction of surface 
markers in 96-well round-bottom microtitre 
plates. As negative controls, T cells (1×106 
cells/mL) in triplicate wells or DC (1.5×105 
cells/mL) in triplicate wells were cultured in 
media alone. The plates were incubated in a 5% 
CO2 incubator at 37 °C. On day 5 each well was 
loaded with 20 µl alamarBlue™ (BioSource) and 
incubated at 37 °C, 5% CO2 for 5 h. Plates were 
read fluorometrically (excitation wavelength 544 
nm and emission wavelength 590 nm) at a Polar 
Star microplate reader (BMG Lab Technologies 
Pty Ltd). 
 
Measurement of BHL and OdDHL in cell 
cultures 
AHLs in the supernatant were quantified by the 
use of the two QS monitor strains; MH205 
(ahyR-ahyI::gfp(ASV)) (44) and MHLAS 
lasB::gfp(ASV) (15) for BHL and OdDHL, 
respectively. The QS monitor strains were 
applied as follows: 150 μl ABT media (9) 
supplemented with 0.5% cas-amino acids were 
added to wells in a microtiter dish (Black 
Isoplate®, Perkin Elmer). A 2-fold serial dilution 
series of supernatants containing AHL was made, 
leaving the last well for reference (concentration 
of AHL = zero). Finally, 150 μl 50× diluted 
overnight culture of either MH205 or MHLAS 
(OD450 of diluted culture = 0.1) was added to the 
wells. The Gfp(ASV)-expression (measured as 
 fluorescence; excitation and emission wave 
length 485 and 535 nm, respectively) was 
measured every 15 min. during the following 18 
hours by the use of a multilabel plate reader 
Wallac 1420 VICTOR2™ (Perkin Elmer). OD450 
was also determined as a measure for growth. 
During the assay the temperature was held 
constant at 34 ˚C. Expression of Gfp(ASV) by 
the monitor bacteria was used as a relative 
measure of the concentration of OdDHL and 
BHL in the supernatants.  
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Data analysis and statistics 
Statistical analyses; one-way analysis of variance 
(ANOVA) followed by Dunnett’s test comparing 
the effect of QSSM with the control stimulus, 
were used for all analyses. Tests were performed 
using InStat 3 from GraphPad (GraphPad 
Software, San Diego, CA). Differences were 
considered significant if P<0.05 or lower. Values 
for 50% inhibitory concentration (IC50) were 
calculated from the regression equation using 
Microsoft Office® Excel 2003 SP2. 
 
RESULTS 
Cytotoxicity of OdDHL, PQS and BHL 
First we tested the cytotoxicity of QSSMs on 
murine Bone Marrow-Derived DCs (BM-DC). 
Viability of cells after incubation with QSSMs 
were investigated by propidium iodide staining 
and showed that the highest non-cytotoxic 
concentration of both OdDHL and PQS was 50 
µM. BHL was not toxic even at the highest 
concentration tested (100 µM). Previous studies 
have shown an anti-proliferative effect of PQS 
and OdDHL on ConA-stimulated human PBMCs 
(17). Therefore we also performed simple viable 
cell counts of DCs exposed to QSSM for 16 h in 
the presence of E. coli LPS, which showed no 
change in cell numbers even at the highest 
concentration of QSSM tested in LPS-stimulated 
cells (30 µM). 
 
Fate of AHLs in cell culture media in the 
presence or absence of DCs 
The concentration of AHLs may change during 
the duration of an experiment e.g. due to 
degradation. Therefore, we decided to investigate 
the fate of AHLs in cell culture medium in the 
presence or absence of cells. For this purpose, we 
applied QS biosensors activated by exogenous 
OdDHL or BHL to measure the relative 
concentration of biologically active AHLs during 
the first 2 hours and at the end point of the 
experiment (16 h). BHL retained its bioactivity 
during the 16 hours incubation both in the 
absence and presence of cells. By contrast, the 
bioactivity of OdDHL in the supernatant was 
almost completely lost after 16 hours incubation 
in the presence of cells; but if incubated in cell 
culture media without cells, OdDHL preserved 
100% of its bioactivity after 2 h incubation and 
90% after 16 h. (See figure 1). 
 
 65 
 
 
 
 
 70 
 
 
 
10000
11000
12000
13000
14000
15000
16000
17000
0 h 0.5 h 1 h 2 h 15 h
RFU
A 
 
 75 
 
 
 
 
 80 
 
 
85 
90 
95 
 
0
50000
100000
150000
200000
250000
0 h 0.5 h 1 h 2 h 15 h
RFU
B 
** 
Figure 1. Fate of AHLs in cell culture media. A) BHL 
in cell culture media measured by the use of a BHL 
specific ahyR-ahyI::gfp(ASV) biomonitor. 
B) OdDHL in cell culture media measured by the use 
of a OdDHL specific lasR-lasB::gfp(ASV) biomonitor. 
Background corrected maximal RFU are shown for 
samples taken at the time points 0, 0.5, 1, 2 and 15 
hours. White bars represent AHL incubated in the 
presence of DCs, and grey bars represent AHL 
incubated in the absence of DCs (** P<0.01 for 
Tukey-Kramer Multiple Comparison test). The 
experiment was performed in duplicate. Data are 
representative of two independent experiments. 
 
 
 Cytokine profile in the presence of QSSM  
In order to assess the effect of P. aeruginosa 
QSSMs on murine BM-DC cytokine production, 
either OdDHL, BHL or PQS or vehicle (DMSO) 
was added to cell cultures in final concentrations 
of 0, 5, 10 , 20 and 30 µM along with E. coli 
LPS. None of the QSSMs affected IL-10 
production significantly (Figure 2 A). However, 
PQS and especially OdDHL but not BHL caused 
a dose-dependent decrease in IL-12 production 
(Figure 2 B). OdDHL showed a more pronounced 
effect on IL-12 production than PQS as the IC50 
(the concentration required to lower the cytokine 
release to 50%) for OdDHL was 7.0 µM, whereas 
it was 17.2 µM for PQS.  
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Figure 2. Effect of P. aeruginosa QSSM on cytokine 
production in murine BM-DCs stimulated with 1 
µg/mL LPS for 16 h. A) IL-10 and B) IL-12. Control 
0.1% DMSO (white bar), BHL (black bars), PQS 
(dark gray bars) and OdDHL (light grey bars).  
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(* P<0.05, ** P<0.01, Dunnett’s test comparing the 
effect of QSSM with DMSO vehicle (control)). The 
experiment was performed in duplicate. Data are 
representative of four independent experiments. 
 
Surface marker expression in the presence of 
QSSM 
Upon culturing murine bone marrow cells with 
GM-CSF (Granulocyte-macrophage colony-
stimulating factor ), cells other than DC, such as 
myeloid progenitors, granulocytes, macrophages 
and lymphocytes may develop. Therefore, DC 
purity was verified by flow cytometry using the 
DC marker CD11c. In day 9 cultures, the 
proportion of CD11c+ cells was in the range 90-
95%, and microscopic inspection showed that the 
vast majority of cells appeared as irregularly 
shaped cells with clearly visible protrusions, 
which are characteristic morphological features 
for DC (not shown). The level of DC purity 
obtained in the cultures is consistent with results 
from previous studies (7, 21). DCs express many 
accessory molecules that interact with receptors 
on T cells to enhance adhesion and signaling. 
These molecules are regulated by exposure to 
various microbial stimuli collectively termed 
pathogen-associated molecular patterns 
(PAMPs). The maturation level of DCs can thus 
be followed by detection of several typical 
surface markers. In the current study we have 
investigated surface expression of MHC class II, 
CD80, CD86 and CD40 after LPS stimulation 
and in the presence or absence of QSSMs. The 
expression of CD80, CD86, CD40 and MHC II 
by unstimulated BM-DC or in LPS-stimulated 
BM-DC in the absence or presence of QSSM 
(BHL, PQS or OdDHL) is shown in figure 3. The 
results expressed as median of fluorescence 
intensity of cells either treated with QSSM or left 
untreated are summarized in table 1. OdDHL 
caused a decreased expression of the two T cell 
co-stimulatory molecules CD80 and CD86. 
While the expression of MHC II did not notably 
change by the presence of OdDHL, OdDHL 
slightly lowered the CD40 expression. The 
surface marker data showed no clear trend as 
response to the challenge by BHL and PQS. 
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Mixed Lymphocyte Reaction in the presence of 
QSSM 
Since we noticed that OdDHL and PQS caused a 
decreased production of IL-12 and that OdDHL 
reduced the expression of surface markers related 
to maturation of LPS-stimulated DCs we decided 
to test whether OdDHL and PQS also influenced 
the ability of DCs to activate proliferation of T 
cells. 
Immature BM-DCs derived from transgenic mice 
over-expressing a TCR specific for the COOH-
terminal epitope of pigeon moth cytochrome c 
(MCC) (3) were generated as for cytokine 
production and investigation of surface markers.  
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Figure 3. Effect of QSSM on expression of surface phenotypes A) OdDHL B) PQS, C) BHL, and D) isotype controls. 
Legend description for A), B) and C) Black solid line; cells stimulated with 1 µg/mL LPS along with 30 µM QSSM. 
Black dashed line; cells stimulated with 1 µg/mL LPS along with 10 µM QSSM. Black thin line; cells stimulated with 
1 µg/mL LPS along with 5 µM QSSM. Filled light grey histogram; LPS stimulated cells and not added QSSM. Dark 
grey solid line; unstimulated cells. Legend description for D) Black solid line; binding of isotype-matched control 
antibody to LPS stimulated cells. Black dashed line; binding of matched isotype-control to unstimulated cells. Filled 
light grey graph; LPS stimulated cells with fluorochrome-conjugated Abs instead of isotype control (inserted for 
comparison). Dark grey solid line; unstimulated cells. with fluorochrome-conjugated Abs instead of isotype control 
(inserted for comparison). X-axis: Fluorescence intensity. Y-axis: Cell number.  
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Data shown are representative of three experiments performed.  
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Figure 4. Effect of P. aeruginosa QSSMs on T cell proliferation in syngeneic MLR. Ratio of DC to CD4+ cells: 1:7, 
(white bar), 1:13 (light grey bars) and 1:26 (black bars). DC cells alone (dark grey bar). No detectable proliferation of 
T cells alone. (* P<0.05, ** P<0.01, Dunnett’s test comparing the effect of QSSMs+MCC vs. MCC, and DMSO 
(vehicle) vs. MCC). The experiment was performed in triplicate. Data are representative of four independent 
experiments. 
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Table 1. Table corresponds to figure 3 and 
summarizes the median of stained cells stimulated 10 
with LPS and challenged with QSSM compared to 
stained cell only stimulated with LPS (control) and 
unstimulated cells. In the table the median of QSSM 
challenged cells/median of control is shown as 
percent. 
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Median of stained cells  
QSSM challenged vs. control (%)
 CD80 CD86 CD40 MHCII
BHL 30 µM 175 107 92 87
BHL 10 µM 108 111 50 236
BHL 5 µM 89 104 85 136
PQS 30 µM 89 227 181 215
PQS 10 µM 105 111 64 77
PQS 5 µM 118 75 78 88
OdDHL 30 µM 55 38 63 87
OdDHL 10 µM 81 63 79 137
OdDHL 5 µM 66 38 84 126
Unstimulated 35 6 4 21
Control (LPS) 100 100 100 100
 
On day 8 the DCs were exposed to the MCCT102S 
peptide (an altered version of the wild type MCC 
peptide (35)) in the absence or presence of QSSM 
and incubated for 20 h, after which they were 
mixed with syngeneic T cells and co-cultured for 
5 days. On day five, proliferation of T cells was 
measured by a fluorometric Alamar Blue 
microassay. DCs stimulated with MCC peptide in 
the presence of OdDHL – and to a lower extent 
PQS – had a lowered ability to induce 
proliferation of T cells compared to cells only 
exposed to MCC or to MCC and BHL (Figure 4).  
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DISCUSSION 
An expanding body of data shows that P. 
aeruginosa possesses the ability to interfere with 
the immune system via its signal molecule 
OdDHL. In the current study we have for the first 
time demonstrated that OdDHL and PQS alter the 
maturation pattern in LPS-stimulated DCs away 
from a TH1-skewing phenotype. We have shown 
that OdDHL and PQS change the cytokine profile 
of LPS-stimulated DCs by reducing IL-12 
release. IL-12 is an important factor in polarizing 
naïve T cells to develop into TH1 cells, therefore 
a reduction of IL-12 is likely to modulate the 
TH1/TH2 balance. We also provide evidence that 
OdDHL inhibits LPS-stimulated DC expression 
of T cell stimulatory and maturation related 
surface markers (CD86, CD80 and CD40). 
Finally, we found that murine BM-DCs 
challenged with PQS and OdDHL during antigen 
stimulation exhibit a decreased capacity to induce 
T cell proliferation. Collectively, these results 
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suggest that the P. aeruginosa QSSMs OdDHL 
and PQS restrain the DCs in exerting their T cell 
stimulatory effects. These observations indicate 
that P. aeruginosa QSSMs impede the 
development of a host-protective pro-
inflammatory TH1 response. This is consistent 
with earlier findings showing an OdDHL-induced 
TH2 skewing of the cytokine response by LPS-
stimulated macrophages (45). A previous study 
has shown that OdDHL affects T cell 
differentiation and cytokine production in an 
early step of T cell maturation (35) and our 
observations suggest that this early step could 
involve the activation of T cell differentiation by 
DCs or perhaps other APCs.  
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In order to ensure that changes in cytokine 
patterns imposed by QSSMs were not caused by 
toxic or antiproliferating effects we examined the 
cytotoxicity and effect on DC proliferation. In the 
concentrations used, QSSMs did not effect 
neither cell proliferation nor viability measuring 
exclusion of Trypan blue and propidium iodide. 
Telford et al. assessed the cytotoxicity of 
OdDHL, OHHL and of DMSO alone by exposing 
Jurkat E6.1 cells to the compounds and found 
that none of the compounds were cytotoxic in the 
concentrations investigated (concentrations 
range: 0.1 to 100 µM) (45) 
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We also investigated the fate of AHL during the 
incubation with DCs. Elevated pH (pH above 8) 
is known to promote non-enzymatic lactonolysis 
of AHLs (53), and partial hydrolysis may take 
place under the conditions used for mammalian 
cell cultures, i.e. pH 6-7 and 37 °C,  thereby 
reducing the concentration of bioactive AHL in 
the assays. The hydrophobic properties of long 
chain AHLs such as OdDHL may also cause it to 
bind to the plastic of the cell culture plates or 
sequestered by serum in the medium or 
partitioned into tissue cell membranes. We found 
that while BHL retained its bioactivity during the 
16 hours incubation both in the absence and 
presence of cells, bioactivity of OdHDL in the 
supernatant was reduced to 10 % after 16 hours 
incubation in the presence of DCs. However, if 
incubated in cell culture media without cells, 
OdDHL preserved 90% of its bioactivity after 16 
h incubation. Short chain AHLs such as BHL are 
more susceptible to non-enzymatic lactonolysis 
than long chain AHLs (53), and considering that 
OdDHL retained its bioactivity in the absence of 
cells, the result suggests that OdDHL may be 
taken up by the cells or degraded e.g. by enzymes 
released by the cells (e.g. paraoxonases) during 
incubation (8, 51). Recently Ritchie et al. (36) 
presented in vitro results indicating that OdDHL 
passively enters the cytoplasm of T cells and 
cultured DCs. The effect of OdDHL on cytokine 
release by spleen cells stimulated with anti-CD3 
antibody or antigen pulsed APCs has been 
studied and it seems that OdDHL must be present 
within the first 2 hours after stimulation in order 
to significantly suppress cytokine production 
(35). Even though it remains to be elucidated 
whether a similar time-dependent effect of 
QSSMs is exerted on DCs, it is however likely 
that the “programming” of the DCs take place 
early after stimulation.  
However, results indicating that OdDHL supports 
a TH2 response are in contrast to the observations 
by (43). In this study OdDHL was found to 
activate splenic T cells activated via antigen and 
irradiated APCs to produce IFN-γ and hence 
potentially promote the TH1 response. Another 
study by the same authors showed that expression 
of the TH1 associated neutrophil attracting 
chemokine IL-8 were induced by OdDHL (42). 
Conflicting data and conclusions about the 
immune modulating TH1/TH2 bias mediated by 
OdDHL could be explained as suggested by 
Ritchie et al., 2003; who expounded the theory 
that OdDHL accentuates the underlying TH1/TH2 
bias of the TH  cell population used, rather than 
targeting either Th1 or Th2 (37). Concentration 
issues could also explain the apparent 
contradictions between observations on the 
ability of OdDHL to induce a skew in either the 
TH1 or TH2 direction, as some investigators tend 
to use high doses of OdDHL (50-100 µM) (43) 
while other studies have used low doses of 
OdDHL (≤10 µM) (45). Although a great number 
of studies deal with QS in P. aeruginosa, there 
are very few studies which aim to quantify the 
concentration of AHLs in P. aeruginosa liquid 
cultures and biofilms. The concentration of 
OdDHL in PAO1 cultures has been reported to be 
in the order of 5 µM (30). HPLC-(UV) have been 
used to measure the production of OdDHL by P. 
aeruginosa PAO1 grown in liquid culture ( OD = 
0.5-1.5) and the concentration of OdDHL was 
found to be in the range of 0.45 µM to 1.16 µM 
(33). In biofilms the concentration of OdDHL is 
much higher and has been measured to be as high 
as 251 µM to 1031 µM (5). Further complicating 
the picture is the possibility that host modulators 
of OdDHL, such as the OdDHL degrading 
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enzyme paraoxonase, are present in in vivo 
settings and may decrease the amount of 
bioactive OdDHL (8, 51). A small number of 
studies have aimed to measure the concentration 
of OdDHL in the sputum or lung tissue of CF 
patients and have detected OdDHLs 
concentrations in the pico to nanomolar range 
(12, 41), though OdDHL is likely to be unevenly 
distributed in the lungs, and may locally be 
higher e.g. in biofilm microcolonies. Moreover, 
the concentration may be underestimated due to 
enzymatic degradation of OdDHL during 
harvesting. However, the concentration of 
OdDHL in vivo is probably more likely to be in 
the low micromolar range (where OdDHL seems 
to be anti-inflammatory) rather than in the 50-100 
µM range (which seems to promote a 
proinflammatory outcome).  
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PQS has been shown to inhibit proliferation of 
ConA stimulated human PBMCs (17), but the 
same study found that PQS in contrast  to 
OdDHL does not decrease IL-2 secretion in a 
anti-CD3/anti-CD28 antibody driven T cell 
stimulation assay. Considering the high structural 
diversity between PQS and OdDHL, these results 
suggest that PQS and OdDHL may have 
differential targets as immunomodulators. 
However, in this study we found that PQS and 
OdDHL seems to have almost similar effects on 
DCs with respect to changes in the cytokine 
profile of LPS-stimulated DCs and effect in a 
MLR, where the major difference between the 
two QSSMs is that OdDHL seems to have a more 
pronounced immunosuppressive effect than PQS. 
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Both PQS and OdDHL are hydrophobic 
molecules (predicted logP values are 3.6 and 1.9 
for OdDHL and PQS, respectively (23)) and as 
such they share their lipophilic properties with 
signaling compounds among members of Fungi, 
Plantae and Animalia (see review by (39)). This 
may facilitate binding to eukaryotic membranes 
and perhaps also uptake for PQS and OdDHL as 
well as for steroid hormones and other eukaryotic 
signal mediators. Uptake or sequestering of 
OdDHL could explain the observed decrease of 
OdDHL during incubation with murine BM-DCs 
and offer an alternative explanation to enzymatic 
degradation as the cause of the reduced OdDHL 
bioactivity during the experiment. 
The immune suppressive effect of OdDHL-
related compounds has been shown to be 
dependent on an 11-13 carbon side chain 
containing either a 3-oxo or a 3-hydroxy group 
and a high lipophilicity of the molecule (6). The 
possibility that the immuno-suppressive effect of 
OdDHL could involve insertion of the signal 
molecule within the lipid bilayer causing 
disruption of the association of molecules, 
including the TCR, within the plasma membrane, 
has recently been investigated, however, it seems 
more likely that the target of OdDHL is an (yet 
unknown) intracellular site (35). It appears that 
no matter the acyl chain length, AHLs (e.g. BHL, 
OdDHL and N-(3-oxooctanoyl)-L-homoserine 
lactone, OOHL) are able to cross the cell 
membrane of various cell lines and to function in 
mammalian cells (25, 36, 40, 47).  However, 
whether PQS is also capable of crossing the 
eukaryotic cell membrane remains to be 
elucidated.  
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A highly relevant issue is how OdDHL and PQS 
exert their immunomodulatory effects. The effect 
of PQS on eukaryotic cells is not nearly as well 
investigated as for OdDHL. Compounds sharing 
structural properties with PQS have been found 
to have immunosuppressive effects. For example, 
quercetin (4H-1-Benzopyran-4-one) has been 
shown to decrease superoxide production and 
Platelet Activating Factor (PAF) released by 
neutrophils via inhibition of phosphatidylinositol 
3-kinase (PI3K) and to decrease expression of the 
transcription factor nuclear factor κB (NF-κB) (4, 
38). The antibacterial fluoroquinolones also have  
been shown to possess immunomodulatory 
effects, e.g. ciprofloxacin has been shown to 
inhibit production of TNF-α and IL-12 after LPS 
challenge in an in vivo mouse model (32). 
Nevertheless, whether PQS works in the same 
manner as some of these structurally related 
compounds will require further investigations.   
NF-κB and Activator Protein-2 are both 
important factors for the maximal IL-8 
transcription induced by OdDHL (42). The 
authors also found that OdDHL by activation of 
NF-κB induces the expression of inducible 
cyclooxygenase (COX-2) (43). Interestingly, it 
has been suggested that COX-2 plays a dual role 
in the inflammatory processes; as mediator of a 
proinflammatory response in the early phase of 
an inflammation via conversion of arachidonic 
acid to precursors of the 2-series prostanoids e.g. 
PGE2 , and being involved in the resolution of the 
inflammation later by generating an alternative 
set of anti-inflammatory prostaglandins such as 
the anti-inflammatory cyclopentenone 
prostaglandins (14). These prostacyclins, such as 
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15deoxyΔ12-14prostaglandin J2 (15d-PGJ2), bind 
to and activate the peroxisome proliferator-
activated receptors which mediate anti-
inflammatory effects on several immune cells, 
including inhibition of the IL-2 production by T 
cells and down-regulation of DC maturation and 
IL-12 production by DCs (18, 52). The 
prostacyclin 15d-PGJ2 has also been shown to 
inhibit toll like receptor-mediated activation of 
DCs via the MAP kinase and NF-κB pathways 
(1). Thus, consistent with the above mentioned 
findings, one hypothesis for the 
immunomodulatory mechanism put forth by 
OdDHL could be that OdDHL induces COX-2 
expression which further generates either pro-
inflammatory prostaglandins which promote a 
TH1 dominated response as observed by (42, 43) 
or anti-inflammatory prostacyclins which merely 
gives a TH2 or anergy-like effect which would 
lead to impaired maturation of DCs, decreased 
IL-12 production and inhibition of IL-2 release 
from stimulated T cells.  
60 
65 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
70 
75 
80 
85 
90 
100 
105 
 
CONCLUSIONS  
We have investigated the effect of PQS, 
OdDHL and BHL on LPS-matured murine BM-
DCs and found that OdDHL and PQS, but not 
BHL decrease the production of IL-12 by 
murine BM-DCs without altering the IL-10 
release. OdDHL also inhibited LPS stimulated 
DCs’ expression of T cell stimulatory and 
maturation related surface markers. Murine 
BM-DCs exposed to PQS and OdDHL during 
antigen stimulation exhibit a decreased ability 
to induce specific T cell proliferation. These 
results suggest that the P. aeruginosa QSSMs 
OdDHL and PQS impede DCs in exerting their 
T cell stimulatory effects. As DCs are essential 
APCs and play an imperative role in the 
immune response, the immunosuppressive 
effect of these two signal molecules may 
facilitate establishment of P. aeruginosa 
infections. OdDHL and PQS may therefore be 
considered as modulators of the immune 
system along with their ability to mediate 
release of QS-controlled toxins and tissue 
degrading enzymes. The immunosuppressive 
effects of OdDHL and PQS may however also 
help to protect the host against excessive tissue 
destruction due to prolonged TH1 response 
during a chronic lung infection e.g. in CF 
patients. 
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